Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),0.6873618687464599,2.110785475336162,0.0,0.025983699666668737,0.022,16/29,17.65%,GRIA4;GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GABRB3;GRID1;GRIK1;GABRA5;CHRNB1;GLRA3;GABRB1;GABRG1;GABRG3;GABRG2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.8094849711325268,2.0794223218115233,0.0,0.01898808821795023,0.034,3/13,1.32%,BMP6;BMP2;BMP5
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.6670281132773209,2.034736862536374,0.0,0.023318704829061683,0.059,15/28,17.65%,GRID2;CHRNA1;GABRA2;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNA4;CHRNA7;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,ligand-gated channel activity (GO:0022834),0.6560231142266035,2.0306130038149925,0.0021008403361344537,0.01873824495192457,0.064,14/29,14.41%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;CHRNA4;GRIA3;CHRNB1;GRIN2A;GABRB1;GRIA1
prerank,ligand-gated ion channel activity (GO:0015276),0.650182661377473,2.020607385187249,0.0021141649048625794,0.01718921670256547,0.072,14/30,14.41%,GRIA4;GRID2;GRIN3A;CHRNB4;GRIK5;GRIK2;GRID1;GRIK1;CHRNA4;GRIA3;CHRNB1;GRIN2A;GABRB1;GRIA1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.770158201964964,2.0134765024730035,0.0,0.01582340684829186,0.078,5/15,9.48%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1;ALDH1L1
prerank,BMP receptor binding (GO:0070700),0.8094857907373804,2.003321275240376,0.0,0.016132736606228392,0.092,3/12,1.32%,BMP6;BMP2;BMP5
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.7078349621597677,1.980071932528315,0.0022123893805309734,0.01911300985096306,0.118,12/19,17.65%,GRID2;CHRNA1;GABRA2;GRIK5;GRIK2;GRID1;GRIK1;GABRA5;CHRNB1;GABRG1;GABRG3;GABRG2
prerank,cadherin binding (GO:0045296),-0.42730570211444097,-1.9736177084520297,0.0,0.054029577166904375,0.048,144/315,25.92%,DOCK9;PTPRB;PKP4;COBLL1;MRTFB;ITGA6;AHNAK;BSG;STXBP6;CDH1;NOTCH3;PTPRJ;PROM1;BAIAP2L1;TMOD3;SPTBN1;ESYT2;WASF2;RPL6;FNBP1L;RACK1;BMPR2;F11R;KDR;FXYD5;CTNNA1;IQGAP1;EEF2;EHD4;CLIC1;PLCB3;TJP2;ANXA1;DAB2IP;CD2AP;TRIM25;EPS8L2;HSP90AB1;PDLIM1;MPRIP;ARHGAP1;RPL14;ANXA2;PAICS;TES;HSPA8;SHTN1;ATXN2L;CAST;PTPRM;LRRFIP1;CDH4;CHMP2B;EZR;PKM;RPL23A;GIPC1;PFKP;HCFC1;RPL29;JUP;RPL34;EEF1D;NOP56;UBAP2;USP8;SPTAN1;PFN1;ADD1;CTNNA3;VCL;LDHA;ZC3H15;CDH6;TRPC4;HSPA5;SH3GLB2;RAB11B;DBNL;STK38;ACVR1;LASP1;DBN1;YWHAZ;PLIN3;ABI1;TAGLN2;RPL15;SLC3A2;EPN2;RAB1A;EGFR;HNRNPK;EPHA2;RPL24;STAT1;TXNDC9;PPFIBP1;IST1;HSPA1A;PCBP1;GIGYF2;CCS;EIF5;BZW2;RPS26;TBC1D2;EHD1;RANGAP1;CAPG;GLOD4;CCT8;CTTN;SERBP1;PACSIN2;NCK1;SFN;CDH5;PPP1CA;BZW1;PTPRO;STX5;DNAJB1;CNN3;PTPN1;ENO1;MYH9;RSL1D1;ARHGAP18;ANLN;NUMB;YWHAB;FSCN1;LRRC59;RPL7A;TJP1;EVPL;CIP2A;EPS15;YWHAE;EIF4H;UBFD1;RDX;PARK7
prerank,vinculin binding (GO:0017166),-0.8292213623099975,-1.9572892142028229,0.0,0.038020813561895676,0.064,6/11,6.60%,UTRN;SORBS3;DMD;PXN;CTNNA1;ACTN1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.7761286729783528,1.9449389076823598,0.0,0.029425984665244508,0.2,5/13,9.48%,ALDH1A1;ALDH1A2;ALDH4A1;ALDH7A1;ALDH1L1
prerank,glutamate receptor activity (GO:0008066),0.6985129812161601,1.9285890954130662,0.0,0.03397868417948988,0.246,9/19,14.41%,GRIA4;GRID2;GRIK5;GRIK2;GRM1;GRID1;GRIK1;GRM4;GRIA1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.705660598013164,1.8831124799069288,0.0022522522522522522,0.055056370622382,0.4,5/18,5.36%,ALDH1A1;ALDH1A2;AKR1B1;ALDH18A1;ALDH6A1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.6652176926105303,-1.8408812146264013,0.001937984496124031,0.13307284746663484,0.297,6/18,4.62%,STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;ANXA2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.515653331096056,-1.8308600692470445,0.0,0.11256161909771745,0.33,35/57,28.25%,COX4I1;NDUFV2;COX6B1;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;UQCRQ;COX15;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;CYBRD1;NDUFC1;NDUFA4;UQCR11;NDUFA3;COX10;UQCRH;NDUFA10;NDUFA4L2;NDUFB10;NDUFB3;COX8A;NDUFA7;NDUFA1;COX4I2;CYB561D2;NDUFA8
prerank,phospholipid transfer activity (GO:0120014),-0.6337025294729356,-1.8271221212131037,0.0,0.09545225299486439,0.348,8/21,14.03%,PITPNC1;CERT1;PLTP;TNFAIP8L3;PITPNA;PITPNM2;PRELID2;PITPNM1
prerank,lipase activator activity (GO:0060229),0.7617647585635852,1.8232020025490592,0.013245033112582781,0.10226917689317054,0.642,3/10,2.25%,ARHGAP6;APOH;PDPK1
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.646383198006261,1.8191889412516924,0.0021598272138228943,0.09832293453748317,0.655,8/21,13.02%,CHRNA1;P2RX4;CHRNB4;GRIK2;GLRB;CHRNA4;CHRNA7;CHRNB1
prerank,amino acid:sodium symporter activity (GO:0005283),0.76173678132015,1.8169797628293212,0.004395604395604396,0.09394106802564851,0.669,6/11,9.33%,SLC1A3;SLC6A12;SLC6A13;SLC38A1;SLC6A11;SLC6A1
prerank,protein phosphatase 1 binding (GO:0008157),-0.6351014050862808,-1.8159701542809543,0.0037313432835820895,0.09238390663723772,0.399,11/21,24.04%,PPP1R3B;PPP1R16B;SHOC2;KCNQ1;SH3RF2;PHACTR4;PPP1R3F;PPP1R3C;PPP1R16A;PPP1R3E;SMTNL2
prerank,double-stranded RNA binding (GO:0003725),-0.4852168577840478,-1.8016434677851016,0.0,0.09748193552335659,0.461,22/70,14.18%,VIM;MBNL1;IFIH1;STRBP;TFRC;HSP90AB1;MSN;ADAR;LRRFIP1;ACTN1;TLR3;DUS2;RC3H1;DHX15;DHX9;HSPD1;DHX58;ILF2;TUBB4B;FMR1;SLC3A2;EIF4A1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.7134876773279579,1.7992879240461155,0.006607929515418502,0.10446779763419635,0.738,2/14,0.06%,SLC7A11;SLC1A3
prerank,ephrin receptor activity (GO:0005003),0.6678173979254436,1.7849947730426199,0.006818181818181818,0.10699170450981244,0.781,8/17,12.88%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.6678173979254436,1.7849947730426199,0.006818181818181818,0.10699170450981244,0.781,8/17,12.88%,EPHA7;EPHA3;EPHA6;EFNA3;EPHB1;EPHA8;EPHA5;EPHA1
prerank,voltage-gated calcium channel activity (GO:0005245),0.5595564121387006,1.7820383989534643,0.00816326530612245,0.10393479866667493,0.788,9/37,8.22%,CACNA2D3;CACNA1E;CACNA2D1;CACNA1I;CACNG4;CACNA1G;CACNB4;CACNB2;CACNB1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.6181553590280198,1.7554345691465003,0.00423728813559322,0.12707817488799933,0.87,8/21,14.41%,CHRNA1;CHRNB4;GRM1;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1;GRIA1
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.548635895362568,-1.740276666084073,0.001893939393939394,0.16008763605008702,0.712,22/34,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.548635895362568,-1.740276666084073,0.001893939393939394,0.16008763605008702,0.712,22/34,25.74%,NDUFV2;NDUFB2;NDUFB8;NDUFB4;NDUFS4;NDUFA13;NDUFB7;NDUFS2;NDUFA12;NDUFB5;NDUFA9;NDUFB9;NDUFS3;NDUFS6;NDUFC1;NDUFA4;NDUFA3;NDUFA10;NDUFB10;NDUFB3;NDUFA7;NDUFA1
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.715760553954659,-1.7351408567471605,0.008976660682226212,0.15118276129480093,0.731,6/11,18.52%,MAP3K5;MAP3K1;MAP3K20;TAOK2;EGFR;MAP3K6
prerank,GABA-A receptor activity (GO:0004890),0.6347573279187219,1.7181980481736923,0.0043859649122807015,0.16819448668847492,0.937,9/18,17.65%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.7219151462516289,-1.7143421366932596,0.0018450184501845018,0.1737314686679922,0.816,4/10,1.27%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1
prerank,GABA receptor activity (GO:0016917),0.6080741863789941,1.7139839138009438,0.0022471910112359553,0.1669904800921989,0.943,10/21,18.35%,GABRA2;GABRR3;GABRB3;GABRR2;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2;GPR156
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.729086560050535,1.7126471712865614,0.020454545454545454,0.16139874985257696,0.944,5/10,9.33%,SLC6A12;SLC6A13;SLC10A1;SLC6A11;SLC6A1
prerank,rRNA binding (GO:0019843),-0.5060713691151149,-1.7092401152268544,0.0018450184501845018,0.16842553376102906,0.836,21/42,23.22%,RPS14;RPS9;RPS3;RPL11;RPL23;RPS5;CAVIN1;RPS13;PTCD3;ERI1;RPL12;CIRBP;PPAN;ERAL1;MRPL16;EMG1;MRPS18C;MRPS18A;RPL5;MRPS6;MRPL11
prerank,calcium:sodium antiporter activity (GO:0005432),0.7242032182302726,1.7016300285588999,0.021176470588235293,0.16889404783334677,0.957,5/10,8.94%,SLC24A3;SLC8A1;SLC24A5;SLC24A4;SLC24A2
prerank,acetylcholine receptor activity (GO:0015464),0.5893420584076217,1.694800412722974,0.008583690987124463,0.1718505264813171,0.968,8/22,13.02%,CHRNA1;CHRNB4;CHRM2;CHRM3;CHRNA4;CHRNA7;CHRFAM7A;CHRNB1
prerank,hexosaminidase activity (GO:0015929),0.682651329234416,1.6828226101719614,0.016877637130801686,0.18188589766668115,0.976,3/12,1.32%,CEMIP;SPAM1;HYAL3
prerank,ligand-gated anion channel activity (GO:0099095),0.6218368128525497,1.666639070180188,0.011235955056179775,0.2004511742036649,0.985,9/17,17.65%,GABRA2;GLRB;GABRB3;GABRA5;GLRA3;GABRB1;GABRG1;GABRG3;GABRG2
prerank,MHC class II protein complex binding (GO:0023026),-0.686396001205151,-1.6613667731136132,0.007054673721340388,0.2554475307933841,0.943,9/11,25.60%,HSP90AB1;HSPA8;CD81;PKM;ATP1B1;CD74;HSP90AA1;ANXA11;YWHAE
prerank,CARD domain binding (GO:0050700),-0.6382872241625825,-1.6484966822331153,0.013358778625954198,0.2676465165212393,0.961,11/14,29.98%,NOD1;CARD14;CARD19;MAVS;NOD2;CASP1;CARD16;BCL10;CARD10;CARD11;IRGM
prerank,protein phosphatase binding (GO:0019903),-0.4062257406681639,-1.6394580783735089,0.002,0.2723490908302106,0.97,43/117,18.75%,MAP3K5;ITGA1;CTTNBP2NL;PXN;RACK1;FOXO1;IQGAP1;PTK2;PPP1R3B;PPP1R16B;SHOC2;DAB2IP;CDKN1B;AP3B1;MFHAS1;KCNQ1;SH3RF2;JUP;FLT4;STRN4;VRK3;PHACTR4;PPP1R3F;VCP;PPP3CB;FBXL2;EGFR;ERBB2;STRN;PPP1R3C;MET;STRN3;ANAPC7;CDC27;PIK3R2;IGBP1;BAD;GTF2F1;JAK3;BOD1;PPP1R16A;PPP6R3;SMG7
prerank,receptor ligand activity (GO:0048018),0.3703745577460851,1.6379327531933574,0.0019120458891013384,0.24292168221132035,0.994,24/245,5.86%,GREM2;IGF1;BMP6;EPHA7;WNT4;BMP2;IL34;AREG;PTN;SEMA5A;NRG3;GPHB5;BMP5;NRG1;GDNF;VEGFB;SEMA3A;ARTN;TGFA;SEMA3D;IL4;FAM3D;TAFA2;TAFA5
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.4791629310870377,1.6298814539441693,0.006147540983606557,0.24912942812273048,0.996,21/53,15.99%,SLC7A11;SLC1A3;SLC6A9;SLC43A1;SLC7A2;SLC38A1;SLC36A2;SLC7A9;SLC25A13;SLC1A5;SLC38A3;CTNS;SLC38A9;SLC25A15;OCA2;SLC1A2;SLC38A6;SLC7A3;SLC1A7;SLC3A1;SLC25A18
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6424386559991563,1.6261547616333292,0.02320185614849188,0.2469485302537774,0.998,7/12,17.29%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;B4GAT1;B3GNT6
prerank,poly-purine tract binding (GO:0070717),0.543496966223838,1.618397895142776,0.008298755186721992,0.2519086370248064,1.0,7/27,10.47%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.6782511691031441,1.6141052790715495,0.03524229074889868,0.2511650174975386,1.0,5/11,13.02%,CHRNA1;CHRNB4;CHRNA4;CHRNA7;CHRNB1
prerank,poly-pyrimidine tract binding (GO:0008187),0.5629337704756424,1.6100084479965546,0.034013605442176874,0.2504678741907251,1.0,7/23,10.47%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.4994098297967238,-1.6063752904861217,0.015594541910331383,0.3464396498896415,0.99,11/34,10.94%,CYTH3;PARD3;ARAP3;IQGAP1;FERMT2;ARAP2;HIP1R;JPH2;AKT1;MAPKAP1;KIF16B
prerank,low-density lipoprotein particle binding (GO:0030169),-0.6013671141183794,-1.6034949337034434,0.010619469026548672,0.3351246322313219,0.991,5/16,4.25%,PLTP;THBS1;SCARB1;SCARF1;STAB1
prerank,"DNA binding, bending (GO:0008301)",-0.6212294043210347,-1.600920847132819,0.016333938294010888,0.324066291031947,0.992,5/14,16.39%,LEF1;FOXD1;HHEX;TOP2A;SAP30L
prerank,ligand-gated cation channel activity (GO:0099094),0.4286683077819601,1.5941978480067558,0.011928429423459244,0.2717386213391825,1.0,26/75,17.81%,GRIA4;CHRNA1;GRIN3A;P2RX4;CCDC51;CHRNB4;GRIK5;GRIK2;TRPM5;KCNJ16;KCNJ3;ASIC2;GRIK1;KCNJ5;CHRNA4;GRIA3;KCNJ14;CHRNA7;CHRNB1;GRIN2A;GRIA1;KCNJ6;KCNN1;KCNJ9;GRIN2B;ASIC4
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.475702881647091,-1.5896534744361732,0.007736943907156673,0.3387117352217631,0.995,10/42,4.96%,ESAM;BSG;STXBP6;BAIAP2L1;TMOD3;ANXA1;PDLIM1;JAM3;ANXA2;ROBO4
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.6586156261827171,-1.5854405263064704,0.01818181818181818,0.33473324150347883,0.996,3/11,10.12%,SGMS1;SGMS2;PIGF
prerank,phospholipase activator activity (GO:0016004),0.6749098773896152,1.5818865750086732,0.040632054176072234,0.28602644961125956,1.0,2/10,2.25%,ARHGAP6;PDPK1
prerank,poly(U) RNA binding (GO:0008266),0.5749823378207636,1.5794113356284818,0.04367816091954023,0.2830224517538687,1.0,7/20,10.47%,RBMS3;ATXN1;RBMS1;DAZAP1;PABPC1L;KHDRBS1;PNPT1
prerank,phosphatidylinositol binding (GO:0035091),-0.4045121545201028,-1.577903472938758,0.0038684719535783366,0.3411391292019712,0.997,26/91,15.71%,PITPNC1;ITPR2;MCF2L;ESYT2;PARD3;SCARB1;SNX11;DENND1A;TNFAIP8L3;ITPR3;BCAS3;EEA1;HIP1R;DENND1B;PITPNA;AIDA;MREG;HIP1;PITPNM2;RPH3A;FCHO2;MITD1;PHF12;PITPNM1;MTM1;ESYT3
prerank,FAD binding (GO:0071949),0.5373824167715882,1.5762651329775288,0.022774327122153208,0.28187872480272896,1.0,8/24,10.68%,MICAL3;KDM1B;PRODH;CYB5R2;KMO;DDO;CRY1;MICAL1
prerank,Wnt-activated receptor activity (GO:0042813),-0.6046978434255024,-1.5739864276787612,0.01981981981981982,0.3365933506837199,0.997,6/15,8.56%,LRP5;FZD6;FZD4;PKD1;FZD3;FZD7
prerank,GABA-gated chloride ion channel activity (GO:0022851),0.6431888083030846,1.5694700951870633,0.04439252336448598,0.28709017022559463,1.0,8/12,21.66%,GABRA2;GABRB3;GABRA5;GABRB1;GABRG1;GABRG3;GABRG2;GABRB2
prerank,disordered domain specific binding (GO:0097718),-0.5358196633439278,-1.5688151332380424,0.018867924528301886,0.3374890979555911,0.998,11/23,18.21%,FN1;HSP90AB1;CALM1;GAPDH;RB1;TEAD2;CALM3;FKBP8;HSP90AA1;HSPA1A;SMAD2
prerank,LRR domain binding (GO:0030275),0.5949664798172412,1.564717338442374,0.049783549783549784,0.2885032240317369,1.0,3/14,4.39%,ROBO1;PAWR;PMF1
prerank,aspartic-type peptidase activity (GO:0070001),-0.656703722709981,-1.5612282926515189,0.03935599284436494,0.34473038085889834,0.998,3/10,8.59%,BACE2;BACE1;CTSD
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.6273193124555019,1.5610779861930428,0.03233256351039261,0.2878706923622846,1.0,7/13,17.65%,GABRA2;GLRB;GABRA5;GLRA3;GABRG1;GABRG3;GABRG2
prerank,histone methyltransferase binding (GO:1990226),-0.6483273252336819,-1.5609420298145866,0.03302752293577982,0.3315414942597303,0.998,5/11,13.35%,HSP90AB1;PRDM4;CBX1;NOP56;LCOR
prerank,phospholipase binding (GO:0043274),0.6238572841367993,1.5599956788720981,0.05592841163310962,0.2825227652218174,1.0,3/13,5.39%,ARHGAP6;PDPK1;PRKN
prerank,sodium channel activity (GO:0005272),0.47625725827394794,1.5580184281763407,0.030800821355236138,0.27887383479020356,1.0,9/37,7.76%,SCN7A;GRIK5;GRIK2;SCN3A;CACNA1I;ASIC2;SCN2A;CACNA1G;GRIK1
prerank,protein phosphatase activator activity (GO:0072542),-0.6285119844035686,-1.5524704597651942,0.0285204991087344,0.3422258046618808,1.0,6/13,17.33%,CALM1;IGFBP3;PPP2R5A;PHACTR4;CALM3;PPP2R5E
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.36606334253212547,-1.552076170631297,0.0,0.3305883799080617,1.0,53/147,20.92%,DOCK9;RAPGEF5;CYTH3;PLCE1;FGD5;ARHGEF28;RAP1A;DOCK1;RIN3;RASGRF2;RAPGEF1;RGL1;ARHGEF15;DENND1A;EPS8L2;DOCK4;FGD6;DENND1B;SPATA13;BCR;NUCB1;EEF1D;DENND3;DENND6A;ITSN1;HERC2;PREX1;EEF1B2;ABR;DENND2C;ARHGEF5;ARHGEF18;LAMTOR2;RGL2;MADD;EIF2B3;HPS1;DENND5B;RAPGEF3;CYTH2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;RAB3GAP2;RASGRP4;ARHGEF6;RCC1;FGD2;DNMBP;CYTH4;RINL;RAPGEF2
prerank,actin monomer binding (GO:0003785),-0.537801207022294,-1.5506850201002247,0.03669724770642202,0.32292677834478495,1.0,8/22,14.24%,TMSB4X;NOS3;COBL;PFN1;TMSB10;ABL2;PRKCE;MRTFA
prerank,insulin-like growth factor receptor binding (GO:0005159),0.633500012532645,1.549901912715013,0.0367816091954023,0.2866773018168727,1.0,2/12,0.26%,IGF1;PIK3R1
prerank,neurexin family protein binding (GO:0042043),0.6624092187841317,1.5485627080452973,0.07439824945295405,0.28238099369411906,1.0,5/10,7.71%,SYTL5;NLGN2;NLGN3;SYTL2;NLGN1
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.5764706300663385,-1.5462622461681763,0.028933092224231464,0.3238669481901222,1.0,7/17,10.27%,PITPNC1;ATP10A;PLTP;ATP8B1;PITPNA;ABCG1;PITPNM2
prerank,calcium channel activity (GO:0005262),0.4097707610822031,1.5412521995249215,0.011928429423459244,0.2890686587916897,1.0,16/84,8.94%,CACNA2D3;SLC24A3;CACNA1E;SLC24A5;CACNA2D1;P2RX4;TRPM1;ORAI2;CACNA1I;TRPM5;CACNG4;CACNB4;CACNB2;CACNB1;SLC24A4;SLC24A2
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.6002574948504339,-1.5387460374478528,0.04275092936802974,0.33308233775671237,1.0,6/13,22.73%,KCNQ1;EZR;PRKAR2B;PRKAR2A;SOX9;CSK
prerank,tropomyosin binding (GO:0005523),-0.5890618093353905,-1.5331984842859674,0.04066543438077634,0.3362808629044066,1.0,5/16,9.78%,NEBL;TMOD3;LMOD1;TMOD1;S100A6
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.43593333328611167,1.532361375694524,0.024539877300613498,0.2989235876182575,1.0,26/60,12.88%,EPHA7;NRP1;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;ROR1;EPHA1
prerank,glycerophospholipid flippase activity (GO:0140333),-0.6260855726325658,-1.529571162446592,0.047619047619047616,0.3354961591440301,1.0,5/11,4.97%,ATP10A;ATP8B1;ATP8A1;ATP11C;ATP11A
prerank,acylglycerol lipase activity (GO:0047372),-0.6216632609623964,-1.5276603610513053,0.05025996533795494,0.32981691381682704,1.0,3/11,13.79%,ABHD2;MGLL;FAAH
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.5922114054789951,1.518291619022246,0.0640176600441501,0.317974438395789,1.0,2/15,2.58%,PLA2G5;PLA2G4A
prerank,phosphate ion binding (GO:0042301),-0.6537135568431012,-1.5166440962649725,0.03169014084507042,0.34857317077450023,1.0,5/10,19.73%,PDE2A;ADSS2;RPH3A;RELA;ADSS1
prerank,insulin-like growth factor binding (GO:0005520),-0.5873751154991687,-1.5130511682507888,0.027726432532347505,0.3482191954868054,1.0,8/15,8.53%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGF2R;IGFBP3;INSR
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.43538244597683007,1.5121127774129282,0.02268041237113402,0.3232652913521807,1.0,25/60,12.88%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;EPHA6;DDR1;AXL;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;MST1R;MERTK;FGFR1;ROR1;EPHA1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.5837173680146996,1.5115378182986168,0.04932735426008968,0.3178006343846407,1.0,5/15,13.92%,P2RY13;P2RX4;GPR171;P2RY1;GPR34
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5578640299001605,1.5041439462012793,0.04967602591792657,0.32457189677815246,1.0,9/17,17.49%,GRIA4;GRIN3A;GRIK5;GRIK2;GRIK1;GRIA3;GRIN2A;GRIA1;GRIN2B
prerank,BMP binding (GO:0036122),0.617884268658435,1.5032764188832697,0.10022779043280182,0.319779393051564,1.0,1/11,0.03%,GREM2
prerank,chemorepellent activity (GO:0045499),0.5062964234860682,1.4998927185728754,0.04487179487179487,0.3205440114233538,1.0,6/25,4.77%,EPHA7;SEMA5A;NRG3;NRG1;SEMA3A;SEMA3D
prerank,outward rectifier potassium channel activity (GO:0015271),0.6411115326788938,1.4995804817566052,0.05517241379310345,0.3148986087561888,1.0,4/11,8.58%,KCNK2;KCNT2;KCND2;KCND1
prerank,lipoprotein particle binding (GO:0071813),-0.5233104693915291,-1.4934906384373425,0.03893805309734513,0.3944937336970374,1.0,6/20,10.02%,PLTP;THBS1;SCARB1;SCARF1;STAB1;HSPD1
prerank,SH3 domain binding (GO:0017124),-0.4097959640180025,-1.482757789238431,0.025096525096525095,0.41587630993484603,1.0,21/62,20.37%,AFAP1L1;SHANK3;AFAP1L2;WASF2;ARHGAP27;DAB2IP;CD2AP;ADAM15;CRK;ABI3;GPX1;SGIP1;RUFY1;ABI1;PTPN12;RAD9A;SYNJ1;CABYR;WIPF1;SHANK1;DNM2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6150013597090535,-1.478960125035413,0.04895104895104895,0.4165174859665011,1.0,3/11,9.91%,PPP1R1A;PABIR1;PPP1R8
prerank,metalloendopeptidase activity (GO:0004222),0.39919281902045534,1.477105308435287,0.017057569296375266,0.35221300876176004,1.0,14/76,12.01%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;MMP11;ECE2;EEF1AKMT4-ECE2;THOP1;ADAMTS9;ADAMTSL4
prerank,ubiquitin-like protein ligase binding (GO:0044389),-0.3274012564540243,-1.4754400222340078,0.002061855670103093,0.416407439219385,1.0,90/269,21.43%,ACTG1;NFKBIA;FZD6;FOXO1;NLK;GPI;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;MID1;RPL23;MFHAS1;UBB;HSPA8;RALB;PRR5L;PPARGC1A;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;CCDC50;UBE2L6;CKB;DNAJA1;CAMLG;TRIM28;VCL;OTUB1;ARRDC1;ATP6V0C;TRIB1;RB1;HERC2;ERLIN2;DDRGK1;HSPD1;UCHL1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;ITCH;FAF2;TRAF1;MAP1LC3A;CCT2;SUMO3;RNF20;SLF1;RBX1;UBE2G1;TSG101;RAD18;EGFR;LAPTM4B;CDKN1A;STAT1;AMBRA1;HSP90AA1;HSPA1A;PRKAR2A;RELA;CUL1;SMAD2;HSPA9;CDK5RAP3;SKI;CASC3;ELOB;LAPTM5;LTBR;TMBIM6;UBE2B;RPL5;FZD5;RRAGA;TRIB3;HSPA1B
prerank,nuclear receptor coactivator activity (GO:0030374),-0.4224106996200644,-1.4739667016730995,0.03102189781021898,0.4104246769234106,1.0,21/52,22.76%,ACTN4;ETS1;PPARGC1B;PPARGC1A;DCAF6;TACC1;ACTN1;MED24;ENY2;FGF2;ZMIZ2;SS18;CCAR2;KDM1A;MED14;USP22;SRA1;HELZ2;SFR1;MED13;RBM14
prerank,ubiquitin protein ligase binding (GO:0031625),-0.3296903285629152,-1.4731621492941855,0.002053388090349076,0.4026838540339156,1.0,85/254,21.43%,ACTG1;NFKBIA;FZD6;FOXO1;NLK;GPI;FZD4;SMAD7;MAP1LC3B;HSP90AB1;RPL11;MID1;RPL23;MFHAS1;UBB;HSPA8;RALB;PRR5L;PPARGC1A;UBC;RPS27A;SMAD6;GABARAP;PRKAR2B;USP7;CASP8;TNFRSF1B;RIPK1;TRIB2;CUL4A;CCDC50;UBE2L6;CKB;DNAJA1;CAMLG;TRIM28;VCL;OTUB1;ARRDC1;ATP6V0C;TRIB1;RB1;HERC2;ERLIN2;HSPD1;UCHL1;VCP;BAG5;HSPA5;UBXN1;NDUFS2;YWHAZ;FAF2;TRAF1;MAP1LC3A;CCT2;RNF20;SLF1;RBX1;UBE2G1;TSG101;RAD18;EGFR;LAPTM4B;CDKN1A;AMBRA1;HSP90AA1;HSPA1A;PRKAR2A;RELA;CUL1;SMAD2;HSPA9;SKI;CASC3;ELOB;LAPTM5;LTBR;TMBIM6;UBE2B;RPL5;FZD5;RRAGA;TRIB3;HSPA1B
prerank,G protein-coupled amine receptor activity (GO:0008227),0.5139169423392675,1.4689470788925492,0.06535947712418301,0.34833505068249115,1.0,7/22,12.43%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.5139169423392675,1.4689470788925492,0.06535947712418301,0.34833505068249115,1.0,7/22,12.43%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,serotonin receptor activity (GO:0099589),0.5139169423392675,1.4689470788925492,0.06535947712418301,0.34833505068249115,1.0,7/22,12.43%,HTR7;CHRM2;CHRM3;HRH1;HRH2;HTR4;HTR5A
prerank,translation elongation factor activity (GO:0003746),-0.5714402759476176,-1.4680568796695117,0.0661625708884688,0.4079852462788379,1.0,5/14,12.70%,EEF1A1;EEF2;EEFSEC;EEF1B2;TSFM
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5869505023345967,-1.4623181654887285,0.05860805860805861,0.41494808338389566,1.0,6/13,17.60%,SH3BP4;ARHGDIA;ARHGDIB;GDI1;GDI2;EIF5
prerank,leak channel activity (GO:0022840),0.5361048339359815,1.461585035880693,0.07172131147540983,0.35626773092220565,1.0,2/18,0.55%,KCNK2;NALCN
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.5960378031169538,-1.4598226395647051,0.06457564575645756,0.4124303203182427,1.0,6/11,10.93%,ITPR2;TRPC3;ITPR3;TRPC6;RPH3A;TRPC4
prerank,actin binding (GO:0003779),-0.3413210364691309,-1.4563921665370139,0.011834319526627219,0.4130705697970163,1.0,41/170,12.59%,UTRN;ABLIM1;TMSB4X;MYRIP;SYNE1;NOS3;SORBS1;PARVB;DMD;COBL;EPS8;ACTN4;FXYD5;PTK2;FERMT2;EPS8L2;PDLIM1;SSH2;MICAL2;KLHL2;EZR;GIPC1;FLII;CAP1;TMOD1;PFN1;TMSB10;ADD1;VCL;SYNPO;SPEF1;PHACTR4;TRPV4;MAEA;ABL2;FHDC1;MLPH;DBNL;DBN1;PRKCE;BCL7B
prerank,CoA-ligase activity (GO:0016405),0.5718293432052037,1.454780238179059,0.0957683741648107,0.36330656994145244,1.0,2/14,4.21%,ACSS3;ACSL1
prerank,organic cation transmembrane transporter activity (GO:0015101),0.5608629693354301,1.4527914981016927,0.1032258064516129,0.36129877046287096,1.0,4/16,9.41%,SLC22A4;SLC22A3;SLC25A42;SLC44A1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.5382361230717492,1.4473450635944785,0.08968609865470852,0.3662702279936189,1.0,5/18,9.35%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,poly(A) binding (GO:0008143),0.5211284481304652,1.4424028846031205,0.08403361344537816,0.37057080880225735,1.0,4/21,7.13%,RBMS3;RBMS1;PABPC1L;KHDRBS1
prerank,phosphatidylglycerol binding (GO:1901611),-0.5900377795147945,-1.4389425471797848,0.07706422018348624,0.4530958623042613,1.0,3/13,6.89%,PITPNC1;PLTP;PITPNA
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",-0.5863005205812286,-1.4332136648981577,0.08680555555555555,0.461444095614586,1.0,9/12,31.66%,FXN;ISCA2;SDHB;ISCA1;AOX1;CIAPIN1;CISD3;XDH;CISD1
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.5538055558791897,-1.4322145786599616,0.06486486486486487,0.45483232013188785,1.0,4/15,7.32%,SLC26A7;SLC26A2;SLC39A8;SLC4A8
prerank,active ion transmembrane transporter activity (GO:0022853),-0.4446754419686655,-1.4308280588923281,0.05523809523809524,0.4497359928575468,1.0,16/37,20.84%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;COX4I1;COX6B1;UQCRQ;COX15;SLC22A6;NDUFA4;UQCR11;SLCO4A1;COX10;UQCRH;NDUFA4L2
prerank,nucleosomal DNA binding (GO:0031492),-0.4975010518523495,-1.42981170071608,0.05776173285198556,0.44354280663127243,1.0,10/21,22.69%,ACTB;H3-3A;MTA2;MBD3;SMARCA4;GATAD2B;RBBP4;CHD4;RCC1;SMARCC1
prerank,gated channel activity (GO:0022836),-0.5706763547851376,-1.428962167653386,0.07473309608540925,0.4373766860417451,1.0,6/14,17.42%,PIEZO2;PIEZO1;TMC6;PACC1;TMEM266;TMEM63B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.4812925084799959,-1.427162148992483,0.06099815157116451,0.4340068171569427,1.0,4/23,3.36%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6001994557721019,-1.4213138087100996,0.08286252354048965,0.44209106851662006,1.0,2/10,4.27%,MECOM;PRDM16
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.60416719486416,-1.4212990809404322,0.07308377896613191,0.43392272553900335,1.0,5/10,19.17%,CXADR;JUP;DSG2;DSP;CD200
prerank,voltage-gated sodium channel activity (GO:0005248),0.49901664276598984,1.4210593247879684,0.07692307692307693,0.40858239401409374,1.0,6/22,7.51%,SCN7A;SCN3B;SCN3A;CACNA1I;SCN2A;CACNA1G
prerank,nucleotidyltransferase activity (GO:0016779),0.5051051228259356,1.420309059218354,0.09090909090909091,0.40384189628452544,1.0,11/19,26.29%,TUT4;CRPPA;PAPSS1;YRDC;PNPT1;PAPSS2;TENT4A;TENT2;MTPAP;REV1;TENT4B
prerank,insulin-like growth factor I binding (GO:0031994),-0.5695470670806414,-1.4170762651131383,0.06914893617021277,0.4372939312922718,1.0,7/13,8.53%,IGF1R;ITGA6;IGFBP6;ITGB4;IGFBP5;IGFBP3;INSR
prerank,phospholipase inhibitor activity (GO:0004859),-0.6026517268813049,-1.4157729528844258,0.09009009009009009,0.43295129428188717,1.0,3/10,7.31%,ANXA1;ANXA2;ANXA4
prerank,sulfuric ester hydrolase activity (GO:0008484),0.5926723599324732,1.4142689089958131,0.11162790697674418,0.41050810128428755,1.0,4/12,6.02%,SULF1;SULF2;GNS;GALNS
prerank,phosphatidic acid binding (GO:0070300),-0.5104223795898759,-1.4137871950337275,0.08424908424908426,0.43121851614105683,1.0,8/19,20.92%,PITPNC1;PLTP;JPH2;MAPKAP1;PITPNM1;OPA1;PACSIN2;RAPGEF2
prerank,MHC class I protein binding (GO:0042288),-0.5596578396164293,-1.410714106065751,0.08711433756805807,0.43265063708364043,1.0,7/13,29.76%,ATP5F1A;TAPBP;ATP5F1B;TUBB4B;TAP2;LILRB1;DERL1
prerank,semaphorin receptor activity (GO:0017154),0.581327544973045,1.4075990995105212,0.12268518518518519,0.4181530649907631,1.0,2/11,0.36%,PLXNA2;NRP1
prerank,GTP binding (GO:0005525),-0.32871419336782165,-1.4071137052298068,0.021653543307086614,0.4344072971460836,1.0,56/172,25.43%,RAP1A;EEF1A1;RHOJ;RAP1B;RASL12;TGM2;GBP5;GCH1;TUBA1A;RAB27A;MFHAS1;RAC1;RALB;ADSS2;REM1;GBP7;KRAS;ATL3;RIT1;ARF5;INSR;ATL2;RHOT1;RAB8A;RHOB;RHOT2;RAB11B;RAB7A;TUBD1;TUBB4B;RAB4A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;RAB32;ARL8B;ADSS1;DNM2;RND2;RRAGA;ARL4C;TUBE1;TUBA4A;RRAGC;NRAS;NMUR2;NME1;CDC42;TSR1;RNF112;ARL3
prerank,retinoid binding (GO:0005501),0.49578644474718037,1.4035616933251094,0.09911894273127753,0.4208723381323179,1.0,3/22,3.53%,ALDH1A2;NR2F2;ABCA4
prerank,anion transmembrane transporter activity (GO:0008509),-0.5654070490979312,-1.401905268942186,0.0990990990990991,0.44159173856691203,1.0,5/12,14.43%,ABCG2;SLCO2B1;SLC39A8;SLC4A2;SLC22A6
prerank,RNA binding (GO:0003723),-0.27083501806986265,-1.3989662463423516,0.0,0.4427505696618852,1.0,449/1321,27.71%,MSI2;TMSB4X;AHNAK;SORBS2;SYNE1;EEF1A1;TPT1;SPTBN1;DDX5;RPS16;RPS14;RPL41;VIM;NOVA2;RPL6;RPL26;RPL19;MBNL1;RPS11;RACK1;RPSA;IFIH1;RPS12;STRBP;ACTN4;RPS23;RPL13;CTNNA1;RPS25;EEF2;RPS15;NOP14;RPL28;TFRC;RPL30;RPS21;RPS4X;RPS27;RPL27A;RPS9;RPL10;LARP1B;RPS3;HNRNPA2B1;RPL37A;RPL38;LBR;RPL39;TRIM25;MAP3K20;HSP90AB1;KMT2C;DDX17;RPL11;MAP4;HNRNPLL;FAU;RBM20;CNBP;RPL18A;DHX32;RPS28;RPS8;RPL32;MSN;RPS10;ADAR;RPL23;RPL17;RPL14;RPS15A;EIF4G3;ANXA2;TES;HSPA8;QKI;PPARGC1B;RPS5;PPIA;CAVIN1;SARS1;RPL21;EIF5B;ATXN2L;PPARGC1A;CAST;RPS24;UBC;RPS27A;PEBP1;RPL18;PRPF8;DIAPH1;LRRFIP1;RPS13;SRSF2;RPS19;MTREX;RPL35;SRSF5;ATP5F1A;PTBP3;RPL27;DDX55;LTA4H;ACAA2;RBFOX2;SNRPA;PCDHGA9;SNRPC;EZR;PTCD3;PKM;ANP32A;ACTN1;RPL23A;N4BP1;ZNF326;PRKDC;SAFB;ERI1;TLR3;PSMA6;SRPK1;HSPB1;FAM120A;ISY1;DUS2;RPL29;RPL34;CMSS1;RPL31;NOP56;RPL35A;ISG20L2;UBAP2;YBX3;DDX41;THUMPD1;RC3H1;RPL8;HDGF;SRSF6;DHX15;YY1;NMD3;RPS18;CARS1;RBM47;RPL22L1;FUS;NOP2;RBM22;NCL;DHX9;PCBP4;PFN1;TNS1;TRMT9B;ADD1;ACO1;TRIM28;SNRPD3;TDRD7;MRPL28;IFIT1;RPL12;PPP1R8;JMJD6;RPS20;U2AF1;ZC3H8;HSPD1;RPL13A;CAPRIN1;ZC3H15;SEC63;UTP14A;VCP;LUC7L2;RPS27L;HNRNPDL;PELP1;DHX58;EIF3D;PES1;DHX37;ILF2;LARP4B;SFPQ;YTHDF2;PDAP1;FAM133B;ZC3H18;FNDC3A;EIF3I;CIRBP;RPL10A;NELFE;STAU1;TUBB4B;FAM98A;TRIM56;ZC3H11A;YWHAZ;RCC2;RPS7;RBMS2;SARS2;MRPL43;NUDT4;RPL36;TSFM;RNPS1;RPS6;RPL3;DKC1;FMR1;PPAN;MRPL32;MRPL14;RBM6;BTF3;RPL15;DHX40;RBM42;NUFIP2;SRSF4;SLC3A2;SEC61B;PEF1;S100A16;SAMHD1;MAGOH;RPP38;EIF4A1;TRMT10C;RBM4B;DDX23;MRPS30;RPL22;URB1;CHTOP;FARS2;SRF;GDI2;PURG;DYNC1LI1;HNRNPK;ERAL1;TOP2A;RBM45;HMGN2;YWHAG;ALYREF;AGFG1;CDK13;PNO1;RPL24;EFTUD2;SRP19;TASOR;RPUSD4;MTHFSD;OAS2;LGALS1;DSP;ASCC3;PSMC1;SF3A3;HSP90AA1;ANKRD17;MRPL16;DDX51;EMG1;DDX20;MRM3;FASTKD3;NQO1;CCT3;DDX39B;HSPA1A;PCBP1;DUSP14;LSM14A;GIGYF2;CCAR2;GTF2F1;KDM1A;HNRNPA1;MCRS1;EIF5;NOSIP;DNM1;SPATS2;DCP1B;RPS26;HSD17B10;SCAF11;PPIG;HSPA9;PPIL4;PHF5A;DUSP11;SNRPG;SMG7;HSPE1;PNN;EXD1;LSM14B;LSM2;RANGAP1;CASC3;MRPL54;SRP68;CHERP;PRPF40A;PUM2;TRIP6;RPP21;SERBP1;RPL7;LSM1;NOL7;EDF1;SYNCRIP;PTCD2;LSM7;RBM7;STIP1;EIF1;KIF1C;HELZ2;ZCCHC7;UBA1;DDX10;PDIA4;CPNE3;RPL5;PSMA1;RBM19;CPSF4;FKBP4;ZC3H7A;UTP4;MEPCE;YTHDF1;LSM3;MKI67;TRMT6;TBRG4;BZW1;MEX3D;HSPA1B;SRRM2;AARS2;DDX49;ZCCHC3;ANXA11;EIF4G1;DDX39A;EIF4A2;NSA2;API5;PWP2;PHF6;NCBP2;PEG10;NOM1;RBM14;FDPS;LSM10;PTPN1;PPIB;TUFM;PYM1;MRPL13;KCTD12;MRPL11;ENO1;TBL3;MYH9;RTCB;ABT1;RSL1D1;ANXA7;NME1;WDR6;REPIN1;CCDC137;SMG1;CSTF2T;FSCN1;TSR1;LRRC59;DDX47;SNRPB;SF3A1;RPL7A;EIF4E;MRPL21;GANAB;ACIN1;EIF4B;DHX57;NSUN5;MRPS24;RPP25L;PABPC1;YWHAE;RBPMS2;EIF4H;UBFD1;RDX;MRPL2;UTP15;PARK7;PSIP1;MRPL42;FTSJ3;RPF2;ADAT1;FAM50A;KNOP1;NUP42;DNA2;SF3A2;CEBPZ;RO60;CLNS1A;RAD51AP1;TXN;TUBA1B;PRRC2A;GOLGB1;PDCD11;NTPCR;KIN;NPM1;ZRANB2;IBA57;RTRAF;TDRD9;NOCT;NUP98;DQX1;TSNAX;RBM25;MAZ
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.6019844563427286,1.398331810130537,0.11316397228637413,0.425941749530076,1.0,5/10,17.65%,GABRA2;GABRA5;GABRG1;GABRG3;GABRG2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.5291330063580285,-1.392206471353116,0.08021390374331551,0.454248667292122,1.0,4/16,7.32%,SLC26A7;SLC26A2;SLC1A1;SLC4A8
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.5712028558208196,1.3921160222168465,0.12938596491228072,0.4330812566614221,1.0,5/12,9.35%,LTBP1;TGFBR3;TGFBR3L;TGFBR1;BMPR1A
prerank,store-operated calcium channel activity (GO:0015279),-0.5835918302160714,-1.3898424651441907,0.09874326750448834,0.453486345215693,1.0,5/10,10.93%,TRPC3;STIM2;TRPC6;ORAI1;TRPC4
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.4457643524247844,-1.3897399635806618,0.07272727272727272,0.44663512444481807,1.0,10/31,21.93%,SLC12A7;SLC12A2;KCNK5;ABCC9;KCNK9;KCNA2;SLC12A5;SLC12A9;PKD2;ABCC8
prerank,acid-thiol ligase activity (GO:0016878),0.5506634126838825,1.3893833972335652,0.125,0.43268508575365766,1.0,2/13,4.21%,ACSS3;ACSL1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.5457750546981787,-1.389093878676486,0.11439114391143912,0.44156480074353816,1.0,6/14,13.28%,MINDY2;MINDY1;USP7;OTUD5;USP9X;USP15
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.46295578137308613,-1.3890279294825976,0.08442776735459662,0.43502602311489563,1.0,5/27,5.47%,SLC26A7;SLC26A2;ANO1;SLC22A8;SLC39A8
prerank,myosin binding (GO:0017022),-0.393037164536163,-1.3887922989357322,0.049429657794676805,0.42916030641860087,1.0,13/55,11.50%,SHROOM4;MYRIP;DMD;RAB11A;TRAK1;MYOC;GIPC1;TRAK2;RAB6B;RAB8A;LMTK2;MLPH;RAB11B
prerank,solute:anion antiporter activity (GO:0140323),0.5469837231818221,1.3882388503432963,0.13333333333333333,0.4292450077901441,1.0,2/14,5.34%,SLC7A11;SLC26A1
prerank,E-box binding (GO:0070888),0.4380657972393333,1.3781959793350425,0.10126582278481013,0.44521366221924813,1.0,7/34,11.53%,TCF4;ZEB1;MITF;HES3;ATOH8;GATA3;AHR
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5919699052752132,1.3779164354176745,0.13541666666666666,0.4396269869350421,1.0,3/11,9.52%,SLC22A4;SLC22A3;SLC25A47
prerank,single-stranded DNA binding (GO:0003697),0.36113369208063206,1.377057651332853,0.0486815415821501,0.4357129659067786,1.0,25/93,15.02%,RBMS1;DMC1;MCM3;STN1;JCHAIN;TOP1;RNF138;TOP3A;SETMAR;SWSAP1;POLR2G;RADX;BLM;FUBP1;RPA2;MCM2;MCM9;NUP35;MCM8;RAD51B;PMS2;SSBP2;MAPT;RPA1;SMC6
prerank,mRNA 5'-UTR binding (GO:0048027),-0.46253449443194533,-1.3728953713371024,0.09611829944547134,0.46393043792823935,1.0,10/24,23.58%,RPS14;RPL41;RPL26;RPS13;NCL;RPS7;FMR1;SYNCRIP;RPL5;RSL1D1
prerank,MHC protein binding (GO:0042287),-0.487912562501998,-1.3688789554593441,0.09737827715355805,0.4685753506632711,1.0,7/20,18.23%,CD81;ATP5F1A;TAPBP;ATP5F1B;CD74;TUBB4B;TAP2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3924194279465816,-1.367259169211821,0.0642570281124498,0.46674122031960197,1.0,11/48,10.66%,PIEZO2;SLC12A7;SLC12A2;TRPM7;ABCC9;TRPM6;PIEZO1;TMEM165;TRPC6;SLC39A1;TRPV4
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4089944386672837,1.3656612514643345,0.08298755186721991,0.4543906231729399,1.0,15/46,17.29%,B3GALT1;B3GALNT1;MGAT4C;B3GNT7;B3GLCT;MGAT3;B3GALT2;PIGP;EXTL1;B3GALT5;MGAT2;MGAT5B;EXTL2;B4GAT1;B3GNT6
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4085984086792009,1.3609099353029295,0.08547008547008547,0.4589654109326861,1.0,12/47,11.88%,SLC7A11;SLC43A1;SLC7A2;SLC6A13;SLC22A4;SLC38A1;SLC36A2;SLC7A9;SLC6A1;SLC1A5;SLC38A3;SLC38A9
prerank,protein kinase binding (GO:0019901),-0.28232875557023807,-1.3496083971948398,0.004329004329004329,0.5107584754400841,1.0,119/479,17.09%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;PTPRJ;CCND3;ESR1;PLCG2;RACK1;BMPR2;CAVIN2;CAV2;DCTN2;IQGAP1;EEF2;WNK1;TFRC;PTK2;FOXO3;RPS3;TJP2;CSPG4;DAB2IP;FERMT2;GCH1;MAP3K1;RICTOR;CALM1;CDKN1B;MAPKAPK3;MSN;ADCY4;RAC1;NBEA;HDAC7;HDAC9;LIMS1;ADAM10;KCNQ1;NEDD9;PKD1;LYST;ADIPOR1;PEBP1;CRK;RPS19;ACTA2;CAVIN3;IKBKB;RARA;EZR;GATA6;ATF4;PRKAR2B;SHC1;CEP192;NR3C1;HSPB1;RGCC;TRIB2;MAP3K11;WARS1;MAP3K2;TRIM14;LRBA;MAPKAP1;RELB;TRIB1;INKA2;EMP2;PPP1CB;DCTN1;TIRAP;RHOB;TRPV4;BAG5;TAOK2;VRK1;MTCP1;STK38;DUSP3;GRK5;CALM3;ACVR1;YWHAZ;BCL2L1;RCC2;FBXW5;RPS7;SRCIN1;MAVS;HINT1;RPS6;ACE;TRIM68;JAK2;CEP68;SPAG9;TRIM5;PRKAG1;TOP2A;AP2A1;YWHAG;SIKE1;NOD2;PTPN6;RAD9A;CDKN1A;UFL1;DSP;TCF3;CCNK;HSP90AA1;PRKAR2A;RELA;BAD
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5506431930211584,-1.3446153106085648,0.1366120218579235,0.5186033411244095,1.0,10/12,24.65%,VEGFC;DAB2IP;VEGFA;VEGFD;GREM1;PGF;ITGB3;CDH5;CADM4;CCDC88A
prerank,guanyl ribonucleotide binding (GO:0032561),-0.30834505292843173,-1.3446048238696098,0.02385685884691849,0.5115128918997645,1.0,60/196,24.44%,RAP1A;EEF1A1;RHOJ;PDE5A;RAP1B;RASL12;TGM2;GBP5;RAB8B;GCH1;TUBA1A;RAB27A;MFHAS1;PDE2A;RAC1;RALB;ADSS2;REM1;MIEF1;RAB18;GBP7;KRAS;ATL3;RIT1;ARF5;INSR;ATL2;RHOT1;RAB8A;RHOB;RHOT2;RAB11B;RAB7A;TUBD1;TUBB4B;RAB4A;ARL4A;ARHGEF5;HRAS;ARL6;DYNC1LI1;RRAGD;AGAP2;ARL2;RAB32;ARL8B;ADSS1;DNM2;RND2;RRAGA;RAPGEF2;ARL4C;TUBE1;TUBA4A;RRAGC;NRAS;NMUR2;NME1;CDC42;TSR1
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.33973507111882123,-1.3433134843601002,0.04024144869215292,0.5088190810673037,1.0,37/100,24.70%,CYTH3;CERT1;PARD3;ARAP3;SNX11;IQGAP1;DAB2IP;DENND1A;FERMT2;ARAP2;HIP1R;DENND1B;ZFYVE26;JPH2;AKT1;TECPR1;MAPKAP1;HIP1;RPH3A;KIF16B;TTPAL;GAB2;LAPTM4B;SAP30L;PHLDA3;PLEKHF1;SNX3;WIPI2;RUBCNL;BTK;VEPH1;PLEKHA4;RUBCN;GOLPH3;ZFYVE16;ANXA8;MYO10
prerank,GTPase activity (GO:0003924),-0.3087204298328797,-1.343249205424067,0.0189873417721519,0.5021548923801106,1.0,57/192,22.87%,DNM3;RAP1A;EEF1A1;RHOJ;RAP1B;RAB11A;RASL12;EEF2;GBP5;RAB8B;GCH1;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;RIT1;GPN3;HBS1L;RAB6B;ATL2;RHOT1;RAB8A;RHOB;ENTPD7;RHOT2;RAB11B;RAB24;RAB7A;RAB4A;GNB1;HRAS;RAB1A;GNG5;EFTUD2;OPA1;RRAGD;DNM1;AGAP2;ARL2;RAB32;NKIRAS2;ARL8B;DNM2;RND2;GNG11;RRAGA;GNA11;RAB23;RAP1GAP;RRAGC;GNGT2;NRAS
prerank,metallopeptidase activity (GO:0008237),0.3352950815244996,1.3410069000842413,0.045454545454545456,0.4982926696198102,1.0,23/113,14.82%,ADAMTS6;ADAMTS12;PAPPA;ADAM33;ADAMTS10;TRABD2B;ADAMTS5;MMP16;OMA1;ADAM12;MMP11;ANPEP;ADAM21;CHMP1A;ECE2;EEF1AKMT4-ECE2;THOP1;ADAMTS9;ADAMTSL4;ADAM2;NRDC;MMP19;METAP1
prerank,steroid hydroxylase activity (GO:0008395),0.5113151296345883,1.3399153333742704,0.14285714285714285,0.4940537020536524,1.0,4/16,9.74%,CYP7B1;CYP27A1;CYP2A6;CYP46A1
prerank,glycine binding (GO:0016594),0.551908240997188,1.339555598888507,0.17105263157894737,0.48857811606956547,1.0,5/11,17.49%,GRIN3A;GLDC;GLRB;GLRA3;GRIN2B
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5611271916966273,1.338555195178203,0.15975103734439833,0.4846579852139302,1.0,5/10,13.31%,PRDM9;SETMAR;NSD1;SETD5;NSD3
prerank,lipase activity (GO:0016298),-0.3883883269845531,-1.3382372710423058,0.08974358974358974,0.5094762687090721,1.0,10/43,20.00%,ABHD2;MGLL;PNPLA2;PITPNM3;FAAH;LYPLA1;PLA1A;LCAT;DAGLB;LDAH
prerank,secondary active transmembrane transporter activity (GO:0015291),-0.3751554825321823,-1.3378406868675297,0.08091286307053942,0.504120124042141,1.0,10/51,8.22%,SLCO3A1;SLCO2A1;SLCO1C1;SLCO2B1;SLC22A8;SLC7A5;SLC5A6;SLC25A3;MFSD2A;CLCN3
prerank,potassium ion antiporter activity (GO:0022821),0.5183138484955246,1.3363211108406727,0.14352941176470588,0.48368407086237825,1.0,5/15,8.94%,SLC24A3;SLC24A5;SLC9A7;SLC24A4;SLC24A2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.4313265199749862,-1.333356664643271,0.09694793536804308,0.5094198950686784,1.0,14/29,25.37%,CDKN1B;PRKAR2B;HSPB1;INKA2;CIB1;YWHAG;CDKN1A;PRKAR2A;CDKN2C;SFN;CDKN2B;CIT;RPTOR;PKIG
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.5149056122911824,1.3325336847606428,0.16192560175054704,0.4862258405335937,1.0,7/15,18.23%,SLC1A3;SLC25A13;SLC1A5;SLC1A2;SLC1A7;SLC25A18;SLC38A7
prerank,GTPase activator activity (GO:0005096),-0.28849090665371624,-1.3319425540181224,0.012422360248447204,0.5069104070623959,1.0,98/313,20.64%,ARHGAP31;DOCK9;RAPGEF5;CYTH3;CHN2;PLCE1;FGD5;RGS3;ARHGEF28;ARHGAP42;RAP1A;RGS5;RASGRP3;DOCK1;SIPA1L1;OPHN1;RIN3;ASAP2;RASGRF2;ARAP3;STARD13;SGSM2;RALGAPA2;IQGAP1;STARD8;RAPGEF1;ARHGAP17;RGL1;TBC1D8;ARHGAP26;ARHGAP27;ARHGEF15;GRTP1;DENND1A;EPS8L2;ARHGAP1;DOCK4;CHN1;TBC1D1;ARHGAP25;FGD6;TBC1D12;DENND1B;SPATA13;BCR;NUCB1;EEF1D;TBC1D22A;RALGAPB;DENND3;RGS6;SIPA1;DENND6A;ITSN1;HERC2;SIPA1L3;ADAP1;WNT11;PREX1;GMIP;NF1;EEF1B2;ABR;DENND2C;TBC1D9B;ARHGEF5;TBCK;PGAM5;ARHGEF18;LAMTOR2;RANBP2;RAP1GDS1;RGL2;MADD;EIF2B3;HPS1;DENND5B;RAPGEF3;CYTH2;TBC1D25;AGAP2;TSC2;TBC1D2;ARHGEF17;ARHGEF4;ARHGEF2;ECT2;RASA1;RAB3GAP2;RANGAP1;RASGRP4;ARHGEF6;RCC1;FGD2;RGS10;DNMBP;CYTH4;RINL
prerank,death domain binding (GO:0070513),-0.5458863730270217,-1.3301605326199306,0.1350844277673546,0.5056142861403804,1.0,6/11,12.16%,RACK1;DAPL1;CRADD;RIPK1;BAX;BCL2L1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.4549229375307321,1.3284421236670276,0.1257995735607676,0.4890712401143292,1.0,6/24,7.17%,CAMK1D;PHKA1;MAPKAPK5;CAMK4;DAPK1;CAMK2B
prerank,NAD binding (GO:0051287),0.4452562184990842,1.3284090465220246,0.12938596491228072,0.4832269780919446,1.0,6/26,14.73%,ALDH1A1;CRYL1;SIRT2;HPGD;GRHPR;SIRT6
prerank,ion channel activity (GO:0005216),0.3584098533385913,1.3259314019950124,0.07142857142857142,0.48298272512274903,1.0,23/80,15.22%,NALCN;GRIA4;GRID2;CHRNA1;GRIN3A;TRPM3;TRPM1;CHRNB4;GRIK5;GRIK2;UNC80;TRPM5;GRID1;GRIK1;CHRNA4;GRIA3;CALHM6;CHRNA7;CHRNB1;GRIN2A;GABRB1;GRIA1;TRPC1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),-0.27890466778145484,-1.3252548045805104,0.006085192697768763,0.5131327537929526,1.0,132/431,23.84%,CDK6;MAP3K5;RAP1A;EEF1A1;RPS6KA5;RHOJ;RAP1B;MAP4K3;RASL12;TGM2;PEAK1;NLK;WNK1;ATP1A1;SMC4;GBP5;GCH1;TUBA1A;MAP3K20;HSP90AB1;PI4K2A;RAB27A;MFHAS1;RAC1;HSPA8;ATP5F1D;RALB;ADSS2;MINK1;REM1;MTREX;GBP7;ATP5F1A;ACLY;PRPS2;PFKP;PSMA6;SRPK1;IDE;KRAS;ATL3;RIT1;ARF5;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;ATL2;DHX9;CDC42BPB;RHOT1;TRIB1;RAB8A;LMTK2;RHOB;RHOT2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;RAB11B;RAB7A;TUBD1;STK38;TUBB4B;ACVR1;PPP5C;RAB4A;SARS2;PNKP;ABCA2;ARL4A;TARS1;RRM1;ARHGEF5;HSPA4;TBCK;HRAS;ARL6;CAD;CARS2;NUAK2;UHMK1;DYNC1LI1;PRKAG1;STK38L;STK26;PGK1;OAS2;MLKL;RRAGD;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;ARL2;RAB32;BMPR1B;ARL8B;ADSS1;PYGL;DNM2;SNRK;RND2;RRAGA;ARL4C;HSPA1B;TUBE1;BTK;AARS2;EIF4G1;TUBA4A;PFKL;RRAGC;MTHFS;NRAS;NMUR2;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,5'-nucleotidase activity (GO:0008253),-0.5101208767544553,-1.3206150337615508,0.15145985401459855,0.5197845433001264,1.0,5/13,15.77%,NT5E;NT5C;NT5C1A;NT5DC3;NT5C3B
prerank,adenylate cyclase binding (GO:0008179),0.5634363982960968,1.3205534643831807,0.18843683083511778,0.48966928674996363,1.0,2/10,1.26%,ADCY2;ADCY5
prerank,nucleotidase activity (GO:0008252),-0.4837508427128677,-1.3205099878969486,0.15073529411764705,0.5138837226791536,1.0,5/15,15.77%,NT5E;NT5C;NT5C1A;NT5DC3;NT5C3B
prerank,estrogen receptor binding (GO:0030331),-0.4156396288194672,-1.318648033135419,0.1287313432835821,0.5127092415282698,1.0,9/32,14.87%,LEF1;ESR1;PPARGC1B;TACC1;NRIP1;WBP2;LCOR;PHB2;STRN
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.4485244757034441,1.3181838342926333,0.1456953642384106,0.4893441828995619,1.0,8/25,10.68%,MICAL3;CYP27B1;CYP27A1;POR;MSMO1;KMO;CYP46A1;MICAL1
prerank,cytochrome-c oxidase activity (GO:0004129),-0.5081647997943318,-1.3168451541783854,0.1607773851590106,0.5113975991320612,1.0,11/15,37.90%,COX4I1;COX6B1;COX15;NDUFA4;COX10;NDUFA4L2;COX8A;COX4I2;COX7A2L;COX5B;COX6A1
prerank,ligand-gated calcium channel activity (GO:0099604),0.4855189424765383,1.3157504814876477,0.1371308016877637,0.4886589672060513,1.0,7/19,17.49%,ITPR1;P2RX4;TRPM5;TRPA1;RASA3;GRIN2A;GRIN2B
prerank,ribosomal small subunit binding (GO:0043024),-0.49103116784457257,-1.3139230028348174,0.12903225806451613,0.5131530060509586,1.0,12/17,41.06%,PTCD3;ERAL1;EIF1;NME1;EIF4B;EIF4H;NPM1;MTIF2;CPEB2;UNG;PIM1;EIF1B
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.5261852453793674,-1.3137658839150201,0.15162454873646208,0.5076572148364182,1.0,7/12,23.23%,PIK3R6;IPMK;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5370274644544151,-1.309777986457123,0.16291161178509533,0.5127124900598455,1.0,3/12,8.78%,PIEZO2;PIEZO1;TMC6
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.5285913948633417,1.3095997814036842,0.16853932584269662,0.4970518212459603,1.0,2/12,4.01%,PIK3R1;STAP1
prerank,phosphatase binding (GO:0019902),-0.33061956296542017,-1.3094826004337528,0.056112224448897796,0.5077273811046406,1.0,34/105,18.62%,MAP3K5;ITGA1;PXN;RACK1;MAPK3;IQGAP1;WNK1;PTK2;SHOC2;CDKN1B;AP3B1;SH3RF2;CEP192;CTSC;JUP;FLT4;CHCHD3;VRK3;PPP1R3F;VCP;FBXL2;EGFR;ERBB2;PPP1R3C;MET;ANAPC7;CDC27;PIK3R2;BAD;GTF2F1;JAK3;TSC2;SMAD2;PPP6R3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5409669369533778,1.307388243527886,0.14988814317673377,0.49610450949571794,1.0,7/12,22.36%,TENT5A;PAPOLB;TENT5B;PAPOLA;TENT4A;TENT2;MTPAP
prerank,cation:chloride symporter activity (GO:0015377),-0.557694876749405,-1.3042812207872143,0.16512059369202226,0.5163048606554266,1.0,2/10,0.97%,SLC12A7;SLC12A2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.5430184871387799,1.3018755884555444,0.175,0.5028290051306669,1.0,6/10,21.65%,B3GALT1;B3GALT2;B3GALT5;B4GALT7;B4GALT6;B3GALT6
prerank,ion channel inhibitor activity (GO:0008200),-0.4118912221239114,-1.301806477136376,0.12121212121212122,0.5173821292563803,1.0,8/35,6.19%,NEDD4L;RACK1;WNK1;MCUB;CAMK2D;CALM1;FKBP1A;STX1A
prerank,NAD+ binding (GO:0070403),0.5229565244677953,1.2967157282680002,0.17011494252873563,0.508647943263495,1.0,7/12,23.59%,CRYL1;SIRT2;HPGD;SIRT6;ZC3HAV1;SIRT3;SIRT1
prerank,kinase binding (GO:0019900),-0.27403896373608744,-1.2947843473392817,0.008438818565400843,0.530931950022364,1.0,103/434,16.26%,UTRN;SLC12A7;CAV1;ACTB;FRMD5;SLC12A2;EEF1A1;TTC28;PTPRJ;CCND3;ESR1;TAX1BP1;PLCG2;CAV2;DCTN2;IQGAP1;EEF2;WNK1;TFRC;PTK2;FOXO3;RPS3;CSPG4;DAB2IP;FERMT2;MAP3K1;RICTOR;HSP90AB1;CALM1;CDKN1B;MSN;RAC1;NBEA;HDAC7;LIMS1;HTT;ADAM10;PKD1;LYST;CHP1;MYOM1;ADIPOR1;PEBP1;CRK;RPS19;ACTA2;PIK3IP1;STX1A;IKBKB;GATA6;ATF4;SHC1;CEP192;PDE8A;NR3C1;HSPB1;PPP2R5A;RGCC;WARS1;MAP3K2;TRIM14;LRBA;MAPKAP1;RELB;FAS;RB1;INKA2;EMP2;PPP1CB;DCTN1;RHOB;TOLLIP;TRPV4;BAG5;VRK1;MTCP1;DUSP3;CALM3;YWHAZ;BCL2L1;RCC2;FBXW5;RPS7;SRCIN1;MAVS;RPS6;TRIM68;JAK2;CEP68;TRIM5;EGFR;PRKAG1;AP2A1;CAB39;SIKE1;NOD2;PTPN6;LAPTM4B;BCAR3;RAD9A;CDKN1A;MYOM2;UFL1
prerank,sialyltransferase activity (GO:0008373),-0.46271093805485064,-1.291189086540793,0.15828677839851024,0.5352177229986378,1.0,6/20,6.49%,ST3GAL6;ST3GAL4;ST6GALNAC3;ST8SIA4;ST6GAL1;ST8SIA6
prerank,sodium:proton antiporter activity (GO:0015385),-0.5424580432947208,-1.2901012012604087,0.1836007130124777,0.5325894253591859,1.0,2/11,1.78%,SLC9A2;SLC9B2
prerank,growth factor activity (GO:0008083),0.3480277205439888,1.288594077439014,0.11623246492985972,0.522422269259657,1.0,11/74,8.25%,AREG;PTN;NRG3;NRG1;GDNF;VEGFB;ARTN;TGFA;IL4;THPO;IGF2
prerank,ubiquitin protein ligase activity (GO:0061630),0.2975032306732731,1.2875686812646023,0.04655493482309125,0.519007744623973,1.0,43/228,13.68%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;PELI2;RNF24;CBLB;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;PRKN;HECW1;UBE2O;RNF138;RNF149;DTX1;ASB2;SMURF2;RNF181;TRIM27;KCMF1;MGRN1;RNF26;TOPORS;UBR3;PPIL2;SIAH2;GID4;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1
prerank,calcium activated cation channel activity (GO:0005227),-0.47963868087099903,-1.2845514092424917,0.17100371747211895,0.5421388858998836,1.0,2/17,1.35%,ANO6;ANO1
prerank,nucleotide diphosphatase activity (GO:0004551),0.5035519850184568,1.2838625095416505,0.1696035242290749,0.5222149525069975,1.0,1/14,0.21%,ENPP1
prerank,protein homodimerization activity (GO:0042803),-0.25912457601787064,-1.2831406333928752,0.00228310502283105,0.5403687282740145,1.0,141/589,18.05%,ABCG2;PECAM1;MAP3K5;B2M;NADK2;SYNE1;ANO1;DPP4;ZHX3;RASIP1;NOD1;RACK1;ACTN4;F11R;CAV2;TPD52;PAXX;TFRC;MID2;FAP;TBX1;STK10;FZD4;CAMK2D;TPD52L1;IRAK2;GBP5;DAB2IP;MGLL;GCH1;SLIT2;HSP90AB1;CUBN;TGFB2;MID1;ST6GAL1;PDE2A;ADAM10;SARS1;EEA1;BHLHE40;MYOM1;ZBTB16;LRRFIP1;VEGFA;HIP1R;S100B;NRBP1;USF2;PSAP;IKBKB;SNRPC;PRPS2;ACTN1;CEP57;HSPB1;TOX3;IDE;JUP;RIPK1;TBC1D22A;FLT4;STK25;STARD3NL;FBXO4;BAX;AKT1;ABCG1;MAP3K11;GSTA4;PDGFC;PDGFA;PRMT8;WARS1;TRPC6;ADD1;TRIM14;HHEX;S100A10;S100A6;ATG7;PON3;FOXP2;HIP1;CARNMT1;S100A13;SFPQ;PRPS1;PRPS1L1;GSTM2;ACVR1;BCL2L1;APOE;BAK1;HES1;TMEM266;FMR1;GRHL1;CSF1R;QTRT2;S100A1;HSPB8;INHBB;MLX;PHB2;TRIM68;NAA60;S100A16;JAML;RAB11FIP3;CASQ2;BNIP3L;TSG101;TRIM5;MFSD1;GOLGA5;SRF;LDB1;TOP2A;SMAD4;GSTM1;ALDH1A3;ATP5IF1;SNF8;STK26;SOX6;NPR3;STAT1;GREM1;TCF3;HSP90AA1;IMPA2;GALM;RABEP1;RELA;MAP3K9;NR6A1;SP1;QTRT1;CHUK;TSC2
prerank,peptidase activator activity (GO:0016504),-0.4485828705328134,-1.2826333127995528,0.15047619047619049,0.536314210617798,1.0,8/22,17.36%,CAV1;PSENEN;MAL;VCP;PCOLCE2;PSMD14;APH1A;VSIR
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.5332281517551822,1.2753951183025918,0.2020618556701031,0.5361478693163719,1.0,3/11,9.59%,ITPR1;TRPA1;RASA3
prerank,GTPase binding (GO:0051020),-0.2889646464625215,-1.2747631624242857,0.05,0.5527311505407916,1.0,53/194,20.02%,PLCE1;FGD5;CAV1;EXOC4;SPTBN1;FNBP1L;EPS8;RASIP1;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;GNB2;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;MAPKAP1;RAB8A;TNFAIP1;RTKN;MLPH;CIB1;RCC2;SPHK2;GNB1;RAB11FIP3;RANBP2;GOLGA5;TNPO3;SIKE1;STRN3;NCKAP1;RRAGD;AMBRA1;HSP90AA1;GCC2;TSC2;EHD1;ARHGEF2;RASA1;RAB3GAP2;LSM2;RANGAP1;RCC1;FGD2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.504010800857272,1.273901641967633,0.19419642857142858,0.5340712115381034,1.0,5/14,7.28%,TIMP3;RECK;SPOCK3;COL4A3;TIMP4
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.4930736357296971,-1.2734756758655579,0.16970802919708028,0.5505134863184528,1.0,2/14,1.09%,SLC26A7;SLC26A2
prerank,voltage-gated cation channel activity (GO:0022843),0.33251394645357,1.2693190508127796,0.11354581673306773,0.5394450954984569,1.0,26/97,20.15%,CACNA2D3;CACNA1E;GRIN3A;CACNA2D1;CACNA1I;KCND2;CACNG4;CACNB4;CACNB2;CACNB1;KCND1;KCNMA1;KCNH7;GRIN2A;KCNQ4;KCNS3;KCNS1;KCNG2;KCNC2;GRIN2B;KCNG4;KCNH5;KCNH1;HVCN1;KCNS2;KCNH4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2931022906690651,1.2683599281128781,0.05534351145038168,0.5359800905731719,1.0,46/232,14.55%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;PELI2;RNF24;CBLB;TRIM38;RNF145;DTX4;SH3RF1;MDM2;ZNRF3;TRIP12;RNF43;RNF2;PRKN;HECW1;UBE2O;RNF138;RNF149;DTX1;ASB2;SMURF2;RNF181;TRIM27;KCMF1;MGRN1;RNF26;TOPORS;UBR3;PPIL2;SIAH2;GID4;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1;RNF34;PIAS1;UBE3C
prerank,transforming growth factor beta binding (GO:0050431),0.4460310919676774,1.265001431700557,0.1723404255319149,0.5381876317128115,1.0,6/23,10.15%,LTBP1;TGFBR3;TGFBR3L;LRRC32;TGFBR1;LTBP3
prerank,cytokine activity (GO:0005125),0.31049509283744164,1.2646940599752858,0.09411764705882353,0.5334653416179913,1.0,15/131,9.97%,BMP6;WNT4;BMP2;IL34;BMP5;NRG1;IL4;FAM3D;CXCL16;PPBP;SCG2;IL18;CCL25;AIMP1;CNTF
prerank,epidermal growth factor receptor binding (GO:0005154),0.4337328906322224,1.264053130463597,0.1670428893905192,0.5295094074493948,1.0,5/25,13.30%,AREG;TNK2;TGFA;ERBB4;BTC
prerank,DNA replication origin binding (GO:0003688),0.43623096466403943,1.2633580926522816,0.1762114537444934,0.525983760522415,1.0,10/23,23.13%,MCM3;ORC4;MCM2;MCM9;MCM8;ORC1;ORC3;ORC5;MCMDC2;MCM7
prerank,phosphotyrosine residue binding (GO:0001784),-0.3854296712484966,-1.2617119022876537,0.1520572450805009,0.5788568810026085,1.0,16/37,18.94%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;SHF;ABL2;SYK;PIK3R3;PTPN6;YES1;BCAR3;PIK3R2;HCK;RASA1
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5193663607162367,-1.2599916437696745,0.18505338078291814,0.5779005158798192,1.0,6/12,21.92%,ENTPD1;ENTPD7;ENTPD6;ENTPD2;CANT1;NUDT18
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.47319100974318495,-1.2599468342992521,0.1977401129943503,0.5667762871952899,1.0,3/16,5.26%,PTPRB;PTPRG;PTPRM
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.47319100974318495,-1.2599468342992521,0.1977401129943503,0.5667762871952899,1.0,3/16,5.26%,PTPRB;PTPRG;PTPRM
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.357541537421525,1.258670189770921,0.11974789915966387,0.5312007428494324,1.0,18/55,15.99%,SLC13A3;SLC6A12;SLC16A12;SLC7A2;SLC6A13;SLC22A4;SLC16A14;SLC38A1;SLC36A2;SLC25A10;SLC6A11;SLC38A3;SLC46A1;SLC38A9;SLC38A6;SLC7A3;SLC3A1;SLC16A7
prerank,protein tyrosine kinase activity (GO:0004713),0.3227799722035667,1.2569142095777717,0.09917355371900827,0.5299752233787405,1.0,31/108,12.88%,EPHA7;NTRK3;DDR2;FGFR2;KIT;PDGFRA;EPHA3;TNK2;EPHA6;LYN;DDR1;AXL;BAZ1B;PDGFRB;EPHB1;ERBB3;RYK;FGFR4;EPHA8;ERBB4;EPHA5;ALK;MUSK;WEE2;MST1R;MERTK;ITK;FGFR1;TEC;ROR1;EPHA1
prerank,nuclear receptor binding (GO:0016922),-0.3128329735061352,-1.2547488872784116,0.07751937984496124,0.5756324235447631,1.0,30/111,17.36%,LEF1;FOXP1;ESR1;DDX5;ACTN4;JMJD1C;NCOR1;ZBTB7A;TACC2;NR4A2;BCAS3;PPARGC1B;PPARGC1A;TACC1;NRIP1;KDM3A;JUP;MED24;ARID1A;WBP2;LCOR;PHB2;TRIM68;SMARCA4;GAS2L1;STRN;STAT1;YWHAH;KDM1A;MED14
prerank,deubiquitinase activity (GO:0101005),-0.32546508651935985,-1.2528660118422854,0.11067961165048544,0.5750195422503841,1.0,26/88,20.53%,USP53;MINDY2;MINDY1;EIF3F;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;JOSD1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.5143813467312784,-1.2526712185971733,0.2024866785079929,0.5702178121335942,1.0,2/12,1.78%,SLC9A2;SLC9B2
prerank,anion:anion antiporter activity (GO:0015301),-0.4593271881681348,-1.252528971845531,0.17477477477477477,0.5653188157151905,1.0,2/17,1.09%,SLC26A7;SLC26A2
prerank,transcription coactivator binding (GO:0001223),0.44337496037383317,1.252494917205168,0.2076271186440678,0.5341411081660987,1.0,3/20,2.77%,RORA;AR;SMAD3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.4948273351439153,-1.2509759743820437,0.18470149253731344,0.5642070094378676,1.0,8/14,37.85%,CAPN2;CAPN15;CAPN5;CAPN10;CAPN6;CAPN3;CAPN11;CAPNS1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.43840099807081917,1.2507449479154535,0.20594965675057209,0.5331938138420841,1.0,8/21,14.56%,PDE1A;PDE7B;PDE1C;PDE3B;PDE11A;PDE4B;PDE3A;PDE4A
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.5345835928330593,-1.250131976078971,0.20076481835564053,0.5614816813022778,1.0,6/11,24.46%,DAB2IP;MAP3K11;STK38;TCF3;TRAF6;PPEF2
prerank,sulfotransferase activity (GO:0008146),0.3990831334288844,1.2488707610454635,0.16844349680170576,0.5324043249817103,1.0,8/33,11.03%,CHST8;GAL3ST3;GAL3ST2;UST;TPST1;SULT6B1;CHST1;HS2ST1
prerank,calcium ion binding (GO:0005509),0.27631108241766716,1.248434975797528,0.051470588235294115,0.5285017887329481,1.0,48/323,10.92%,ENPP1;ADGRV1;FBN1;CLEC3B;PLSCR2;PAM;FBLN1;SLC8A1;KCNIP4;LRP1;NRXN1;CDH8;SCUBE1;ITPR1;PLA2G5;ANXA10;PLA2G4A;CDH18;DCHS1;AMY1A;AMY1C;AMY1B;TNNC1;ATP2A2;MAN1C1;ASTN2;ASPH;CDH11;CDH20;CDH19;CDH7;LOXL2;SYT1;SLC25A13;MICU3;OTOF;SCIN;S100A7A;C2CD5;CDK5R1;CDH10;MCTP2;MEX3B;NAALADL1;EML1;SYT13;CDHR3;BAIAP3
prerank,MAP-kinase scaffold activity (GO:0005078),0.5382595488155828,1.2458729373177837,0.22746781115879827,0.5292276330837872,1.0,3/11,7.83%,KSR1;SH3RF1;MAPK8IP2
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4782186945396378,1.2450257941435356,0.21212121212121213,0.5262880259757995,1.0,10/16,24.38%,SLC13A3;SLC25A13;SLC25A10;SLC1A5;SLC25A30;SLC25A18;SLC38A7;SLC13A5;SLC25A14;SLC1A6
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.5321350991960988,-1.2437633795326268,0.20786516853932585,0.5736867780292636,1.0,4/10,19.90%,SHANK3;SHISA7;NSF;SHANK1
prerank,ATPase activator activity (GO:0001671),-0.43749611961912416,-1.2401231941845652,0.19813084112149532,0.5782985573439968,1.0,7/20,22.07%,DNAJA2;ATP1B1;DNAJA1;TOR1AIP1;TOR1AIP2;ATP1B2;DNAJB1
prerank,protein serine/threonine kinase activity (GO:0004674),-0.26580807173785576,-1.240080588353356,0.02553191489361702,0.5733138466043742,1.0,79/334,16.04%,PRKCH;CDK6;MAP3K5;RPS6KA5;TGFBR2;MAP4K3;PTK2B;BMPR2;LIMK2;HIPK1;NLK;MAPK3;WNK1;STK10;NEK7;RPS6KA3;CAMK2D;IRAK2;MAP3K1;MAP3K20;MAPKAPK3;FAM20A;TRIO;CSNK1G2;PRKCZ;MINK1;PRKD3;TAOK3;NRBP1;IKBKB;BRD4;PRKDC;BCR;CSNK1G3;SRPK1;MAP3K8;RIPK1;PLK2;DYRK2;AKT1;MAP3K11;CDC42BPB;MAP3K2;VRK3;CSNK2B;STK32B;PIM3;LMTK2;CAMK1;CDK4;TAOK2;ULK3;RPS6KB2;HTATIP2;STK36;VRK1;STK38;GRK5;ACVR1;PKN3;PRKCE;CDK10;CLK1;SYK;FASTK;RPS6KA2;CDKL4;NUAK1;NUAK2;MAST4;EGFR;UHMK1;STK35;LIMK1;NEK3;STK38L;CDK13;CSNK2A1;CSNK2A2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.5302031467777182,-1.2389292415766429,0.2014388489208633,0.571569528888563,1.0,5/10,24.24%,ANKRD13A;IDE;USP15;LAPTM5;FAN1
prerank,protein kinase regulator activity (GO:0019887),-0.31561664187022026,-1.234918075077341,0.12475247524752475,0.5777460974928222,1.0,25/95,20.40%,CCND3;RPLP1;CCNY;WNK1;CDKN1B;TAOK3;PRKAR2B;RGCC;DUS2;CCNG2;TRIB1;CSNK2B;WNT11;KIDINS220;PRKAG1;CAB39;MADD;CCNF;CDKN1A;CCNK;PRKAR2A;AGAP2;CCND1;TPX2;NCK1
prerank,metal ion transmembrane transporter activity (GO:0046873),-0.41161777833602686,-1.2343121887752588,0.18285714285714286,0.5746015080247772,1.0,6/27,7.32%,ITPR2;SLC12A2;SLC9B2;TMEM165;ATP2A3;SLC4A8
prerank,deoxyribonuclease activity (GO:0004536),-0.48956164344746866,-1.2337378748146577,0.20833333333333334,0.571148868336671,1.0,6/14,28.92%,RPS3;ERCC4;DNASE1L2;DFFB;NME1;MRE11
prerank,lysine-acetylated histone binding (GO:0070577),-0.43978393213126,-1.2312967850662357,0.2032967032967033,0.5675140614847629,1.0,7/20,13.97%,MLLT3;BRD3;DPF2;BRD9;BRD4;ZMYND8;SMARCA4
prerank,acetylation-dependent protein binding (GO:0140033),-0.43978393213126,-1.2312967850662357,0.2032967032967033,0.5675140614847629,1.0,7/20,13.97%,MLLT3;BRD3;DPF2;BRD9;BRD4;ZMYND8;SMARCA4
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.4770923746705942,1.2301201162953777,0.22048997772828507,0.5553363060082447,1.0,4/15,8.81%,CCR6;ACKR4;ACKR2;CCR9
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",-0.32710882967364746,-1.2288141616860127,0.12601626016260162,0.5700095167216177,1.0,19/74,18.84%,NADK2;DGKH;HK1;RFK;FAM20A;PKM;IPMK;HYKK;NMRK1;CHKA;PIK3C2A;SPHK2;PIK3CA;PIK3C2B;TRPT1;DGKZ;POMK;NADK;FAM20B
prerank,death receptor activity (GO:0005035),-0.5050881480058698,-1.2284532478447432,0.21794871794871795,0.5661849440615188,1.0,5/11,13.25%,TNFRSF1B;TNFRSF11A;FAS;EDA2R;TNFRSF1A
prerank,GDP binding (GO:0019003),-0.33337761093556295,-1.2270999387277313,0.14980544747081712,0.56541696166492,1.0,17/63,16.46%,RAP1A;RAP1B;RASL12;RAB8B;RAB27A;RALB;MIEF1;RAB18;KRAS;RIT1;RAB8A;RAB11B;RAB7A;RAB4A;HRAS;DYNC1LI1;RRAGD
prerank,histone deacetylase binding (GO:0042826),-0.32005319380526137,-1.2254231811638783,0.12048192771084337,0.5651864466389215,1.0,34/88,25.91%,LEF1;MEF2C;NCOR1;MEF2A;HSP90AB1;HDAC9;HDAC4;TAL1;MTA2;MTA1;SFPQ;MIER2;HES1;SATB2;LCOR;TOP2A;RAD9A;RBBP4;HSP90AA1;MIER1;HSPA1A;RELA;SP1;CHD4;CCND1;NIPBL;HSPA1B;PHF6;YWHAB;CAMTA2;TRAF6;YWHAE;HDAC5;ANKRA2
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3894354067620039,-1.2233834417515665,0.18216318785578747,0.5660009002218017,1.0,15/35,22.73%,PTK2B;PEAK1;PTK2;BMX;STYK1;ABL2;FRK;CLK1;SYK;YES1;HCK;SLA;TXK;BTK;CSK
prerank,death receptor binding (GO:0005123),-0.4632689578230126,-1.2230024303179274,0.21933085501858737,0.5622352012265128,1.0,4/15,15.42%,DAB2IP;NGF;RIPK1;MADD
prerank,endopeptidase inhibitor activity (GO:0004866),0.3251753894432239,1.2204032060466246,0.15723270440251572,0.5733010657910255,1.0,12/82,8.56%,TIMP3;SERPINE2;AHSG;SERPINI2;RECK;SERPINF1;SPOCK3;UBE2O;SERPINE1;COL4A3;TIMP4;PSMF1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.40265539470696293,-1.2203092788833068,0.19318181818181818,0.5648532150391271,1.0,8/26,11.02%,ABCG2;SLC6A6;SLC16A6;SLC16A9;SLC5A6;SLC16A13;SLC16A4;SLC16A1
prerank,retinoic acid binding (GO:0001972),0.50032263520367,1.2194975042554648,0.2672811059907834,0.5702794152165191,1.0,1/12,1.19%,NR2F2
prerank,NADP binding (GO:0050661),-0.38344917884277746,-1.2182421644641517,0.1669724770642202,0.5657382709698611,1.0,8/32,16.60%,NOS3;ME1;LBR;DUS2;DECR1;NNT;TM7SF2;SPR
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.4754560762471133,-1.2182110871613792,0.2300556586270872,0.5613703005289838,1.0,8/14,22.83%,ACO1;ISCA2;ETFDH;RSAD2;CIAO3;NFU1;SDHB;ACO2
prerank,protein phosphatase 2A binding (GO:0051721),-0.41959780503352956,-1.217137450081704,0.19516728624535315,0.5599471543365203,1.0,10/23,18.75%,CTTNBP2NL;FOXO1;DAB2IP;MFHAS1;STRN4;STRN;STRN3;IGBP1;BOD1;SMG7
prerank,metal ion:proton antiporter activity (GO:0051139),-0.4914297485618224,-1.2167098229352717,0.23243243243243245,0.5567001006538274,1.0,2/13,1.78%,SLC9A2;SLC9B2
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.2697775563381957,-1.216219895488881,0.0673469387755102,0.5536338424995632,1.0,70/248,22.87%,DNM3;RAP1A;EEF1A1;RHOJ;MYL6;RAP1B;RAB11A;RASL12;KLC1;EEF2;GBP5;RAB8B;GCH1;GNB2;RAB27A;RAC1;RALB;ARHGDIB;RAB18;GBP7;KRAS;ATL3;RIT1;GPN3;HBS1L;RAB6B;ATL2;DHX9;RHOT1;CHD1L;RAB8A;RHOB;VCP;ENTPD7;RHOT2;RAB11B;RAB24;RAB7A;KIF26A;RAB4A;GNB1;HRAS;RAB1A;GNG5;EFTUD2;OPA1;ATP2B1;RRAGD;HSP90AA1;HSPA1A;DNM1;AGAP2;ARL2;RAB32;NKIRAS2;ARL8B;PIN1;DNM2;KIF1C;KIF18B;RND2;GNG11;RRAGA;GNA11;RAB23;HSPA1B;RAP1GAP;RRAGC;GNGT2;NRAS
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.32370694984469284,-1.215983171445457,0.14455445544554454,0.5499499115529803,1.0,19/78,13.37%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;CTSC;USP7;CASP8;USP8;CAPN15;USP9X;CTSF;CAPN5;UCHL1;USP5;CTSB;USP15;CAPN10
prerank,cAMP response element binding (GO:0035497),0.5258911443337728,1.214265838269242,0.2399103139013453,0.5773658717093352,1.0,4/10,17.20%,CREB5;CREB3L1;ATF7;ATF2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4237093840859905,1.2135613692409242,0.22832980972515857,0.5742310724328217,1.0,5/22,16.67%,RBMS3;CPEB3;KHSRP;RBM24;CPEB1
prerank,Tat protein binding (GO:0030957),-0.52005544438087,-1.2129825659253914,0.2230347349177331,0.5536591477275808,1.0,6/10,30.94%,ACTB;DNAJA1;SMARCA4;GABARAPL1;NPM1;DLL1
prerank,NF-kappaB binding (GO:0051059),-0.4080132208546011,-1.2102849596732077,0.20072992700729927,0.5562894894435966,1.0,12/24,30.06%,NFKBIA;PSMA6;ANXA4;COMMD7;RELA;CDK5RAP3;HIF1AN;BCL10;RNF25;NPM1;COMMD6;HDAC3
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4713592814646025,1.2097542472579759,0.23672566371681417,0.5788265403862087,1.0,3/14,12.32%,ALDH4A1;ALDH1L1;MTHFD1
prerank,copper ion binding (GO:0005507),0.36941338589297457,1.207512367701872,0.20374220374220375,0.5791067948720602,1.0,8/42,11.01%,PAM;HEPH;P2RX4;MOXD1;LOXL2;LOXL3;ANG;SOD3
prerank,metallocarboxypeptidase activity (GO:0004181),0.40607322807077484,1.2073540299097967,0.2266949152542373,0.5745717577529792,1.0,7/26,10.82%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1;FOLH1
prerank,frizzled binding (GO:0005109),0.3816900036750981,1.2035365845010308,0.19532908704883228,0.5780407395141594,1.0,6/34,9.20%,WNT4;ZNRF3;SFRP1;RNF43;RYK;DVL3
prerank,voltage-gated chloride channel activity (GO:0005247),-0.5075199430284442,-1.2030280732041145,0.2381852551984877,0.5710290137391072,1.0,3/10,8.22%,ANO6;ANO1;CLCN3
prerank,beta-tubulin binding (GO:0048487),0.3986840908306327,1.201058442724569,0.23333333333333334,0.5791700030829522,1.0,7/31,9.26%,GJB6;EML4;UXT;DLEC1;PACRG;IFT74;CDK5R1
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.3583225946659067,-1.1987887602511966,0.22323049001814882,0.5779756578578699,1.0,17/42,19.47%,PLCG2;SHE;SHB;CRK;SHC1;PFN1;SHF;ABL2;SYK;PIK3R3;PTPN6;YES1;BCAR3;PIK3R2;HCK;RASA1;PIN1
prerank,four-way junction DNA binding (GO:0000400),0.4381149276066779,1.1984911193961176,0.21889400921658986,0.5803714532349478,1.0,6/17,12.09%,GEN1;MEN1;BLM;RAD51C;RAD51B;FANCM
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.4486228626918066,-1.1977590726546987,0.2392086330935252,0.5765288418687992,1.0,5/17,16.53%,LBR;DECR1;DHCR24;TM7SF2;MECR
prerank,U6 snRNA binding (GO:0017070),-0.46963849283489056,-1.1969368513219703,0.21482889733840305,0.5744312466187749,1.0,6/14,21.06%,PRPF8;RBM22;DDX39B;LSM2;LSM7;LSM3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.41488023481142233,1.1957180591403203,0.2557603686635945,0.5821921509172384,1.0,8/23,14.56%,PDE1A;PDE7B;PDE1C;PDE3B;PDE11A;PDE4B;PDE3A;PDE4A
prerank,myosin II binding (GO:0045159),-0.5063314760635712,-1.1919734161596012,0.2504672897196262,0.5831888176324639,1.0,1/10,0.39%,SHROOM4
prerank,ATPase regulator activity (GO:0060590),-0.35728035594448315,-1.1913748344150354,0.2034548944337812,0.5808935354875011,1.0,14/38,23.34%,FNIP2;DNAJA2;ATP1B1;PFN1;DNAJA1;BAG5;TOR1AIP1;KATNB1;ATP5IF1;TOR1AIP2;ATP1B2;DNAJB1;BAG1;BRSK2
prerank,androgen receptor binding (GO:0050681),-0.396825972371438,-1.1904688063998579,0.2025089605734767,0.5791527572585224,1.0,7/25,17.32%,FOXP1;DDX5;ZBTB7A;KDM3A;TRIM68;SMARCA4;KDM1A
prerank,Hsp90 protein binding (GO:0051879),-0.37509772292227184,-1.187255619289154,0.23228346456692914,0.5830425766143329,1.0,13/33,25.21%,SLC12A2;KDR;RPS3;NR3C1;UNC45B;PPP5C;NOD2;CSNK2A1;PTGES3L;TSC2;STIP1;PPEF2;PPID
prerank,ADP binding (GO:0043531),-0.40109553795436015,-1.185706176220135,0.22388059701492538,0.5830163410956141,1.0,10/25,19.56%,ME1;ATP5F1D;MIEF1;ATP5F1A;ABCG1;PPP5C;PRKAG1;COQ8A;PGK1;GCLC
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5048694768209948,1.1853922887939612,0.2838427947598253,0.6021832085038002,1.0,5/11,22.27%,AKR1B1;AKR1B10;RDH13;RDH11;AKR1A1
prerank,receptor tyrosine kinase binding (GO:0030971),0.34267317890471705,1.1807460148398747,0.20250521920668058,0.6083119365511237,1.0,7/56,4.01%,PIK3R1;ANGPT2;NRG3;NRG1;CBLB;LRP4;STAP1
prerank,protein kinase activator activity (GO:0030295),-0.3302980392899614,-1.1797715153153083,0.20040899795501022,0.594787140093785,1.0,15/60,15.87%,AFAP1L2;RPLP1;IQGAP1;WNK1;RICTOR;CALM1;FAM20A;RGCC;WNT11;MTCP1;CALM3;ABI1;CAB39;MADD;CDKN1A
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.31774585624848867,-1.1792079387740109,0.19008264462809918,0.5920949611982711,1.0,22/71,23.36%,PTPRB;PTPRG;PTPN14;PTPRJ;CDC14A;PALD1;PTPRM;PTP4A2;DUSP3;CDC14B;PTPN12;PTPN6;DUSP23;UBASH3B;DUSP11;PTPRK;TIMM50;PTPRO;PTPRU;PTPN22;PTPN1;DUSP4
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.40429951824596744,1.1759826805630675,0.25,0.6149502237726644,1.0,16/25,28.63%,PARP16;SIRT2;PARP11;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;PARP8;TNKS2;PARP6;SIRT4
prerank,C-C chemokine receptor activity (GO:0016493),0.41714292476465414,1.1734592652866676,0.24242424242424243,0.6160421102289867,1.0,5/21,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,pyridoxal phosphate binding (GO:0030170),0.418860461223375,1.1733340924597344,0.2654320987654321,0.611529755359124,1.0,5/20,11.58%,ABAT;GLDC;PLPBP;PDXK;PYGM
prerank,G protein-coupled receptor binding (GO:0001664),0.2935559110608755,1.1731159617794862,0.17058823529411765,0.6072830960856854,1.0,30/132,18.99%,WNT4;GRK3;GPHB5;GNAI1;ZNRF3;SFRP1;RNF43;PRKN;TAFA5;ADM;PACRG;TULP3;RYK;DVL3;BICD1;CCL25;GNA15;UTS2B;GPRASP2;PNOC;WNT6;GPRC5B;WNT5B;ARHGEF11;INSL3;USP20;AGTR1;CXCL12;HOMER2;PDYN
prerank,protein kinase C binding (GO:0005080),-0.34509056276795264,-1.1711599779643693,0.2255083179297597,0.6094646709693056,1.0,14/43,16.29%,RACK1;CAVIN2;ADCY4;HDAC7;HDAC9;CAVIN3;HSPB1;TIRAP;TRPV4;GRK5;HINT1;TOP2A;YWHAG;DSP
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.4969237195380569,-1.169679052583116,0.2792321116928447,0.6091622380503504,1.0,4/10,24.71%,CDKN1B;CDKN1A;CDKN2C;CDKN2B
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4944349410261861,1.1685441132909495,0.27056277056277056,0.6130960071319311,1.0,6/10,26.09%,KDM7A;KDM2A;PHF8;KDM4C;KDM2B;KDM4B
prerank,tau protein binding (GO:0048156),-0.3515176726464263,-1.1666673798582339,0.2366412213740458,0.613063497732457,1.0,11/40,20.32%,ACTB;HSP90AB1;S100B;DCTN1;TAOK2;PPP5C;APOE;HSP90AA1;SMAD2;PIN1;MAP1A
prerank,kinase activity (GO:0016301),-0.29214878615748113,-1.1645102801280933,0.186,0.6147013680527962,1.0,26/109,18.82%,ITPKB;NADK2;DGKH;RFK;TRRAP;PRKD3;IPMK;HYKK;AKT1;SCYL3;CKB;NMRK1;CHKA;PIK3C2A;SPHK2;CERKL;IP6K1;PIK3CA;COQ8A;CSNK2A1;PGK1;PIK3C2B;SEPHS2;DGKZ;POMK;NADK
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),-0.39677275872986556,-1.1628756852775368,0.2557726465364121,0.6146922028686627,1.0,6/22,17.01%,MINDY2;PRPF8;UIMC1;SPRTN;TNFAIP3;TAB2
prerank,phospholipase C activity (GO:0004629),-0.3860663553183154,-1.161734393725235,0.2381852551984877,0.6135958980254774,1.0,4/25,3.36%,PLCE1;EDNRA;PLCG2;PLCB3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.47282658812804373,-1.1600729159390493,0.28,0.6137797072566044,1.0,7/12,38.74%,DUSP3;DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,kinase activator activity (GO:0019209),-0.37077163982967565,-1.1595911858998011,0.2652671755725191,0.6110252802775217,1.0,12/30,25.43%,RPLP1;WNK1;RGCC;WNT11;CAB39;MADD;AGAP2;TPX2;BCL10;RPTOR;TREM2;SPDYA
prerank,small GTPase binding (GO:0031267),-0.26925832425457863,-1.1582937544010068,0.15904139433551198,0.6102490985819433,1.0,44/169,20.02%,PLCE1;FGD5;CAV1;EXOC4;EPS8;UNC13B;RIN3;SH3BP4;AP3M1;SGSM2;IQGAP1;CYRIB;IFT20;RNF41;ARHGAP1;DOCK4;ARHGDIB;FGD6;YBX3;TRIP11;MAPKAP1;RAB8A;TNFAIP1;RTKN;MLPH;CIB1;RCC2;SPHK2;RAB11FIP3;RANBP2;GOLGA5;TNPO3;SIKE1;STRN3;NCKAP1;GCC2;TSC2;EHD1;ARHGEF2;RAB3GAP2;LSM2;RANGAP1;RCC1;FGD2
prerank,hormone activity (GO:0005179),0.3365132508021388,1.1581764684650324,0.22406639004149378,0.6337947097687883,1.0,2/54,1.28%,IGF1;GPHB5
prerank,omega peptidase activity (GO:0008242),-0.2999474564016453,-1.157812929232005,0.1941747572815534,0.6074948958438023,1.0,25/89,20.53%,USP53;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;GGT5;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;GGT1;JOSD1
prerank,C-C chemokine binding (GO:0019957),0.4049041355162204,1.1546624850550782,0.2754237288135593,0.6380043414043374,1.0,5/22,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),-0.3642354787538268,-1.1533092158620195,0.246,0.6149689077104714,1.0,15/33,25.92%,RNF144B;DCUN1D5;RPS3;RNF125;DCUN1D1;RNF185;TOLLIP;RNF5;UBA2;ZMYM2;FOXL2;RNF19A;TRAF6;DCUN1D3;PARK7
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4585016585447381,-1.1511337600862364,0.2841918294849023,0.6166965697711525,1.0,7/14,20.16%,NOD1;RACK1;ATP2A3;MAL;RPS27L;BAD;CASP1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.25397813191762525,1.1506488468642546,0.12252252252252252,0.6427331583631047,1.0,59/346,13.68%,RNF220;HECW2;SH3RF3;PDZRN3;MYCBP2;BCOR;PELI2;RNF24;CBLB;TRIM38;RNF145;FBXO24;DTX4;SH3RF1;DDB2;MDM2;ZNRF3;DZIP3;RNF214;TRIP12;RNF43;RNF2;PRKN;TTC3;HECW1;UBE2O;RNF138;RNF149;DTX1;KLHL42;ASB2;SMURF2;FBXO25;UBE2E3;RNF181;TRIM27;CDC23;CUL2;KCMF1;MGRN1;AKTIP;RNF26;TOPORS;UBR3;MIB1;PPIL2;SIAH2;GID4;FBXO7;BTRC;RNF146;RNF217;RNFT2;RNF122;TRIM63;BIRC2;ARIH2;FBXO44;ASB1
prerank,ferrous iron binding (GO:0008198),-0.3995963808150183,-1.1499589697409893,0.26785714285714285,0.6159805155277552,1.0,7/21,12.72%,EGLN3;CDO1;FTL;EGLN2;EGLN1;FTH1;FXN
prerank,potassium ion leak channel activity (GO:0022841),0.4514414656497123,1.1493717120885,0.3072033898305085,0.6412668874935926,1.0,1/15,0.14%,KCNK2
prerank,translation initiation factor activity (GO:0003743),-0.36082214184247985,-1.1457576187417802,0.2624521072796935,0.6225496603025319,1.0,14/36,24.95%,EIF3F;EIF4G3;EIF5B;EIF3D;EIF3I;COPS5;EIF4A1;EIF3K;EIF2B3;EIF5;EIF1;EIF4G1;EIF4A2;EIF4E
prerank,intracellular chloride channel activity (GO:0061778),-0.4301739944794296,-1.1445984196829653,0.29690346083788705,0.6176881382220076,1.0,4/16,13.45%,ANO6;ANO1;TTYH2;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.4301739944794296,-1.1445984196829653,0.29690346083788705,0.6176881382220076,1.0,4/16,13.45%,ANO6;ANO1;TTYH2;ANO2
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",-0.25173017143663046,-1.1439853758458287,0.14367816091954022,0.6154797864568524,1.0,58/254,18.21%,MECOM;LEF1;ELK3;ERG;MEF2C;RREB1;ESR1;MEF2A;FOXO1;KLF4;ELF1;FOXO3;ETS1;SOX17;SIX1;KLF7;PRDM16;REL;NR4A2;TFCP2L1;PRDM2;ZBTB16;PRDM4;ATF4;NR3C1;NR2C2;YY1;PLAGL1;NFATC1;HHEX;PRDM15;SOX18;FOXF2;ZIC3;MYBL1;GABPA;FOXC2;E2F3;SOX12;SOX4;SATB2;PLAGL2;GRHL1;FOXD2;ETV5;SRF;SMAD4;ETV4;RFX5;NR1H2;ZNF76;TCF3;KLF6;ZNF319;RELA;SP1;E2F4;SMAD2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.38249570888048107,1.1414261999902868,0.2644444444444444,0.6562077447104426,1.0,10/26,19.39%,B3GALT1;B3GALNT1;B3GNT7;B3GALT2;B3GALT5;CHSY3;CHSY1;EXTL2;B3GNT6;CHPF2
prerank,anion channel activity (GO:0005253),-0.31294440495475784,-1.1399370725786988,0.23015873015873015,0.6219824643541693,1.0,7/61,2.95%,ANO6;SLC26A7;CLIC4;ANO1;LRRC8C;LRRC8D;CLIC1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.46602070230831477,-1.1394197824230807,0.3129496402877698,0.619418840253615,1.0,6/12,20.16%,NOD1;RACK1;ATP2A3;RPS27L;BAD;CASP1
prerank,hexosyltransferase activity (GO:0016758),0.28886503825967114,1.1373167318087942,0.22828282828282828,0.6617478292315817,1.0,27/101,19.56%,TMTC1;B3GALT1;B3GALNT1;MGAT4C;B3GNT7;B3GLCT;ALG5;FUT4;TMTC3;TMTC4;POGLUT2;FUT9;B3GALT2;EXTL1;POMT2;B3GALT5;GBA2;DPY19L1;CHSY3;CHSY1;B4GAT1;B3GNT6;B4GALT7;B4GALT6;CHPF2;DPY19L4;RFNG
prerank,transforming growth factor beta receptor binding (GO:0005160),-0.4153992823790335,-1.1364440019052047,0.2821869488536155,0.6233351319692623,1.0,10/18,13.28%,TGFBR2;FERMT2;SMAD7;TGFB1;TGFB2;FKBP1A;SMAD6;TGFB3;ENG;USP15
prerank,glutamate receptor binding (GO:0035254),-0.4140203799287185,-1.1356804633102262,0.3021978021978022,0.6215948222949346,1.0,6/17,19.90%,SHANK3;HIP1;HOMER1;SHISA7;NSF;SHANK1
prerank,thiol-dependent deubiquitinase (GO:0004843),-0.2998436232607755,-1.1351850506555619,0.22957198443579765,0.6192124666541262,1.0,23/83,20.53%,USP53;USP1;USP46;BRCC3;USP7;OTUD5;USP8;USP3;USP9X;OTUB1;UCHL1;USP5;PSMD14;COPS5;USP15;PAN2;TNFAIP3;UCHL3;USP22;USP4;USP49;USP38;JOSD1
prerank,adenyl ribonucleotide binding (GO:0032559),-0.249124719134063,-1.1339512111447627,0.14343434343434344,0.6187459028980796,1.0,89/291,23.84%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;ME1;NLK;WNK1;PDE4D;ATP1A1;SMC4;MAP3K20;HSP90AB1;PI4K2A;PDE2A;HSPA8;ATP5F1D;MINK1;MIEF1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;SRPK1;IDE;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;DHX9;CDC42BPB;TRIB1;LMTK2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;STK38;ACVR1;PPP5C;SARS2;PNKP;ABCA2;TARS1;RRM1;HSPA4;TBCK;CAD;CARS2;NUAK2;UHMK1;PRKAG1;COQ8A;STK38L;STK26;PGK1;OAS2;MLKL;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;BMPR1B;GCLC;PYGL;SNRK;RAPGEF2;HSPA1B;BTK;AARS2;EIF4G1;PFKL;MTHFS;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,peptide hormone receptor binding (GO:0051428),0.4726508029723147,1.1327841799748855,0.3144208037825059,0.6683821749381189,1.0,1/11,1.28%,GPHB5
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2299915149943024,1.1308513036619319,0.07747747747747748,0.6686024639663642,1.0,102/831,9.62%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;EPAS1;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RBAK;RARB;TRPS1;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;SP7;TFDP1;PHOX2A;AEBP1;HDX;HOXC8;FOSB;ZNF35;CEBPB;HOXB8;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ATF5;BBX;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;CUX1;LHX4;DMTF1;ZNF697;SIX4;NFIX;BCL11A;RFX7;RARG;NFXL1;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;CUX2;SOX5;HOXC10
prerank,syntaxin binding (GO:0019905),0.3206448849277563,1.1299042955495857,0.2788844621513944,0.6660386962216249,1.0,21/61,18.36%,ABCA1;UNC13C;STXBP4;SCFD1;DAPK1;SYT1;CPLX2;SNAP25;GOLGA2;TMED10;STX7;BAIAP3;SYP;STXBP3;SNAP47;SCFD2;TMED9;SYT12;VAMP3;SYT6;SYNPR
prerank,signaling receptor complex adaptor activity (GO:0030159),0.346499592524936,1.1272031896823211,0.3084886128364389,0.6678472269887085,1.0,4/38,4.01%,PIK3R1;MAGI2;GRIP1;STAP1
prerank,voltage-gated potassium channel activity (GO:0005249),0.30499570810150245,1.124910634532951,0.23983739837398374,0.6692087572392474,1.0,21/80,18.45%,KCNK2;KCNT2;KCND2;KCNJ16;KCNJ3;KCND1;KCNJ5;KCNJ14;KCNMA1;KCNH7;KCNQ4;KCNS3;KCNJ6;KCNS1;KCNG2;KCNC2;KCNN1;KCNJ9;KCNG4;KCNH5;KCNH1
prerank,potassium channel activity (GO:0005267),0.29560150483614045,1.124878645880515,0.24898785425101214,0.6645122101059813,1.0,23/89,20.15%,KCNK2;KCNT2;CCDC51;GRIK5;GRIK2;KCND2;GRIK1;KCND1;KCNMA1;KCNK10;KCNH7;KCNQ4;KCNS3;KCNS1;KCNG2;KCNC2;KCNN1;KCNG4;KCNH5;KCNH1;KCNK13;KCNS2;KCNH4
prerank,water transmembrane transporter activity (GO:0005372),-0.46390911373336685,-1.1240892800921762,0.3338926174496644,0.6398800485438022,1.0,9/11,53.63%,AQP11;AQP4;AQP1;SLC4A11;AQP9;AQP6;PDPN;AQP7;SLC5A1
prerank,cholesterol binding (GO:0015485),-0.3247176194894515,-1.123036730545186,0.2651821862348178,0.6390894988424093,1.0,13/47,15.33%,CAV1;PROM1;OSBPL3;CD81;OSBPL1A;STARD3NL;ABCG1;ERLIN2;GRAMD1C;GRAMD1A;STARD5;NPC1;STAR
prerank,antiporter activity (GO:0015297),0.4037717701953144,1.1217907939436185,0.3403361344537815,0.6677853041364743,1.0,6/20,15.24%,SLC35D1;SLC35E3;SLC25A10;ATP1A3;SLC35C2;SLC25A30
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.4412078598782097,1.1215882510233066,0.3106212424849699,0.6635767259413295,1.0,14/14,55.92%,DHRS3;RDH11;AKR1A1;ADH1A;RDH12;SDR16C5;RDH5;ADH7;ADH4;SDR9C7;HSD17B6;RDH16;DHRS9;RDH10
prerank,Notch binding (GO:0005112),0.39923757054998454,1.1213677550711614,0.29637526652452023,0.6596001024891908,1.0,4/22,6.22%,SNED1;MEGF10;AAK1;DTX1
prerank,ribosome binding (GO:0043022),-0.32563748839335227,-1.119406540157452,0.28125,0.6447823820659995,1.0,13/46,23.01%,RACK1;RPSA;EEF2;ERI1;NCLN;FMR1;NOMO1;SEC61B;SRP19;SRP68;SERBP1;YTHDF1;PYM1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.35176077535383055,1.1181735792841208,0.27755102040816326,0.6627359705166752,1.0,11/32,18.06%,BBOX1;KDM7A;JMJD4;PHYH;FTO;KDM2A;PHF8;PHYHD1;ALKBH4;P4HTM;KDM4C
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.4627949912966083,-1.1165428389299243,0.33086876155268025,0.6485246095352155,1.0,2/11,6.75%,LEF1;GATA2
prerank,phospholipase A2 activity (GO:0004623),0.3705368546364469,1.1149832190510034,0.3099787685774947,0.6658015013639449,1.0,8/26,25.37%,PLA2G5;PLA2G4A;PLAAT5;PLA2G6;PLA2G12A;PLA2G4C;PNPLA3;PLA2G15
prerank,ATP binding (GO:0005524),-0.24757459154682157,-1.1147705223292572,0.18091451292246521,0.6494310965213579,1.0,82/266,23.84%,CDK6;MAP3K5;RPS6KA5;MAP4K3;PEAK1;NLK;WNK1;ATP1A1;SMC4;MAP3K20;HSP90AB1;PI4K2A;HSPA8;ATP5F1D;MINK1;MTREX;ATP5F1A;ACLY;PRPS2;PFKP;SRPK1;IDE;CARS1;DYRK2;AKT1;INSR;NDUFA13;HACL1;ABCG1;DHX9;CDC42BPB;TRIB1;LMTK2;HSPA5;KCNJ8;PRPS1;PRPS1L1;STK36;STK38;ACVR1;PPP5C;SARS2;PNKP;ABCA2;TARS1;RRM1;HSPA4;TBCK;CAD;CARS2;NUAK2;UHMK1;PRKAG1;STK38L;STK26;PGK1;OAS2;MLKL;HSP90AA1;UBA2;HSPA1A;MYO1F;AGAP2;HSPA9;TAP2;MAP3K6;N4BP2;BMPR1B;PYGL;SNRK;HSPA1B;BTK;AARS2;EIF4G1;PFKL;MTHFS;BRSK2;MYH9;SIK1;NME1;MKNK2;BCKDK
prerank,endopeptidase activator activity (GO:0061133),-0.4698683591044574,-1.1084616595640688,0.3445692883895131,0.6620097998725871,1.0,4/10,17.36%,PSENEN;PSMD14;APH1A;VSIR
prerank,RNA cap binding (GO:0000339),-0.42393556882586636,-1.1064033441865735,0.32136105860113423,0.6638691660194881,1.0,10/16,40.17%,DCPS;EIF3D;EIF4A1;LSM1;NCBP2;EIF4E;CYFIP2;SNUPN;CYFIP1;NCBP1
prerank,RNA stem-loop binding (GO:0035613),0.45615332427947786,1.106062841659698,0.34285714285714286,0.6833128345099097,1.0,5/12,13.66%,LARP6;CSDE1;CPEB3;METTL16;MYH10
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.44597791250178764,-1.105718833743606,0.3333333333333333,0.6619795273138296,1.0,6/13,11.60%,PTPRJ;IL1R1;VEGFA;PDGFC;PDGFA;VEGFD
prerank,peptidoglycan binding (GO:0042834),-0.4712766199566616,-1.096628803226445,0.36493738819320215,0.6819471788941864,1.0,4/10,15.49%,NOD1;HK1;PGLYRP1;NOD2
prerank,neuropeptide receptor binding (GO:0071855),-0.4247374010490628,-1.0965555635875321,0.33589251439539347,0.6782696071461103,1.0,11/14,54.64%,AGRP;NTS;SHANK1;APLN;NPY;NMU;UCN2;GAL;NPPA;GHRH;QRFP
prerank,nuclear export signal receptor activity (GO:0005049),0.4541521277985088,1.0956097181586495,0.34415584415584416,0.7051792420970763,1.0,4/11,12.92%,RANBP17;XPO4;XPO7;XPO5
prerank,SH2 domain binding (GO:0042169),-0.35369017645588685,-1.0938829391706024,0.32710280373831774,0.6817889589812907,1.0,17/31,32.96%,AFAP1L2;RACK1;NLK;PTK2;CRK;TRPV4;RUFY1;JAK2;LAT2;CCDC88A;INPPL1;LAX1;SKAP1;LILRB1;SRC;BLNK;ABL1
prerank,GTPase regulator activity (GO:0030695),-0.24900774875237508,-1.093425701534295,0.24435318275154005,0.6790253470575601,1.0,42/212,11.33%,ARHGAP31;CHN2;RGS3;ARHGAP42;RGS5;RASGRP3;DOCK1;SIPA1L1;OPHN1;SH3BP4;ASAP2;ARAP3;STARD13;SGSM2;RALGAPA2;IQGAP1;STARD8;ARHGAP17;TBC1D8;ARHGAP26;ARHGAP27;GRTP1;SLIT2;ARHGAP1;CHN1;TBC1D1;ARHGAP25;TBC1D12;BCR;TBC1D22A;RALGAPB;RGS6;SIPA1;SIPA1L3;GDI1;ADAP1;WNT11;ARL2BP;PREX1;GMIP;RTKN;NF1
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.33323836208733193,-1.0927855184012554,0.31444241316270566,0.6769316807574878,1.0,16/37,30.43%,SARS1;WARS2;CARS1;LARS2;WARS1;SARS2;TARS1;CARS2;FARS2;FARSB;AARS2;IARS1;GARS1;KARS1;NARS1;IARS2
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.22448257861951332,1.0924482616852362,0.16176470588235295,0.7080323407105192,1.0,90/731,9.95%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RARB;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;CREB3L1;SP7;HDX;FOSB;CEBPB;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;ZNF697;SIX4;NFIX;BCL11A;RFX7;RARG;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;SOX5;HOXC10;HOXB9;HOXC6
prerank,acetyltransferase activity (GO:0016407),0.35388976130378547,1.090498024803292,0.3252212389380531,0.7085355149874923,1.0,6/31,13.45%,NAT8;SAT1;PAFAH2;KAT8;DBT;EP300
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3427481528732005,1.089647705311041,0.34606741573033706,0.7061133258881527,1.0,14/34,23.43%,METTL21A;PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B;VCPKMT;DOT1L;SETD4;CAMKMT
prerank,cholesterol transfer activity (GO:0120020),-0.40953821038193994,-1.0893356180617533,0.34579439252336447,0.6822851024557336,1.0,5/16,12.22%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,cell adhesion mediator activity (GO:0098631),-0.3686372882640213,-1.0892603529185199,0.33271028037383177,0.6787781738703381,1.0,5/24,5.72%,ESAM;BSG;JAM3;ROBO4;BCAM
prerank,phosphatidate phosphatase activity (GO:0008195),0.4288036549863175,1.0887727792541908,0.358695652173913,0.7037230076980149,1.0,6/13,16.50%,PLPP3;PLPPR1;LPIN3;PLPP4;PLPPR5;LPIN1
prerank,sequence-specific DNA binding (GO:0043565),0.22829532483304324,1.0882859306622865,0.18518518518518517,0.7003319031827271,1.0,80/590,11.53%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;TBX3;EPAS1;HLF;NR2F2;RARB;ZIC1;TEAD1;PPARA;HOXC4;GLI2;TBX18;DLX3;NFAT5;PRDM5;SMAD3;CREB5;TFEC;TBX21;BCL2;KLF15;GLI3;TFCP2;ZEB2;PBX4;CREB3L1;STN1;PHOX2A;HOXC8;FOSB;ZNF35;CEBPB;HOXB8;PKNOX2;HOXC9;LIN28B;ATF5;BBX;PRDM9;FOXA2;ZNF296;DMRTA2;CUX1;LHX4;MBD2;SIX4;CXXC4;KMT2A;NFIX;RFX7;RARG;SOX2;RBPJ;SAFB2;FOXD3;HES5;ZBTB45;CXXC1;CREB3L4;CREB3;GLIS1;GATA3;CTCF;CUX2;HOXC10;HOXB9;FOXR2;ZIC4;SKOR2;HNRNPD;KDM2A;GRHL3;SNAPC1;SLTM;AHR
prerank,titin binding (GO:0031432),-0.43476856390075636,-1.0874305984714823,0.36044362292051757,0.6800280023566146,1.0,4/13,14.14%,CAMK2D;CALM1;CALM3;MYBPC1
prerank,Toll-like receptor binding (GO:0035325),-0.4434116929268761,-1.085493939605047,0.36607142857142855,0.681498069403847,1.0,7/11,34.24%,DAB2IP;TIRAP;TOLLIP;CD36;TLR6;TLR1;TLR2
prerank,carbohydrate kinase activity (GO:0019200),-0.4570341128828218,-1.0833973679990831,0.396584440227704,0.6831036780846704,1.0,6/11,39.07%,HK1;POMK;GNE;FGGY;XYLB;HK3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.22200564774729442,1.083202517259994,0.20108695652173914,0.7085814601906991,1.0,89/732,9.95%,TCF7L2;TCF4;RORA;ARNT2;ZBTB20;MAF;SALL1;AR;TBX3;GLIS3;HLF;MXI1;NFIA;NR2F2;ZEB1;HIVEP2;VDR;RARB;ZIC1;TEAD1;PRRX1;PPARA;HOXC4;GLI2;MITF;TBX18;DLX3;NFAT5;PRDM5;IKZF4;SMAD3;CREB5;TFEC;ZKSCAN2;STAT5B;NKX6-1;HOXB3;HOXC5;TBX21;KLF15;GLI3;TFCP2;ZEB2;PBX4;SP7;HDX;FOSB;CEBPB;ZNF112;PKNOX2;EBF1;SOX21;HES3;ZKSCAN7;TOP1;HNF4G;HOXC9;ZNF394;FOXA2;ZNF296;DMRTA2;SP5;DMTF1;ZNF697;SIX4;NFIX;BCL11A;RFX7;RARG;SOX2;ZSCAN21;RBPJ;NSD1;SNAPC3;FOXD3;HES5;ZBTB45;ATOH8;CREB3L4;CREB3;GLIS1;GATA3;MLXIP;CTCF;KCNIP3;SOX5;HOXC10;HOXB9;HOXC6
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.34874847849798796,-1.0810018757064692,0.32972972972972975,0.6853052610844402,1.0,7/30,14.06%,SLC39A10;TMEM165;SLC39A8;SLC40A1;SLC39A1;SLC39A11;SLC39A7
prerank,hormone receptor binding (GO:0051427),-0.42686164929505693,-1.0809992781999427,0.37613019891500904,0.6816405270679459,1.0,7/14,39.67%,SOCS2;JAK2;ADCYAP1;NCOA6;NPPC;VIP;TYK2
prerank,solute:sodium symporter activity (GO:0015370),0.36150135293521446,1.079537912272755,0.33986928104575165,0.713416968838022,1.0,5/27,8.21%,SLC17A1;SLC5A3;SLC28A3;SLC20A2;SLC4A7
prerank,cysteine-type peptidase activity (GO:0008234),-0.29100260373401227,-1.0787212405996716,0.2903225806451613,0.6843320676151726,1.0,15/73,11.24%,CAPN2;CTSZ;USP1;USP46;CTSO;CASP7;CTSC;USP7;CASP8;USP8;USP9X;CTSF;UCHL1;USP5;CTSB
prerank,alanine transmembrane transporter activity (GO:0022858),-0.4403463485539384,-1.0784838055457668,0.3694158075601375,0.6813835887448,1.0,2/12,4.18%,SLC6A6;SLC38A5
prerank,hyaluronic acid binding (GO:0005540),0.4571873653182898,1.0776662352091306,0.37583892617449666,0.713686898758686,1.0,1/10,0.26%,CEMIP
prerank,cation channel activity (GO:0005261),-0.2720615310366004,-1.0754668056931853,0.32558139534883723,0.685859667580113,1.0,11/94,5.19%,PIEZO2;ANO6;KCNK5;ANO1;TRPC3;TRPM7;ABCC9;TRPM6;PIEZO1;ANXA2;PKD1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.4511988606609537,-1.0726288578641394,0.4051094890510949,0.6896235908196909,1.0,3/11,21.23%,RPS3;NEIL1;APEX2
prerank,growth factor receptor binding (GO:0070851),0.2785848219782246,1.0702353713806363,0.3319327731092437,0.7283138081237719,1.0,19/95,13.71%,AREG;KL;PDGFRA;TNK2;VEGFB;TGFA;IL1RAP;IL4;GLMN;PDGFRB;PDGFD;CD300LF;ERBB4;CNTF;ESM1;IL6R;PIBF1;BTC;TSLP
prerank,filamin binding (GO:0031005),-0.4492199716632283,-1.0689122872408434,0.4017857142857143,0.6956620731403098,1.0,7/11,33.61%,NEBL;TMEM67;MICALL2;RFLNB;FBLIM1;RFLNA;DPYSL4
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",-0.2853984770053124,-1.0676150748131594,0.3207171314741036,0.6952769853904607,1.0,17/72,10.99%,STXBP6;KCNJ2;PARD3;VILL;ANXA2;KCNQ1;HIP1R;FLII;JPH2;FZD7;PFN1;MAPKAP1;HIP1;RPH3A;TIRAP;FCHO2;EXOC1
prerank,NADPH binding (GO:0070402),-0.4328901167574599,-1.0668488054304217,0.4074074074074074,0.6936735490045315,1.0,3/13,9.26%,LBR;DUS2;DECR1
prerank,metalloexopeptidase activity (GO:0008235),0.31406393250772197,1.0664346738329133,0.34710743801652894,0.7334133261318337,1.0,12/51,10.89%,AGBL4;MMP16;CPZ;AEBP1;CPA6;CPQ;PEPD;CPXM1;ANPEP;ENPEP;FOLH1;TRHDE
prerank,cytokine receptor binding (GO:0005126),0.28569064021919616,1.0652993400002473,0.30973451327433627,0.7316730755919789,1.0,17/83,13.71%,TGFBR3;IL34;VEGFB;SMAD3;IL1RAP;IL13RA1;IL4;CD300LF;IL18;IL27;CCL25;CNTF;OSMR;IL6R;PIBF1;PRLR;TSLP
prerank,CCR chemokine receptor binding (GO:0048020),-0.35169970207902435,-1.0632096942854605,0.36693548387096775,0.6998343892237026,1.0,19/28,49.42%,NES;CCL15;CCL2;NARS1;CCRL2;CCL5;CCL11;CCL4;CCL7;CCL14;MSMP;CX3CL1;DEFB130A;CCL1;CCL3;XCL1;DEFB1;CCR2;CXCL13
prerank,G protein-coupled receptor activity (GO:0004930),0.24554528958358512,1.0617647901035747,0.3320825515947467,0.735725957629065,1.0,37/239,15.37%,ADGRV1;LGR4;PDGFRL;ADGRB3;LPAR1;GPR88;GPR55;P2RY13;GPR174;GRM1;CCR10;OPRK1;MC5R;GPR171;PDGFRB;HRH1;CALCR;PROKR2;LPAR4;GLP2R;NMBR;ADRA1D;GPR173;C3AR1;ADRA1B;GPR161;CRHR1;GRM4;PAX8;P2RY1;GPR34;CXCR4;DRD2;ADGRL1;HCRTR1;RXFP1;ADRA1A
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.42080246590465553,-1.0603389129207814,0.3808630393996248,0.7040690988297228,1.0,5/14,21.60%,KCNJ2;KCNQ1;KCNJ8;KCND3;KCNIP2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.2631449752984973,1.0579029995523468,0.3431952662721893,0.7405850987889585,1.0,36/134,15.99%,SLC1A3;SLC13A3;SLC6A9;SLC16A12;GJA1;SLC7A2;SLC6A13;SFXN5;SLC35D1;ABCC2;MFSD12;SLC22A3;SLC26A1;SLC38A1;SLC36A2;SLC7A9;SLC25A13;SLC25A42;SLCO5A1;SLC6A1;SLC1A5;SLC38A3;CTNS;SLC46A1;SLC38A9;SLC25A15;SLC35B1;OCA2;SLC1A2;SLC38A6;SLC7A3;SLC1A7;SLC25A24;SLC3A1;SLC25A18;SLC16A7
prerank,gap junction channel activity (GO:0005243),0.3750861864023592,1.0559910000821846,0.4018058690744921,0.7409919442453898,1.0,2/22,1.53%,GJB6;GJA1
prerank,core promoter sequence-specific DNA binding (GO:0001046),-0.3279678079303341,-1.0556547960131106,0.38992537313432835,0.7127251893054795,1.0,14/35,30.31%,FOXP1;NR3C1;H3-3A;POU2F1;SMARCA4;DRAP1;STAT1;RELA;KLF10;PARK7;TAF1B;NPM1;TAF4;MYC
prerank,nuclear localization sequence binding (GO:0008139),-0.3838231339009406,-1.0544722919835179,0.3814814814814815,0.7120766775998094,1.0,8/18,38.22%,NFKBIA;KPNA1;KPNA4;TNPO2;KPNA6;NUP214;IPO5;CABP1
prerank,thioesterase binding (GO:0031996),-0.44243678101950723,-1.0542955579395779,0.4107142857142857,0.7089710233715664,1.0,4/11,24.36%,RAC1;TRAF1;CDC42;TRAF6
prerank,metal ion binding (GO:0046872),0.22457863556470287,1.0532285880676169,0.2943327239488117,0.7438278536008143,1.0,59/477,10.92%,ENPP1;ADGRV1;ADCY2;FBN1;HMGCLL1;CLEC3B;PLSCR2;PAM;FBLN1;SLC8A1;EYA2;KCNIP4;LRP1;NRXN1;CDH8;SCUBE1;ITPR1;PLA2G5;ANXA10;PLA2G4A;CDH18;GNAI1;RAP2A;DCHS1;AMY1A;AMY1C;AMY1B;TNNC1;ATP2A2;MAN1C1;ASTN2;ASPH;CDH11;CDH20;CDH19;CDH7;LOXL2;SYT1;GEN1;SLC25A13;MICU3;OTOF;TRIM27;SCIN;PPA2;S100A7A;PPA1;PDXK;C2CD5;CDK5R1;CDH10;MCTP2;MEX3B;NAALADL1;EML1;SYT13;BRSK1;CDHR3;BAIAP3
prerank,protein kinase C activity (GO:0004697),-0.40673193823578346,-1.0524834469728481,0.4098360655737705,0.7100987261319205,1.0,3/14,5.46%,PRKCH;PRKCZ;PRKD3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),-0.24293092351049375,-1.0513430858715245,0.3525641025641026,0.7096571411134502,1.0,48/188,18.36%,BNC2;MEF2C;FLI1;JUND;NCOR1;KLF4;FOXO3;ETS1;SOX17;VSX1;SIX1;REST;RBBP5;PRDM16;NFYA;SOX13;FOXK1;SMAD6;GATA6;ATF4;YY1;HDAC4;TAL1;SOX7;DHX9;HHEX;SOX18;GABPA;FOXC2;SOX12;KMT2D;SFPQ;SOX4;GRHL1;MTERF3;NR5A2;ETV5;SMAD4;SOX6;SMARCA2;POU2F2;LIN54;ZBTB48;RELA;SP1;ARID4B;GLI1;ZNF568
prerank,transaminase activity (GO:0008483),0.4415958449474959,1.0503082513693374,0.4025695931477516,0.7469277718673984,1.0,5/11,21.85%,ABAT;BCAT2;GOT1;BCAT1;GOT2
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.39593877347194845,1.048186280676816,0.39588100686498856,0.7477612105938435,1.0,1/15,0.26%,PIK3R1
prerank,protease binding (GO:0002020),0.2779311959446736,1.0478770672621347,0.35826771653543305,0.7441115103800408,1.0,12/99,7.28%,CCBE1;COL1A2;TIMP3;SLC2A13;BCL2;CFLAR;PRKN;SUMO1;SERPINE1;TRIP4;ATP9A;TIMP4
prerank,wide pore channel activity (GO:0022829),0.36926230639112184,1.0475597927094191,0.39111111111111113,0.7405055191508343,1.0,2/23,1.53%,GJB6;GJA1
prerank,sodium channel regulator activity (GO:0017080),0.32392237302212706,1.0444238969767534,0.36645962732919257,0.7442771408412528,1.0,6/37,10.37%,FGF14;SCN3B;GPD1L;FXYD1;FXYD7;FXYD6
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",-0.3735922259833929,-1.0428302477392073,0.4043321299638989,0.7283937908213352,1.0,16/18,53.84%,HSD17B10;HSD17B2;HSD11B1;HSD17B1;HSD17B7;SRD5A2;HSD17B8;HSD3B7;HSD3B2;AKR1C1;DHRS9;DHRS11;RDH16;HSD17B6;HSD17B3;RDH5
prerank,exopeptidase activity (GO:0008238),-0.3014389946809786,-1.0427730390931182,0.36553030303030304,0.7249140778121506,1.0,18/50,22.30%,DPP4;FAP;CTSZ;LTA4H;ERAP1;PRCP;CPE;ACE2;DPEP3;DPP8;LNPEP;ACE;RCE1;CNDP2;METAP1D;BLMH;LAP3;NPEPPS
prerank,cytokine receptor activity (GO:0004896),0.28164395372810597,1.0424107497114397,0.3668032786885246,0.7451952391658155,1.0,15/83,12.65%,IL31RA;CNTFR;LEPR;CCR6;IL1RAP;IL13RA1;ACKR4;ACKR2;GHR;IL1RL2;CCR9;OSMR;IL6R;GFRA2;PRLR
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.3322284734750271,-1.0385151284320027,0.38330170777988615,0.7324107442205728,1.0,6/28,17.16%,DAB2IP;RIPK1;TRAF1;MADD;STAT1;BABAM2
prerank,I-SMAD binding (GO:0070411),-0.408459369982184,-1.0354720776931545,0.4188191881918819,0.7370083351861995,1.0,6/13,18.21%,SMAD9;SMAD7;SMAD6;SMURF1;SMAD4;SMAD2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3161132019682702,1.0333962606376081,0.3969957081545064,0.7642029461240428,1.0,4/38,5.80%,SERPINE2;SERPINI2;SERPINF1;SERPINE1
prerank,retinoic acid receptor binding (GO:0042974),-0.3853597038714779,-1.0319286213657675,0.4084249084249084,0.7429843984896196,1.0,4/17,6.24%,ACTN4;NR4A2;TACC1;NRIP1
prerank,sterol transfer activity (GO:0120015),-0.3784556098598544,-1.031161959773666,0.4245810055865922,0.7414928686069928,1.0,5/17,12.22%,PLTP;ABCG1;GRAMD1C;GRAMD1A;STARD5
prerank,mannosyltransferase activity (GO:0000030),0.36676451275764727,1.03027869548015,0.40993788819875776,0.7679217690286262,1.0,9/21,22.70%,TMTC1;TMTC3;TMTC4;POMT2;DPY19L1;DPM1;DPY19L4;PIGB;ALG8
prerank,flavin adenine dinucleotide binding (GO:0050660),0.29327546457007736,1.028120098041261,0.4088176352705411,0.7688839357312032,1.0,8/53,7.61%,MICAL3;KDM1B;PRODH;POR;CYB5R2;KMO;DDO;CRY1
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3205237440783111,-1.0276895448062064,0.38779527559055116,0.746615447084437,1.0,8/34,16.61%,IQGAP1;RICTOR;CALM1;FAM20A;MTCP1;CALM3;CAB39;CCNK
prerank,protein kinase inhibitor activity (GO:0004860),-0.3157952544019382,-1.024804045202006,0.42884990253411304,0.7505544132754979,1.0,18/42,31.80%,RACK1;CDKN1B;TAOK3;DUS2;TRIB1;INKA2;CIB1;CDKN1A;NCK1;CDKN1C;YWHAB;CIT;RPTOR;SPRY4;NPM1;PPP1R1B;SPRED1;SH3BP5
prerank,pre-mRNA binding (GO:0036002),0.3415323397342219,1.0245218369730833,0.3858093126385809,0.7737227136403463,1.0,5/28,9.28%,CELF2;RBM41;RNPC3;CELF4;SLU7
prerank,platelet-derived growth factor binding (GO:0048407),0.417939979997494,1.0241579034451425,0.4305239179954442,0.7701777645450805,1.0,3/11,6.77%,COL1A2;PDGFRA;PDGFRB
prerank,protein tyrosine kinase activator activity (GO:0030296),0.367133964401568,1.0233213069534155,0.42203742203742206,0.7679925015983763,1.0,3/19,8.27%,NRG3;NRG1;ERBB3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.36978684143368623,1.01387919229716,0.4250559284116331,0.7880283740691187,1.0,1/18,0.26%,PIK3R1
prerank,chemokine receptor activity (GO:0004950),0.3462645095120504,1.0124737566745163,0.4264705882352941,0.7874495127578492,1.0,5/24,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3175931095466927,1.0119935878861126,0.44398340248962653,0.7842888915593392,1.0,3/35,2.02%,ENPP1;PLCL1;PLCXD1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.2126458215171242,1.011214439967368,0.4205607476635514,0.7820289634744213,1.0,74/597,10.53%,TCF7L2;TCF4;ARNT2;ZBTB20;MAF;AR;TBX3;HLF;BCOR;TBL1XR1;RARB;MCM3;ZIC1;TEAD1;HOXC4;GLI2;TBX18;DLX3;NFAT5;PRDM5;SMAD3;CREB5;TFEC;ORC4;TBX21;KLF15;GLI3;TFCP2;CREB3L1;PHOX2A;HOXC8;FOSB;CEBPB;HOXB8;PKNOX2;ZNF513;HOXC9;LIN28B;ATF5;BBX;GABPB1;GABPB2;PRDM9;FOXA2;ZNF296;DMRTA2;CUX1;LHX4;MEN1;MBD2;DMTF1;SIX4;NFIX;RFX7;RARG;SOX2;FOXD3;HES5;ZBTB45;CREB3L4;CREB3;GLIS1;GATA3;CTCF;CUX2;SOX5;HOXC10;ERBB4;HOXB9;FOXR2;MCM2;ZIC4;SKOR2;MCM9
prerank,R-SMAD binding (GO:0070412),0.3679620139232087,1.0074448225043988,0.4595744680851064,0.7872117146662309,1.0,4/18,7.29%,LDLRAD4;SMAD3;PMEPA1;MEN1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),-0.2910162847688601,-1.0048702656473743,0.4216417910447761,0.8000522546992431,1.0,20/49,29.00%,MINDY2;MINDY1;PRPF8;BRCC3;UIMC1;VCP;UBXN1;SPRTN;RAD18;UBL7;TNFAIP3;TAB2;BABAM2;ZFAND2B;RAD23A;EPS15;RAD23B;PARP10;ATRIP;UBQLN2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.4351070039364866,-1.0047882202125749,0.47435897435897434,0.7927783266740999,1.0,6/10,38.74%,DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.4351070039364866,-1.0047882202125749,0.47435897435897434,0.7927783266740999,1.0,6/10,38.74%,DUSP4;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2
prerank,proton transmembrane transporter activity (GO:0015078),-0.30204637613325414,-1.0035090659849373,0.4390681003584229,0.7922834814187758,1.0,22/39,40.19%,COX4I1;COX6B1;CLCN3;NNT;UQCRQ;COX15;NDUFA4;UQCR11;COX10;UQCRH;NDUFA4L2;CLCN5;COX8A;COX4I2;COX7A2L;SLC4A11;COX5B;SLC11A2;UQCRFS1;COX6A1;CLCN4;UQCRC1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.4274942191107173,-1.0016000644801535,0.4859154929577465,0.7935839607863747,1.0,5/10,23.23%,PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.36184503027319936,-0.999430901748658,0.4726930320150659,0.7955890140654297,1.0,6/18,29.99%,RPS6KA3;TNFAIP8;SERPINB9;XIAP;BIRC5;RPS6KA1
prerank,microtubule binding (GO:0008017),-0.22702725368745566,-0.9965228050188963,0.456,0.799613654810131,1.0,69/222,27.13%,MTUS1;DNM3;RAB11A;MID2;RPS3;MAP1LC3B;MAP4;MID1;RP1;CHP1;EZR;CEP57;GAPDH;KIF9;KIF23;KIF1B;CEP290;SPEF1;DCTN1;TRPV4;KIF16B;GAS8;FHDC1;SGIP1;KIF26A;RCC2;KATNB1;FMR1;MAP1LC3A;SNPH;NDE1;NDEL1;GAS2L1;OPA1;MAP1B;REEP4;MAPRE2;DNM1;KIF18A;KRIT1;ARHGEF2;TPX2;KNSTRN;FMN1;MAP1A;DNM2;KIF1C;KIF18B;NEFM;APC2;CAMSAP3;KIF13A;RMDN1;KIF22;CCDC170;CEP44;CLIP1;CLIP2;CCDC88A;KIF17;ARL3;HAUS4;CAPN6;RMDN3;KIFC2;MAP7D3;BIRC5;RACGAP1;EML3
prerank,protein tyrosine kinase binding (GO:1990782),-0.2695901003013569,-0.9962075856514189,0.4838709677419355,0.7968509630601424,1.0,14/71,12.11%,PTPN14;RACK1;BMPR2;GRB14;TJP2;RNF41;NEDD9;DOCK4;CRK;SHC1;PITPNM2;DUSP3;ACVR1;PITPNM3
prerank,hexose transmembrane transporter activity (GO:0015149),-0.40647615881804683,-0.9950825093472734,0.4660377358490566,0.7961651989097634,1.0,5/12,19.33%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,PDZ domain binding (GO:0030165),0.28217370327332,0.9938168337807572,0.4816414686825054,0.8190883718977845,1.0,8/61,7.71%,TGFBR3;ARHGAP29;GRID2;PLEKHA2;SLC22A4;PRKN;CXXC4;NLGN1
prerank,sterol binding (GO:0032934),0.2939574737014359,0.9927315920111199,0.4684317718940937,0.8172071223355822,1.0,12/56,12.73%,RORA;ABCA1;OSBPL10;OSBPL8;VDAC2;INSIG2;SCAP;GRAMD1B;SYP;OSBP;SIDT1;ERLIN1
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.42045683022629554,-0.9893678316710837,0.47833935018050544,0.8074922701494459,1.0,4/10,24.24%,ANKRD13A;IDE;LAPTM5;FAN1
prerank,cation transmembrane transporter activity (GO:0008324),0.2954937543883189,0.9887411093766141,0.45114345114345117,0.823346878445701,1.0,14/48,14.90%,SLC6A9;SLC7A2;MFSD12;SLC22A3;SLC38A1;SLC36A2;SLC41A1;SLC1A5;SLC38A3;SLC38A9;SLC25A15;OCA2;SLC38A6;SLC7A3
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.31466624390996234,-0.987810546986333,0.4588910133843212,0.8079331923018711,1.0,5/30,12.06%,RPS6KA3;CAST;TNFAIP8;CST3;SERPINB9
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3253373743743593,0.987317708549715,0.4699570815450644,0.8223373846220695,1.0,10/32,13.29%,SLC6A9;SLC43A1;MFSD12;SLC38A1;SLC36A2;SLC7A9;SLC1A5;SLC38A3;SLC38A9;SLC38A6
prerank,zinc ion binding (GO:0008270),0.22097612432622812,0.9863943937592388,0.4846743295019157,0.820361039247328,1.0,54/293,13.97%,ENPP1;PAPPA;ADAM33;PAM;MYCBP2;ZEB1;SEC24D;RBAK;CBLB;GLI2;IKZF4;SMAD3;KDM1B;BBOX1;P2RX4;MDM2;MMP16;KDM7A;DUSP12;RNF2;PRKN;MNAT1;HDAC10;BAZ1B;SMPDL3B;SIRT2;ANPEP;CXXC4;KMT2A;ENPEP;NSD1;PDXK;BLM;SLU7;CTCF;CHMP1A;RNF26;SEC24A;NAALADL1;TRHDE;DPP3;KDM2A;ZFYVE1;APIP;SEC23A;PHF8;ZFP37;CXXC5;ZNF205;CDADC1;BIRC2;ARIH2;LITAF;GRIN2A
prerank,TBP-class protein binding (GO:0017025),-0.3521317735206543,-0.9843759859971452,0.4876760563380282,0.8131102756493094,1.0,5/21,16.47%,ESR1;HHEX;PSMC5;DRAP1;PSMC1
prerank,potassium:proton antiporter activity (GO:0015386),-0.42631905106089557,-0.9836061603836935,0.4750889679715303,0.8114036424832578,1.0,1/10,0.51%,SLC9A2
prerank,calcium channel inhibitor activity (GO:0019855),-0.410734761596424,-0.9830336963054156,0.47469458987783597,0.8092097982010497,1.0,3/11,4.23%,MCUB;CALM1;FKBP1A
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.3406036483269079,-0.9820013386557028,0.4897579143389199,0.8083085601254423,1.0,6/22,9.56%,ATP6V0B;ATP2C1;ATP2A3;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,aspartic-type endopeptidase activity (GO:0004190),-0.3989820067638568,-0.9813433182429504,0.5044722719141324,0.8064992760264427,1.0,2/12,5.84%,BACE2;BACE1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.2693912504213953,0.981273749670311,0.47540983606557374,0.8295118810459717,1.0,14/70,17.29%,B3GALT1;B3GALNT1;MGAT4C;GXYLT2;B3GNT7;B3GLCT;POGLUT2;B3GALT2;EXTL1;B3GALT5;CHSY3;CHSY1;B4GAT1;B3GNT6
prerank,glucuronosyltransferase activity (GO:0015020),-0.35181190370080556,-0.9800868518834706,0.49355432780847147,0.8063971945790696,1.0,1/19,0.70%,CSGALNACT1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.3273048632550217,0.9793335908699046,0.47058823529411764,0.8300942309184125,1.0,13/29,21.07%,SLC13A3;ABCC2;SLC26A1;SLC25A13;SLC25A10;SLC1A5;SLC46A1;SLC25A30;SLC25A18;SLC26A4;SLC38A7;SLC13A5;SLC19A1
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.34510171114462757,0.9788889228770731,0.46466809421841543,0.8267579463497658,1.0,5/23,6.46%,SH3PXD2B;WDR45B;SNX14;GBF1;WIPI1
prerank,DNA binding (GO:0003677),0.20161936395533187,0.9779876993846991,0.5253623188405797,0.824699573099645,1.0,105/694,13.65%,TCF7L2;TCF4;RORA;TBX3;EPAS1;HLF;NR2F2;RBMS1;C1D;HIVEP2;DMC1;VDR;RARB;MCM3;TEAD1;PPARA;GLI2;DLX3;PRDM5;SMAD3;TBX21;BCL2;DDB2;TFCP2;ZEB2;PBX4;MPG;SP7;STN1;FOSB;ZNF35;JCHAIN;CAMTA1;CEBPB;ZMYM6;SOX21;ZNF292;ZNF513;TOP1;RNF138;TAF6L;ATF5;PRDM9;FOXA2;TOP3A;SETMAR;KHDRBS1;CUX1;LHX4;MEN1;ATAD5;CRY1;RARG;SOX2;RBPJ;TIGD4;SAFB2;RBM5;SNAPC3;DNMT1;SWSAP1;POLR2G;RADX;BLM;GATA3;FUBP1;RPA2;CTCF;CUX2;TOPORS;MCM2;ZIC4;GTF3C3;MCM9;ANG;NUP35;RAD51C;GRHL3;MCM8;ARID5B;GTF3C2;SNAPC1;SLTM;AHR;RAD51B;POGK;PMS2;GLYR1;ORC1;GTF3C6;SURF6;APLP2;DDX60;CXXC5;NBN;SSBP2;PGR;SATB1;PAX8;PAX3;CENPS;EP300;ATF6;NKX2-1;MYBBP1A
prerank,SUMO binding (GO:0032183),-0.38379485742687425,-0.9777907891810078,0.50187265917603,0.8090596399452031,1.0,6/13,26.43%,HERC2;RNF111;UBA2;USPL1;SERBP1;TDG
prerank,leucine zipper domain binding (GO:0043522),0.4056774384868886,0.9777418537224623,0.4847161572052402,0.8209534130109291,1.0,5/10,19.25%,PAWR;PMF1;CRX;DDIT3;AATF
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.2964498666328028,-0.9758099920845626,0.4869402985074627,0.810373443628105,1.0,13/38,20.97%,PARD3;DAB2IP;DENND1A;ZFYVE26;JPH2;TECPR1;HIP1;KIF16B;PHLDA3;PLEKHF1;SNX3;WIPI2;RUBCNL
prerank,calcium channel regulator activity (GO:0005246),-0.30221911617803576,-0.9741240053153022,0.49460431654676257,0.8111951605985604,1.0,9/37,16.79%,PRKG1;MCUB;CALM1;FKBP1A;REM1;STIM2;CACNB3;SRI;NRXN2
prerank,syntaxin-1 binding (GO:0017075),0.35017565274193135,0.9738427835719898,0.4978448275862069,0.8268948772697665,1.0,10/22,19.63%,UNC13C;DAPK1;SYT1;CPLX2;SNAP25;SYP;STXBP3;VAMP3;SYNPR;STXBP5
prerank,snoRNA binding (GO:0030515),-0.31503595350197744,-0.9713173411303195,0.4959677419354839,0.8151549322275397,1.0,6/30,12.96%,NOP14;PRKDC;NOP56;DHX37;NUDT4;DKC1
prerank,double-stranded DNA binding (GO:0003690),-0.2001144772804337,-0.9711775997665509,0.5827956989247312,0.812024609537069,1.0,102/531,18.58%,KLF12;LEF1;FOXP1;ELK3;ERG;MEF2C;TBX15;NR3C2;ESR1;KLF3;FLI1;HMBOX1;JUND;PPARD;KLF2;KLF4;ELF1;TBX1;ZSCAN29;FOXO3;RPS3;ZBTB7A;VSX1;SIX1;LHX6;TBX2;NR4A2;TFCP2L1;BHLHE40;FOXK1;USF2;RARA;PRDM4;GATA6;ATF4;GATA2;PRKDC;SAFB;NR3C1;ZNF276;FOXQ1;HDGF;NR2C2;YY1;ZMYND11;BCL6;SOX7;DHX9;NFATC1;SOX18;ESRRA;JUNB;ZIC3;PRRX2;GABPA;FOXC2;ZBTB18;E2F3;SP3;SOX12;TEAD2;HIVEP1;E2F1;PNKP;SOX4;SPRTN;HES1;GRHL1;AIM2;MLX;RFX2;FOXD2;BCL6B;NR5A2;HEY1;ETV5;EGFR;SRF;IRF9;ETV4;RFX5;POU2F2;STAT1;ZNF76;GMEB2;KLF6;ETS2;ZNF32;ZBTB2;ZBTB48;HOXB4;XBP1;WDR48;FOXL2;NR6A1;SP1;DRGX;GTF2H4;E2F4;SMAD2;IRF8;CGAS
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.34132909109748105,-0.9689582002182505,0.5074906367041199,0.8140447667735501,1.0,6/20,12.90%,EIF3F;USP7;OTUD5;USP9X;OTUB1;COPS5
prerank,ephrin receptor binding (GO:0046875),-0.34415889026081825,-0.9688867713546607,0.5231910946196661,0.8107056034745703,1.0,15/21,37.77%,CHN1;CRK;SHC1;ANKS1A;EFNB3;EFNB1;PTPN1;PIK3CG;EFNA2;EFNA4;SRC;ABL1;CBL;FYN;EFNA1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.34698024074252226,0.9688357759457141,0.516260162601626,0.8312039500981797,1.0,4/21,10.12%,CDK8;CDK14;CDKL3;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.34698024074252226,0.9688357759457141,0.516260162601626,0.8312039500981797,1.0,4/21,10.12%,CDK8;CDK14;CDKL3;CDK20
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",-0.38747220603202737,-0.9684313022969416,0.4952919020715631,0.8083955277581599,1.0,7/12,37.14%,CBR1;NQO1;NQO2;DCXR;DHRS4;NDUFS7;AIFM2
prerank,protein heterodimerization activity (GO:0046982),0.2350993977895214,0.9676805266067675,0.513184584178499,0.8296084283938672,1.0,11/178,3.90%,BMP6;TCF4;ARNT2;ATP1A2;EPAS1;GPHB5;TENM3;ZHX2;DGKD;BCL2;TENM2
prerank,transition metal ion binding (GO:0046914),0.20904103191734344,0.9666013678865394,0.5547169811320755,0.8280036460643657,1.0,65/397,13.97%,ENPP1;ADCY2;PAPPA;ADAM33;PAM;MYCBP2;AGMO;ZEB1;HEPH;SEC24D;RBAK;CBLB;GLI2;IKZF4;SMAD3;KDM1B;BBOX1;P2RX4;MDM2;MMP16;KDM7A;DUSP12;MOXD1;RNF2;PRKN;MNAT1;HDAC10;BAZ1B;SMPDL3B;LOXL2;SCD5;SIRT2;ANPEP;CXXC4;KMT2A;LOXL3;ENPEP;NSD1;PDXK;BLM;SLU7;CTCF;CHMP1A;RNF26;SOD2;SEC24A;NAALADL1;ANG;TRHDE;DPP3;KDM2A;SOD3;ZFYVE1;APIP;SEC23A;PHF8;ZFP37;CXXC5;MGAT2;ZNF205;CDADC1;BIRC2;ARIH2;LITAF;GRIN2A
prerank,chloride channel activity (GO:0005254),0.2741306301967295,0.9654048412281919,0.4930139720558882,0.8268384429643515,1.0,17/59,15.96%,ANO7;CLCN2;GABRA2;GABRR3;GLRB;GABRB3;FXYD1;ANO3;GABRR2;GABRA5;CLCN1;CLCN6;GLRA3;ANO5;GABRB1;GABRG1;GABRG3
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.3270394178205616,-0.9648523370271442,0.5145631067961165,0.8142287082601753,1.0,8/25,16.50%,ARAP3;HIP1R;AKT1;MAPKAP1;HIP1;KIF16B;GAB2;PHLDA3
prerank,single-stranded DNA helicase activity (GO:0017116),-0.3429898490209069,-0.9644627773094309,0.4877126654064272,0.8117494570772792,1.0,11/19,32.39%,DHX9;HELQ;POLQ;RFC3;MCM5;RFC2;DNA2;DSCC1;CHTF18;PIF1;HELB
prerank,semaphorin receptor binding (GO:0030215),0.33430465769076534,0.9631195257451267,0.5011185682326622,0.8285614374965518,1.0,4/23,4.77%,SEMA5A;SEMA3A;RIT2;SEMA3D
prerank,nuclear import signal receptor activity (GO:0061608),-0.37477518696904355,-0.963094760649238,0.5130597014925373,0.811819938340916,1.0,8/15,42.66%,KPNA1;TNPO3;KPNA4;TNPO2;KPNA6;IPO5;KPNA7;IPO9
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",-0.27709865183876004,-0.9616643893176174,0.5304990757855823,0.8122009219959222,1.0,13/54,17.19%,ACER2;TGM2;HDAC9;PIGL;HDAC4;ASAH2;GLS;HINT1;MIER2;ACER3;FAAH;MIER1;AMDHD2
prerank,DNA-binding transcription factor binding (GO:0140297),-0.2239326817102672,-0.9614654076867868,0.5509803921568628,0.8092337901704465,1.0,50/189,18.45%,MEF2C;LMO2;TLE4;PPARD;NCOR1;MEF2A;KLF4;ZBTB7A;PRDM16;HDAC7;HDAC9;WWP2;CTBP1;BHLHE40;PTMA;USF2;TLE3;ATF4;CHCHD2;HCFC1;HSPB1;CBX5;HDAC4;TAL1;DHX9;TWIST1;ZMYND8;NFATC1;HHEX;RB1;DDRGK1;MTA2;GABPA;MTA1;PSMC5;YWHAZ;MIER2;HES1;SRF;LDB1;ZFPM2;STAT1;TCF3;DDX20;MIER1;RELA;KDM1A;SP1;SMAD2;CHD4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.407192710631725,-0.9614589618401258,0.5093984962406015,0.8058869964045359,1.0,7/10,41.97%,NCF2;CYBB;NOX1;NCF1;NOX3;NCF4;DUOX1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.35582359651236406,-0.960506036962716,0.5091575091575091,0.8049468724898127,1.0,9/16,33.34%,RPS3;CD38;SMUG1;NEIL1;ADPRH;TDG;BST1;OARD1;NEIL3
prerank,transcription coregulator binding (GO:0001221),0.28273139902513866,0.9596809491306387,0.5282608695652173,0.8333206679616695,1.0,15/50,18.00%,RORA;AR;SMAD3;CHD6;CTCF;AHR;EHMT2;PER3;PGR;EZH2;THAP7;MTF2;CDK9;USP11;PER1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.3238299707871246,-0.9570128131007498,0.516728624535316,0.8103526986194463,1.0,9/24,24.37%,KCNJ2;ABCC9;KCNJ10;KCNJ8;KCNJ15;KCNK6;ABCC8;KCNN3;KCNJ13
prerank,ubiquitin binding (GO:0043130),-0.25314326708718815,-0.9565233028049123,0.551923076923077,0.8083108026817049,1.0,20/73,17.29%,ASCC2;MVB12B;N4BP1;HSPB1;UBE2L6;PLAA;OTUB1;RNF185;UCHL1;TOLLIP;USP5;UBXN1;SPRTN;FAF2;VPS36;TSG101;TOP2A;TNFAIP3;UCHL3;WDR48
prerank,fatty acid synthase activity (GO:0004312),-0.4167105325607779,-0.9558934663319179,0.56,0.8064414666023134,1.0,3/10,17.96%,ELOVL7;ELOVL5;ELOVL1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.3606250465060719,-0.9552397465967843,0.5152603231597845,0.8047874999543471,1.0,5/15,14.19%,HS3ST3A1;NDST1;NDST3;HS3ST1;HS3ST3B1
prerank,transcription cis-regulatory region binding (GO:0000976),0.20835749931886952,0.9535810343863574,0.6007827788649707,0.8443045139852496,1.0,49/406,9.82%,TCF7L2;RORA;ZBTB20;AR;EPAS1;MXI1;BCOR;TBL1XR1;RBAK;TRPS1;TEAD1;TBX18;PRDM5;SMAD3;TBX21;KLF15;GLI3;TFCP2;CREB3L1;TFDP1;PHOX2A;AEBP1;HOXC8;ZNF35;CEBPB;HOXB8;ZNF513;ATF5;BBX;GABPB1;GABPB2;PRDM9;FOXA2;CUX1;LHX4;MEN1;DMTF1;NFXL1;SOX2;SNAPC3;FOXD3;CREB3;GATA3;MLXIP;CTCF;CUX2;SOX5;HOXC10;ERBB4
prerank,symporter activity (GO:0015293),-0.39989137154999926,-0.951734080382476,0.542649727767695,0.8102606304806425,1.0,2/10,6.76%,SLC5A6;MFSD2A
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",-0.22208115090303093,-0.9504735907851936,0.6019607843137255,0.8102208634756619,1.0,49/173,23.30%,KLF12;FOXP1;ELK3;DACH1;PPARD;FOXO3;REST;PRDM16;TBX2;PRDM2;BHLHE40;SOX13;FOXK1;HEYL;ZBTB16;LRRFIP1;KLF8;NR3C1;YY1;PLAGL1;BCL6;HHEX;MXD1;FOXP2;SKIL;ZBTB18;HES1;MLX;BCL6B;HEY1;ZFHX3;TCF3;ETS2;ZBTB2;RELA;FOXP4;IRF8;SKI;ZBTB33;NFATC3;ZBTB49;E2F6;THAP11;NR2F1;ETV6;ZBTB34;ATF3;ENO1;GZF1
prerank,high voltage-gated calcium channel activity (GO:0008331),0.4093307420960745,0.9495327448349383,0.5171673819742489,0.8501117001135934,1.0,3/10,8.22%,CACNB4;CACNB2;CACNB1
prerank,ion gated channel activity (GO:0022839),0.32819626406666413,0.9474567237349264,0.5308370044052864,0.8513465224883955,1.0,4/24,6.42%,KCNT2;ANO7;ANO3;TRPM5
prerank,mRNA 3'-UTR binding (GO:0003730),0.2575442510301851,0.9466100774922425,0.5484536082474227,0.8493038405708344,1.0,14/79,15.17%,CELF2;RBMS3;RBMS1;DAZAP1;PABPC1L;CSDC2;IGF2BP2;CPEB3;KHSRP;FXR2;SECISBP2;PARN;RBM24;GEMIN5
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.39701281880425365,-0.9440411609016416,0.5355191256830601,0.8227850909379713,1.0,4/10,12.18%,DPP4;FAP;PRCP;DPP8
prerank,alkali metal ion binding (GO:0031420),0.37478280763492405,0.9418334388214072,0.4954954954954955,0.8572602451792396,1.0,2/13,8.89%,ATP1A2;PDXK
prerank,MAP kinase kinase activity (GO:0004708),-0.356809847074735,-0.9381600259133175,0.5380333951762524,0.8340831043630702,1.0,2/15,4.10%,MAP2K5;MAPKAPK3
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3331824761838462,0.937074915106177,0.5368421052631579,0.8644479026736485,1.0,4/21,6.15%,PRKACA;AKAP8L;ACBD3;ARFGEF2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.3845242573028377,-0.9355015128524793,0.5557553956834532,0.8372143124420414,1.0,2/11,13.67%,PRMT8;PRMT3
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.3996206203759831,-0.9302073814733041,0.577570093457944,0.8465710042546098,1.0,5/11,30.48%,ANAPC11;RBX1;AMFR;UBE4A;PRPF19
prerank,palmitoyltransferase activity (GO:0016409),-0.3010674370393841,-0.929583245254412,0.5770676691729323,0.8447957960726468,1.0,12/28,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC5;ZDHHC23;ZDHHC12;ZDHHC17;HHAT;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.3754744936762072,-0.9291243341202414,0.5701107011070111,0.8424770036499516,1.0,5/12,16.61%,CDK6;BRD4;CDK4;CDK13;CCNK
prerank,histone methyltransferase activity (GO:0042054),0.29554713553137424,0.9285861981854626,0.5414937759336099,0.8813544177179563,1.0,9/32,15.92%,PRDM9;MEN1;SMYD1;SETD7;SMYD3;EHMT2;NSD3;EZH2;KMT5B
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.24512150893873957,0.9278860372444829,0.5769230769230769,0.8789922718082602,1.0,12/91,8.16%,SVIL;FRMPD4;SH3PXD2B;WDR45B;SNX14;GBF1;SNAP91;WIPI1;SYTL2;TULP3;GSDMD;SCIN
prerank,thyroid hormone receptor binding (GO:0046966),-0.30191767153306,-0.9274256616245254,0.5671077504725898,0.8430914509972449,1.0,4/28,7.95%,JMJD1C;NCOR1;TACC1;MED24
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),-0.27778873143421745,-0.9250399398695567,0.5765595463137996,0.8455962342528973,1.0,9/42,19.30%,CCND3;CCNY;CDKN1B;CCNG2;CCNF;CDKN1A;CCNK;CDKN2C;CCND1
prerank,ATPase binding (GO:0051117),0.25228738882738916,0.9247641457213805,0.5910852713178295,0.8822001932535076,1.0,14/71,14.06%,AR;ATP6V0A4;ABCA1;SLC2A13;ANK2;METTL21A;TMTC4;ANK1;ATXN3;ALDOB;NKD2;USP25;PGR;ATP1B3
prerank,histone acetyltransferase binding (GO:0035035),0.32422840201982583,0.9238699591809858,0.5668016194331984,0.8801113420009331,1.0,5/21,7.93%,EPAS1;GLI3;TRIP4;SIRT2;CITED2
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3312383917549509,-0.9227630974832772,0.5688729874776386,0.8477023351028206,1.0,5/20,14.06%,SLC39A10;SLC39A8;SLC39A1;SLC39A11;SLC39A7
prerank,cGMP binding (GO:0030553),-0.3816304150590118,-0.9216116597882139,0.5789473684210527,0.8470629256136609,1.0,2/11,4.53%,PDE5A;PDE2A
prerank,voltage-gated anion channel activity (GO:0008308),-0.3514474941986123,-0.9199596910841615,0.5850860420650096,0.8476384374782842,1.0,6/15,20.98%,ANO6;ANO1;CLCN3;GPR89B;GPR89A;CLCN5
prerank,protein phosphatase regulator activity (GO:0019888),0.267247993022159,0.919532607826752,0.5794979079497908,0.8872663584189764,1.0,3/53,2.73%,RCAN2;PTN;DMPK
prerank,glucose transmembrane transporter activity (GO:0005355),-0.34164062637784703,-0.9171213715293204,0.5746268656716418,0.8511300229205424,1.0,5/17,19.33%,SLC2A1;MFSD4A;SLC2A8;SLC2A3;SLC2A4
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.3672702727859499,-0.9170418201709218,0.5815602836879432,0.8480219211100344,1.0,4/12,17.07%,H3-3A;POU2F1;STAT1;RELA
prerank,calcium-dependent phospholipid binding (GO:0005544),-0.2590262651976666,-0.916608426240355,0.5828460038986355,0.8458730141217387,1.0,15/49,25.11%,ESYT2;ANXA1;ANXA2;DYSF;CPNE8;ANXA4;RPH3A;SYT2;ESYT3;CPNE3;SYT15;PLA2G4F;ANXA8;ANXA3;DOC2B
prerank,clathrin adaptor activity (GO:0035615),-0.3528942330653225,-0.9154097921755883,0.576427255985267,0.8451916870937313,1.0,9/15,34.25%,HIP1R;AP2M1;HIP1;AP2A1;AP2A2;AP1G2;AP1G1;AP2B1;STON2
prerank,amyloid-beta binding (GO:0001540),-0.2393118120457001,-0.9128436586863097,0.6195219123505976,0.8477834899140125,1.0,13/79,12.43%,COL25A1;APBB2;ITM2A;FZD6;FZD4;TGFB2;PFDN5;BACE1;INSR;CST3;CD74;APOE;TLR4
prerank,MAP kinase activity (GO:0004707),-0.35179879453440555,-0.9122411959994979,0.5522388059701493,0.845913832356614,1.0,2/14,2.70%,NLK;MAPK3
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.38215150566295075,0.9118392934339631,0.5770065075921909,0.9022340022718667,1.0,1/12,1.29%,GPR88
prerank,chemokine binding (GO:0019956),0.294654408172349,0.9110878310301008,0.5865580448065173,0.8997104668758769,1.0,5/30,8.81%,CCR6;ACKR4;ACKR2;CCR10;CCR9
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.25747729048026236,-0.9098275211885929,0.6206225680933852,0.8483285476008905,1.0,11/55,11.62%,ITPR2;TRPC3;TRPM7;TMEM165;ATP2C1;ANXA2;PKD1;ATP2A3;ORAI1;TRPV4;ATP2B3
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.26897534425865594,0.9073071548693095,0.6,0.9047908888283255,1.0,16/44,15.92%,PRDM9;SETMAR;MEN1;KMT2A;KMT5C;NSD1;SMYD1;CXXC1;SETD7;SMYD3;EHMT2;SETD5;NSD3;EZH2;WDR82;KMT5B
prerank,RNA polymerase II complex binding (GO:0000993),-0.28710359892396475,-0.9065587252793936,0.6158301158301158,0.8522823505436294,1.0,14/32,35.80%,RPRD1B;BRD4;ZNF326;DHX9;SMYD2;PCIF1;CCAR2;SCAF1;RPRD1A;RTRAF;ESRRB;PCF11;ELOF1;CDC73
prerank,ribosomal large subunit binding (GO:0043023),-0.375543137209641,-0.9034949451445781,0.5845323741007195,0.8561840527663784,1.0,5/11,36.47%,NMD3;LTN1;NPM1;RBM3;CPEB2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.3616532648959171,-0.9025089986150403,0.5688405797101449,0.8553376365964365,1.0,4/12,24.36%,TRAF1;STAT1;BABAM2;TRAF6
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",-0.28347894709197685,-0.9016452654403102,0.5964285714285714,0.8540139774080899,1.0,16/33,38.04%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;EXD2;XRN2;ISG20;DCP2;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,mitogen-activated protein kinase binding (GO:0051019),-0.2906397001305689,-0.9011463841058928,0.6081330868761553,0.8519812110333209,1.0,13/29,36.25%,PTPRJ;GCH1;MAPKAPK3;NFATC1;ACE;CDK5RAP3;DUSP4;DUSP6;DUSP1;ABL1;DUSP7;MAPK7;DUSP5
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.37484102529245966,0.898555877517388,0.5838779956427015,0.9221492084121957,1.0,3/11,7.95%,CFLAR;CASP3;CASP12
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.3468257020678346,-0.8974598908744189,0.5963963963963964,0.8569266680633119,1.0,6/15,23.23%,PI4K2A;PIK3C2A;PIK3R3;PIK3CA;PIK3C2B;PIK3CG
prerank,O-methyltransferase activity (GO:0008171),0.3870022466191213,0.8965237674113001,0.5796460176991151,0.9228696550553096,1.0,3/10,15.82%,HENMT1;COMT;BCDIN3D
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.3868853311371403,0.8961000833925783,0.5807860262008734,0.9195301286510572,1.0,3/10,7.95%,CFLAR;CASP3;CASP12
prerank,mRNA binding (GO:0003729),-0.196737201673983,-0.8913567493369734,0.8179871520342612,0.8676771944820422,1.0,46/249,14.96%,DDX5;RPS14;RPL41;NOVA2;RPL26;RPS3;HNRNPA2B1;HNRNPLL;RBM20;CNBP;EIF4G3;QKI;RPS5;RPS13;RPL35;SRSF5;PTBP3;RBFOX2;PKM;N4BP1;YBX3;RC3H1;SRSF6;RBM47;NCL;DHX9;PCBP4;ACO1;TDRD7;PPP1R8;RPL13A;LUC7L2;EIF3D;LARP4B;YTHDF2;CIRBP;ZC3H11A;RPS7;RBMS2;RNPS1;FMR1;SRSF4;EIF4A1;RNF20;RBM4B;HNRNPK
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.3061703742340266,-0.8901146880178784,0.6303142329020333,0.8671376969279886,1.0,5/22,15.15%,MESD;AP2M1;DNAJA1;APOE;AP2A1
prerank,chloride channel inhibitor activity (GO:0019869),-0.3857788274616418,-0.8899071339496447,0.6353790613718412,0.8644221117939941,1.0,3/10,17.38%,WNK1;STX1A;VTI1B
prerank,GABA receptor binding (GO:0050811),-0.37670283881079974,-0.8896684675917569,0.6261180679785331,0.8618390653863732,1.0,3/11,7.11%,TRAK1;GABARAP;TRAK2
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2582723425592779,0.8853084872973439,0.6592741935483871,0.9409513803969766,1.0,7/49,10.27%,ATP1A2;PLCXD1;DUSP12;PXYLP1;SMPDL3B;HDHD2;LHPP
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",0.3604369081233074,0.884221837482442,0.6169724770642202,0.9392633072700737,1.0,5/12,14.56%,PDE7B;PDE3B;PDE4B;PDE3A;PDE4A
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.212134796367128,0.8835151951932301,0.7330595482546202,0.9365959322685997,1.0,18/181,9.09%,TCF7L2;ARNT2;LDB2;AR;TBX3;NCOA2;PRRX1;PPARA;TTC8;SMAD3;PTPRT;TRIP4;CRY1;RBPJ;NCOA1;MIER3;ATN1;BRMS1
prerank,channel activity (GO:0015267),0.2701571275855678,0.8821694029964885,0.6490066225165563,0.935531835030516,1.0,7/41,13.02%,CHRNA1;STEAP1;BCL2;TRPM5;TRPA1;CHRNA7;CHRNB1
prerank,calcium-release channel activity (GO:0015278),-0.32550929655448135,-0.8814064901350489,0.6287878787878788,0.8763783025325282,1.0,2/17,3.95%,ITPR2;ITPR3
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.27286389788524334,-0.8813630533036734,0.6465028355387523,0.8733156203439947,1.0,14/35,23.72%,QRSL1;DUS2;TRMT9B;GATC;QTRT2;TRDMT1;TRPT1;QTRT1;PTRH2;ELAC1;AARS2;MRPL58;TYW3;GATB
prerank,endopeptidase activity (GO:0004175),0.19946376765284252,0.881126611044495,0.7705882352941177,0.9340322361296781,1.0,29/257,12.01%,ADAMTS6;ADAMTS12;ADAM33;ADAMTS10;TRABD2B;PRTN3;ADAMTS5;RHBDL3;CORIN;MMP16;SFRP1;OMA1;USP37;PLG;CASP3;MMP11;PCSK2;PSMA3;SENP1;USP29;PARL;ECE2;EEF1AKMT4-ECE2;USP40;THOP1;USP47;ADAMTS9;USP25;ADAMTSL4
prerank,alpha-tubulin binding (GO:0043014),0.28806882196142575,0.8787615399121479,0.6161825726141079,0.9352775264981601,1.0,6/31,10.13%,EML4;DLEC1;PACRG;DNAL1;CDK5R1;TBCEL
prerank,telomeric DNA binding (GO:0042162),-0.280788447408979,-0.8780020603448832,0.6537037037037037,0.8770952521980703,1.0,14/32,33.31%,HMBOX1;HNRNPA2B1;NCL;UPF3A;ZBTB48;KDM1A;SMG7;SMG1;TERF2IP;UPF1;SMG6;PIF1;TERT;RAD50
prerank,potassium channel regulator activity (GO:0015459),0.25540852453231055,0.8769991928658689,0.6602564102564102,0.9352376224617862,1.0,10/49,15.48%,KCNIP4;DPP10;SLC5A3;SUMO1;KCNIP3;DPP6;AMIGO1;KCNS3;KCNS1;WNK3
prerank,N-acetyltransferase activity (GO:0008080),0.3111841006697407,0.8762327159147538,0.6162280701754386,0.9328945886187934,1.0,3/19,13.45%,NAT8;SAT1;EP300
prerank,bHLH transcription factor binding (GO:0043425),0.31601609837088673,0.8730151378654191,0.6171171171171171,0.936113641442325,1.0,2/19,2.77%,FHL2;SMAD3
prerank,P-type ion transporter activity (GO:0015662),-0.35667772430426364,-0.8708609200951954,0.647887323943662,0.8891713428576777,1.0,7/12,32.64%,ATP2C1;ATP2A3;ATP2B3;ATP2B1;ATP7B;ATP2C2;ATP2A1
prerank,ankyrin binding (GO:0030506),-0.31666865204163064,-0.870743698595338,0.6628131021194605,0.8861886936944963,1.0,2/19,1.41%,CDH1;SPTBN1
prerank,carboxypeptidase activity (GO:0004180),0.2819896279138817,0.8705242231025928,0.6543478260869565,0.937531858895972,1.0,8/35,10.82%,AGBL4;CPZ;AEBP1;CPA6;PEPD;CPXM1;NAALADL1;FOLH1
prerank,methyl-CpG binding (GO:0008327),0.29780020007799035,0.8698497016127694,0.6190476190476191,0.9348383273879801,1.0,5/22,12.76%,LHX4;MBD2;CXXC4;CXXC5;ERH
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.31646903240383906,0.8676893937420279,0.6043956043956044,0.9357257672403885,1.0,3/17,12.07%,NME3;CMPK1;NOL9
prerank,transferrin receptor binding (GO:1990459),-0.37140995213759437,-0.8663802715558093,0.6514084507042254,0.8920185627951024,1.0,6/10,36.91%,CD81;IKBKB;CHUK;SNX2;IKBKG;SNX1
prerank,transcription corepressor binding (GO:0001222),0.2951455051479817,0.865393690556714,0.6171171171171171,0.9368202000771664,1.0,8/27,18.00%,RORA;EHMT2;PER3;EZH2;THAP7;MTF2;USP11;PER1
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.34257937199969485,-0.8638007725496285,0.6556776556776557,0.8939361719435179,1.0,7/13,47.74%,ECH1;ECI1;IDI1;EBP;DCT;HSD3B2;SREBF2
prerank,single-stranded RNA binding (GO:0003727),-0.25920989190227556,-0.8628748561320797,0.7087378640776699,0.8927961598559216,1.0,11/43,20.33%,IFIH1;STRBP;CNBP;SNRPC;DHX9;JMJD6;DHX58;FMR1;HNRNPA1;SRA1;RBM7
prerank,monocarboxylic acid binding (GO:0033293),0.31605255326759707,0.861813091106403,0.634090909090909,0.940488606661871,1.0,1/18,1.19%,NR2F2
prerank,snRNA binding (GO:0017069),-0.25693076285589206,-0.8599577596091881,0.6926147704590818,0.895479644989062,1.0,14/42,22.84%,PRPF8;SNRPA;SNRPC;RBM22;SNRPD3;LSM11;EFTUD2;DDX39B;LSM2;LSM7;RBM7;MEPCE;NCBP2;LSM10
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.28608566968241256,-0.8562675639604825,0.6994535519125683,0.8998996455340978,1.0,10/26,28.46%,PPP1R1A;PABIR1;PPP1R8;LMTK2;BOD1;MGAT5;ARPP19;PPP1R14B;STYXL1;PPP1R1B
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.35949144022117857,0.8553347465724935,0.6261061946902655,0.9502039093487935,1.0,1/11,3.19%,CNGB3
prerank,endoribonuclease activity (GO:0004521),0.2764220805023152,0.8539964690479785,0.6653061224489796,0.9491188757363394,1.0,10/32,20.54%,NYNRIN;EXOG;RIDA;PIWIL2;ENDOV;RCL1;RNASEL;AGO3;AGO1;AGO2
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2791287664758562,-0.8535012512848483,0.6988416988416989,0.9020882316724486,1.0,8/27,18.84%,RNF144B;DCUN1D5;RNF125;DCUN1D1;TOLLIP;ZMYM2;FOXL2;RNF19A
prerank,FMN binding (GO:0010181),-0.3541250060603319,-0.852833533425764,0.6764705882352942,0.9002070820030788,1.0,2/11,7.25%,NOS3;DUS2
prerank,3'-5'-exoribonuclease activity (GO:0000175),-0.26495422702503546,-0.8512490837288722,0.7,0.9002845053389661,1.0,15/34,38.04%,CNOT7;ERI1;DIS3L2;PAN2;DIS3;NOCT;EXOSC9;EXD2;XRN2;ISG20;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,carboxylic ester hydrolase activity (GO:0052689),-0.2168716930922194,-0.8500474849085384,0.7932405566600398,0.899558185010686,1.0,31/85,36.30%,ABHD2;MGLL;NDST3;PNPLA2;PGLS;PLAAT3;PON3;FAAH;LYPLA1;LCAT;DAGLB;GDE1;ABHD8;PTRH2;AARS2;MRPL58;PLA2G4F;ENPP2;BCHE;PLA2G4B;PAFAH1B3;PLA2G7;ESD;ABHD6;AOAH;LIPE;ABHD16A;PLB1;AARS1;LYPLAL1;LYPLA2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.2411809543919918,0.8497867118368758,0.7067209775967414,0.9540825106717161,1.0,7/60,11.75%,PPM1E;LRRK1;ILKAP;PPM1D;PPM1H;PTEN;TAB1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.336505909682168,0.8484644935090963,0.6674311926605505,0.9528872045801353,1.0,6/13,25.21%,FTSJ1;TARBP1;TRMT1L;TRMT5;THUMPD2;THUMPD3
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",-0.3132084771927043,-0.8468614567901888,0.6648351648351648,0.8995577329147804,1.0,4/16,9.56%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",-0.3132084771927043,-0.8468614567901888,0.6648351648351648,0.8995577329147804,1.0,4/16,9.56%,ATP6V0B;ATP6V0A2;ATP5F1B;ATP6V0C
prerank,tubulin binding (GO:0015631),0.18932303497712358,0.846673668889255,0.9273084479371316,0.952475134115844,1.0,66/295,18.53%,GJB6;MTUS2;GJA1;IFT81;KIF13B;TTLL11;EML4;AGBL4;UXT;KIF5C;DLEC1;PRKN;TTLL9;MAP9;ATF5;MDM1;SAXO2;GPAA1;PACRG;TUBGCP4;UNC5C;CEP295NL;KIF7;DNAL1;GOLGA2;IFT74;ALMS1;CDK5R1;KIF21A;CAMSAP1;DYNC1I1;TBCEL;KIF3C;EML1;BRSK1;FSD1;MAP10;KIF3A;B9D2;KIF6;KIF1A;VBP1;MACO1;NAV3;MAPT;TUBGCP2;CEP57L1;DLGAP5;SPAST;MAP6;PAK1;CKAP5;CCDC181;ABRAXAS2;DAG1;SVBP;EMD;NUMA1;EFHC1;HAUS6;KIF21B;NDRG1;DRG1;KATNA1;S100A8;S100A9
prerank,phosphatase activator activity (GO:0019211),-0.3369920628271667,-0.846149698994803,0.670863309352518,0.8977825649367991,1.0,6/14,17.33%,CALM1;PPP2R5A;PHACTR4;CALM3;GTF2F1;PPP2R5E
prerank,glutathione transferase activity (GO:0004364),-0.2835936549133503,-0.8443372270095486,0.7005649717514124,0.8982254999161837,1.0,10/23,29.73%,GSTA4;GSTM2;GSTA3;GSTM1;MGST3;GSTK1;GSTM5;GSTO1;ALOX5AP;MGST2
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.3223129838567174,0.8408126252324778,0.6645299145299145,0.9609290960197164,1.0,2/15,3.83%,PLA2G4A;SH3PXD2B
prerank,endodeoxyribonuclease activity (GO:0004520),-0.29741451735021834,-0.8390138456924987,0.7088607594936709,0.9053459495718634,1.0,9/20,33.31%,RPS3;ERCC1;DCLRE1C;ERCC4;EXO1;DNA2;MRE11;ENDOG;RAD50
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.2338007248233674,0.8383029562992174,0.7427385892116183,0.9619008088304221,1.0,18/69,18.56%,PLA2G4A;BAAT;KAT8;MOGAT3;DBT;MOGAT2;ZDHHC2;EP300;PLAAT5;MCAT;DGAT2;PORCN;CERS4;ASPG;ZDHHC15;CERS6;GTF2B;ZDHHC6
prerank,RNA polymerase core enzyme binding (GO:0043175),-0.2618570058332047,-0.8368483774579625,0.7391304347826086,0.9061740288491951,1.0,7/33,17.25%,RPRD1B;ZNF326;DHX9;MAF1;SMYD2;ERBB2;CCAR2
prerank,voltage-gated ion channel activity (GO:0005244),0.33449594399035715,0.834001189973674,0.6816143497757847,0.966747961161875,1.0,4/14,10.94%,CACNA1E;VDAC2;KCND2;VDAC3
prerank,3'-5' exonuclease activity (GO:0008408),-0.24711684194400138,-0.8339612583352556,0.7730627306273062,0.9084297300082093,1.0,21/45,38.04%,CNOT7;ERI1;RAD1;DIS3L2;REV3L;PAN2;RAD9A;EXD1;DIS3;NOCT;EXOSC9;MRE11;EXD2;XRN2;ISG20;RAD50;ANGEL2;ANGEL1;USB1;PDE12;ERI2
prerank,1-phosphatidylinositol binding (GO:0005545),0.3214079252514553,0.8293712600801948,0.6797385620915033,0.971965887676602,1.0,5/15,16.33%,SNAP91;SCIN;SNX9;ZFYVE1;ZFYVE9
prerank,nuclease activity (GO:0004518),0.24490785396347098,0.8279783469261692,0.7422907488986784,0.9704790562660358,1.0,8/52,13.45%,ENPP1;SETMAR;EXOG;ANG;RNASE4;REXO5;PARN;ANKLE1
prerank,cyclic nucleotide binding (GO:0030551),0.293129013409762,0.8254750636746696,0.6788793103448276,0.97149055561418,1.0,8/21,21.93%,RAPGEF4;CNGB3;PDE11A;PDE4B;PDE4A;KCNH1;SLC19A1;PDE10A
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.28160956674881854,-0.8249621982500336,0.7390510948905109,0.9214909796230736,1.0,11/22,40.16%,PPM1F;DUSP3;DUSP23;DUSP4;MTMR2;DUSP6;DUSP1;DUSP7;DUSP5;DUSP2;MTMR3
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.27663806939948904,-0.8249317561233612,0.7222222222222222,0.9184423760687314,1.0,10/24,31.17%,ZDHHC9;ZDHHC1;ZDHHC20;ZDHHC23;ZDHHC12;ZDHHC17;ZDHHC3;ZDHHC18;GOLGA7B;ZDHHC24
prerank,miRNA binding (GO:0035198),0.27346911915979977,0.8244699325691706,0.7225806451612903,0.9693877254033647,1.0,10/30,22.54%,TUT4;AGO4;SOX2;PNPT1;RBM10;AGO3;AGO1;AGO2;MATR3;ZC3H7B
prerank,pyrophosphatase activity (GO:0016462),-0.23567347502857527,-0.8238022762042205,0.7647058823529411,0.9174855325447484,1.0,9/50,12.49%,ENTPD1;PLPP1;DCPS;DHX9;PRUNE1;ENTPD7;PRUNE2;NUDT4;ENTPD6
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.3322513907080099,-0.821822864240153,0.7072727272727273,0.9180592356791523,1.0,3/13,8.26%,SLC7A1;SLC38A5;SLC7A7
prerank,aminopeptidase activity (GO:0004177),-0.27259984092149697,-0.8206196694273126,0.7317518248175182,0.9170302449193887,1.0,10/26,22.52%,LTA4H;ERAP1;MMP14;MMP15;LNPEP;METAP1D;BLMH;LAP3;NPEPPS;MMP17
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.3461559464996487,-0.8192851823192628,0.7019064124783362,0.9163559412214709,1.0,2/11,12.43%,DCPS;NUDT4
prerank,myosin V binding (GO:0031489),-0.3171634777827653,-0.819151481098046,0.7316176470588235,0.9135496052764187,1.0,4/15,11.50%,RAB11A;RAB6B;RAB8A;RAB11B
prerank,retinoid X receptor binding (GO:0046965),0.345732164039013,0.8187173566919534,0.6739606126914661,0.9764783357250195,1.0,3/11,8.09%,VDR;RARG;NSD1
prerank,histone demethylase activity (GO:0032452),-0.26908364522149075,-0.8179319252438596,0.75,0.9126180114003358,1.0,6/27,17.66%,JMJD1C;KDM5C;KDM3A;JMJD6;KDM1A;KDM6A
prerank,kinesin binding (GO:0019894),-0.26642761940470244,-0.8166722042910987,0.7357414448669202,0.9117679774764967,1.0,4/27,14.48%,ACTB;PLEKHM2;KIF1B;SPAG9
prerank,DNA polymerase binding (GO:0070182),-0.2915921602918029,-0.8099629567700826,0.7345794392523365,0.9199905543701111,1.0,7/18,37.70%,HSP90AB1;SMARCA4;HSP90AA1;FANCD2;SMG6;RAD51;LONP1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.3413998883267597,-0.8075978916758471,0.7382671480144405,0.9209569240105363,1.0,3/11,14.95%,KCNQ1;KCNJ8;KCND3
prerank,galactosyltransferase activity (GO:0008378),-0.3373686257111354,-0.8036243350496215,0.7102803738317757,0.9247334953995511,1.0,3/11,14.83%,A4GALT;B4GALT4;A3GALT2
prerank,carbohydrate:cation symporter activity (GO:0005402),0.3331723857818542,0.8015146377264771,0.6899766899766899,1.0,1.0,1/11,2.70%,SLC5A3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.27379336274992466,-0.8009431973729921,0.749034749034749,0.925937302378859,1.0,8/24,25.55%,CERT1;DAB2IP;JPH2;PLEKHF1;SNX3;RUBCNL;GOLPH3;GOLPH3L
prerank,CXCR chemokine receptor binding (GO:0045236),0.33336540635236267,0.7981474169850704,0.7081447963800905,1.0,1.0,4/11,21.39%,PPBP;CXCL1;CXCL12;CXCL10
prerank,chloride channel regulator activity (GO:0017081),-0.3092024816938793,-0.7968580225636418,0.7389770723104057,0.9294991540958956,1.0,2/14,6.19%,WNK1;STX1A
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.28589786206913104,0.7954936089231516,0.7484276729559748,1.0,1.0,9/20,26.11%,MOGAT3;MOGAT2;DGAT2;ABHD5;LCLAT1;PNPLA3;AGPAT4;PLA2G15;LPCAT1
prerank,regulatory RNA binding (GO:0061980),0.24912831826421314,0.7952001636287691,0.7821576763485477,1.0,1.0,12/38,23.08%,TUT4;AGO4;SOX2;PNPT1;PIWIL2;RBM10;AGO3;AGO1;AGO2;MATR3;ZC3H7B;DICER1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.3405792410442269,0.7918698586198265,0.6822222222222222,1.0,1.0,2/10,13.47%,ADARB2;CDADC1
prerank,GTPase inhibitor activity (GO:0005095),-0.30910739181185276,-0.789441728321298,0.7428057553956835,0.9383818613380474,1.0,5/13,19.08%,IQGAP1;SLIT2;RTKN;CDC42SE1;ARL2
prerank,Hsp70 protein binding (GO:0030544),-0.24756153236159048,-0.7893128624159556,0.8077669902912621,0.9355762608423956,1.0,12/31,29.89%,RPS3;DNAJC8;DNAJB12;DNAJA1;NOD2;IQCG;DNAJB1;PPEF2;PPID;FICD;ERN1;RNF207
prerank,phospholipase activity (GO:0004620),-0.2136358953204459,-0.7890276241630977,0.8552631578947368,0.9330507118306641,1.0,24/67,36.30%,PLCE1;PLCB3;MGLL;SMPDL3A;PLAAT3;PITPNM3;PLD3;LYPLA1;GDE1;PLA2G4F;NAPEPLD;ENPP2;PLD4;SMPD1;LIPH;PLA2G4B;SMPD2;ABHD6;PLCB2;ABHD16A;PLB1;FAM83B;LYPLAL1;LYPLA2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.26788633713214216,0.7853623398164485,0.774468085106383,1.0,1.0,7/28,17.51%,TNK2;PRKACA;MAPKAPK5;AURKC;PRKCG;MAP2K4;MAPK10
prerank,metalloaminopeptidase activity (GO:0070006),-0.29791587001208675,-0.7843991984825053,0.7606679035250464,0.9373698280207455,1.0,7/16,22.52%,LTA4H;ERAP1;MMP14;MMP15;LNPEP;NPEPPS;MMP17
prerank,RNA polymerase binding (GO:0070063),0.2908314807945954,0.7809008659454256,0.7622222222222222,1.0,1.0,8/18,22.97%,PABPN1;YTHDC2;SCAF8;CCNT1;NEDD4;TCERG1L;BIN1;PKN2
prerank,phosphatase inhibitor activity (GO:0019212),0.28660824073034846,0.7808970241045426,0.7296703296703296,1.0,1.0,1/20,0.72%,PTN
prerank,solute:proton symporter activity (GO:0015295),0.2893687553849986,0.7792081168686361,0.7638297872340426,1.0,1.0,4/16,11.47%,SLC2A13;SLC36A2;SLC33A1;CTNS
prerank,microtubule minus-end binding (GO:0051011),0.31130487828379927,0.7786676639813366,0.7340425531914894,1.0,1.0,4/13,17.06%,TUBGCP4;CAMSAP1;TUBGCP2;NUMA1
prerank,hydro-lyase activity (GO:0016836),-0.2319281332201481,-0.7785683774496522,0.8220858895705522,0.9432179288235991,1.0,13/41,26.94%,CA4;ECHS1;ACO1;UROS;ECI1;HACD4;ACO2;ENO1;ALAD;PARK7;AUH;CDYL;HACD2
prerank,motor activity (GO:0003774),0.21749162574891115,0.7783515538017891,0.8278867102396514,1.0,1.0,11/60,12.37%,GPR88;KIF13B;KIF5C;DYNC2H1;KIF7;KIF21A;DYNC1I1;KIF3C;KIF3A;KIF6;KIF1A
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.31989112541281967,-0.7766765801361282,0.7708703374777975,0.9432283725556324,1.0,6/12,40.17%,DCPS;NCBP2;EIF4E;CYFIP2;CYFIP1;NCBP1
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.29787236426974406,0.776379008724359,0.7437070938215103,1.0,1.0,2/14,9.78%,NME3;CMPK1
prerank,exonuclease activity (GO:0004527),-0.2226474231632859,-0.7727151301754491,0.8729281767955801,0.9460667969640583,1.0,19/46,30.72%,CNOT7;ERI1;ISG20L2;RAD1;DCLRE1C;REV3L;AEN;RAD9A;EXOSC8;EXD1;APEX2;ENPP2;FAN1;EXO1;EXOSC9;MRE11;EXD2;XRN2;ISG20
prerank,iron ion binding (GO:0005506),-0.22708027736859424,-0.7723568375645998,0.8508604206500956,0.9436108962650414,1.0,10/48,13.39%,EGLN3;CDO1;KDM3A;FTL;EGLN2;JMJD6;EGLN1;FTH1;FXN;ISCA2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),-0.29396162075025606,-0.7712939819609056,0.7760617760617761,0.9423214934236667,1.0,4/15,21.70%,AGPAT1;ABHD8;AGPAT5;LPCAT2
prerank,lipid phosphatase activity (GO:0042577),0.30101196336483405,0.7704534575916846,0.7796976241900648,1.0,1.0,4/14,16.04%,PLPP3;PLPPR1;PLPPR5;PLPP7
prerank,signal sequence binding (GO:0005048),0.23898181040092364,0.7646639700584222,0.8109243697478992,1.0,1.0,7/35,17.64%,CEMIP;KDELR3;TOMM70;TIMM22;PEX5L;IPO4;KDELR2
prerank,magnesium ion binding (GO:0000287),-0.18616979270048942,-0.763148676325378,0.9484126984126984,0.9507892362485696,1.0,35/135,26.43%,MAP3K5;NLK;MAP3K20;PI4K2A;PDE2A;PGM1;SRPK1;DYRK2;HACL1;CDC42BPB;DIS3L2;ABL2;STK38;NUAK2;TOP2A;STK38L;STK26;OPA1;XYLT2;UBA2;MAPK12;MAP3K6;IDH3A;GCLC;SNRK;ADPRH;NUDT18;RRAGC;BRSK2;SIK1;NME1;FAN1;SIK3;PDCD6;TDG
prerank,histone deacetylase activity (GO:0004407),0.27519264709611035,0.7602786995914715,0.7711111111111111,1.0,1.0,6/19,17.00%,HDAC10;SIRT2;MIER3;HDAC8;SIRT6;HDAC1
prerank,phosphatase activity (GO:0016791),0.2065084830572349,0.7597711981904615,0.8941908713692946,1.0,1.0,27/73,25.01%,ATP1A2;DUSP12;PXYLP1;PLPP3;PLPPR1;HDHD2;LHPP;CILP2;LPIN3;PLPP4;FRA10AC1;PLPPR5;PSPH;LPIN1;OCRL;ARMT1;DUSP28;DUSP26;NT5M;PLPP5;ACP5;DUSP10;PPP1CC;BPNT2;SBF1;PLPPR4;DUSP8
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),-0.24002708232466294,-0.7594442949145337,0.8516260162601627,0.9529048219441659,1.0,14/34,34.73%,UBE2Q2;UBE2L6;UBE2G2;UBE2F;UBE2Q1;UBE2G1;UFC1;UBE2B;UBE2J2;UBE2I;UBE2T;UBE2R2;UBE2QL1;UBE2C
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.29921592975208666,-0.7583620422350069,0.7905282331511839,0.9513965951298089,1.0,6/13,27.46%,PIP5K1B;PIK3C2A;PIK3CA;PIK3C2B;PIK3CG;PIP5K1A
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.2377912120420318,0.7566307666514096,0.8150537634408602,1.0,1.0,14/33,24.69%,AR;SCAF8;NCOA3;LLPH;GTF2B;RPRD2;WAC;AGO1;PAF1;AGO2;UVSSA;URI1;CTR9;SUPT4H1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.3285318807375049,0.7561235647392955,0.755056179775281,1.0,1.0,1/10,3.07%,TATDN1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.24892593119880665,-0.7549268944742134,0.8435754189944135,0.9528188109117333,1.0,3/27,7.32%,SLC9A2;SLC9B2;SLC4A8
prerank,fibroblast growth factor binding (GO:0017134),-0.26900302760044803,-0.7525245050204867,0.8402255639097744,0.9532718452920027,1.0,9/21,23.46%,THBS1;RPS19;CEP57;S100A13;FIBP;FGFRL1;ITGB3;API5;FGFR3
prerank,chemokine activity (GO:0008009),0.24030917802275495,0.7492058224497732,0.832271762208068,1.0,1.0,7/31,21.39%,CXCL16;PPBP;CCL25;CXCL1;CKLF;CXCL12;CXCL10
prerank,tRNA binding (GO:0000049),-0.2236773452685213,-0.7490072902928403,0.8667883211678832,0.9549812425980951,1.0,9/43,18.03%,EEF1A1;SARS1;CARS1;TRMT9B;SARS2;TRMT10C;FARS2;RPUSD4;HSD17B10
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.24173877533670965,-0.7403010359899177,0.8568627450980392,0.9627448224520601,1.0,10/29,27.64%,ACER2;GANC;IDUA;ACER3;GUSB;NEU3;CTBS;GANAB;NEU1;LCT
prerank,gamma-tubulin binding (GO:0043015),0.25572804551595674,0.7362788553323762,0.8289205702647657,1.0,1.0,11/21,28.67%,TUBGCP4;BRSK1;B9D2;TUBGCP2;PAK1;NDRG1;ARHGEF7;OFD1;DDX3X;GIT1;TUBGCP5
prerank,kinase inhibitor activity (GO:0019210),-0.23197226816979477,-0.7349148161140168,0.8458715596330275,0.9663638745876699,1.0,18/33,39.65%,CDKN1B;TAOK3;DUS2;WARS1;TRIB1;CDKN1A;NCK1;CDKN1C;YWHAB;SPRY4;NPM1;PPP1R1B;SH3BP5;ITPRIP;LRP6;GSKIP;SOCS3;GMFG
prerank,DNA secondary structure binding (GO:0000217),0.23209315145787615,0.734735357360748,0.8602150537634409,1.0,1.0,8/31,13.81%,GEN1;MEN1;KMT2A;BLM;RAD51C;RAD51B;FANCM;MAPT
prerank,exoribonuclease activity (GO:0004532),-0.2922613247454158,-0.7300623436929257,0.8093587521663779,0.9692836593473935,1.0,3/12,28.29%,CNOT7;EXOSC8;EXOSC9
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2005276038845359,0.7298434454209268,0.9295774647887324,1.0,1.0,10/73,15.00%,LGR4;SORCS1;OPRK1;MC5R;CALCR;GLP2R;EDNRB;CRHR1;HCRTR1;RXFP1
prerank,amino acid binding (GO:0016597),0.2345605940565994,0.7255118491021475,0.8628318584070797,1.0,1.0,8/31,17.49%,GRIN3A;GLDC;GLRB;GLRA3;ASS1;DDAH2;CASR;GRIN2B
prerank,methylated histone binding (GO:0035064),-0.19767326056353612,-0.7242263343376041,0.9360902255639098,0.9732075306304779,1.0,8/62,9.11%,RBBP5;ING5;DPF2;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.2757258395455661,0.7238176163663087,0.844789356984479,1.0,1.0,4/15,8.67%,PRDM9;SETMAR;KMT2A;CXXC1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.2917986401007898,-0.7222196855944881,0.8245614035087719,0.97263244377681,1.0,2/12,14.93%,CNOT7;PAN2
prerank,WW domain binding (GO:0050699),0.24269038195088385,0.7165471550011913,0.8828828828828829,1.0,1.0,4/26,13.95%,TNK2;PMEPA1;TCEAL1;LITAF
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.22902116194353983,-0.7157377154689928,0.8838951310861424,0.9766494464117602,1.0,6/32,21.37%,KCNB1;KCNQ1;KCNC3;KCNA4;KCNA2;KCNB2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.2899893899702488,0.7123997931224867,0.844789356984479,1.0,1.0,3/11,14.57%,STN1;RPA2;RPA1
prerank,cAMP binding (GO:0030552),-0.30282514422907947,-0.7112950861798816,0.8426763110307414,0.9786833465565797,1.0,2/11,4.53%,PDE4D;PDE2A
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.29171776989133946,-0.711172510670769,0.8457350272232305,0.975900599214717,1.0,2/12,6.71%,JMJD1C;KDM3A
prerank,N-acyltransferase activity (GO:0016410),0.2325634647768771,0.7099990486133235,0.8884120171673819,1.0,1.0,7/32,17.54%,NAT8;SAT1;BAAT;EP300;PLAAT5;CERS4;CERS6
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.2860783542863686,0.7070927989975414,0.8436781609195402,1.0,1.0,4/14,17.92%,MTMR7;PTEN;MTMR10;MTMR9
prerank,microtubule motor activity (GO:0003777),0.20452333975703016,0.7036761283272593,0.9138321995464853,1.0,1.0,9/51,12.37%,KIF13B;KIF5C;KIF7;KIF21A;DYNC1I1;KIF3C;KIF3A;KIF6;KIF1A
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.30173805552844296,0.7008009850455865,0.8187919463087249,1.0,1.0,1/10,2.08%,PRKAG2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.26778611548696707,0.7007984862599509,0.8424657534246576,1.0,1.0,2/16,7.03%,ALOX12;TDO2
prerank,ATP hydrolysis activity (GO:0140603),0.21917797414318124,0.7002965764432076,0.9015317286652079,1.0,1.0,9/41,15.04%,ABCA4;ABCD2;CLPX;SWSAP1;RHOBTB3;SMCHD1;ABCG4;MYO18A;MYO1E
prerank,damaged DNA binding (GO:0003684),-0.20588108776000083,-0.6996716843406798,0.9325842696629213,0.9847456616872167,1.0,10/44,19.11%,RPS3;ERCC1;RAD1;PNKP;DCLRE1C;RAD18;XRCC1;RPA3;POLQ;ERCC4
prerank,chemoattractant activity (GO:0042056),0.2352068909382366,0.6992615222248385,0.8788546255506607,1.0,1.0,3/26,7.29%,GDNF;VEGFB;SCG2
prerank,adrenergic receptor binding (GO:0031690),0.26642550119431047,0.6984199580909556,0.8475750577367206,1.0,1.0,4/16,16.09%,MAGI2;APLP1;DLG4;NEDD4
prerank,microtubule plus-end binding (GO:0051010),-0.25111488351877653,-0.6972326623258116,0.8853046594982079,0.9843119717763225,1.0,7/20,28.74%,DCTN1;MAPRE2;KIF18A;KNSTRN;CLIP1;CLIP2;DST
prerank,manganese ion binding (GO:0030145),0.20598478085231792,0.6923999414687234,0.9290465631929047,1.0,1.0,1/48,0.23%,ADCY2
prerank,histone acetyltransferase activity (GO:0004402),-0.2255120840102297,-0.6918193385742489,0.905123339658444,0.987037353200707,1.0,13/30,32.61%,BAZ1A;EPC1;NAA60;USP22;BRCA2;TADA3;CLOCK;TAF9;KAT6B;TAF10;NAA50;KAT2A;CREBBP
prerank,carboxylic acid binding (GO:0031406),-0.21165370383436266,-0.6894124282466798,0.9219047619047619,0.9864183288003889,1.0,19/38,35.45%,NOS3;PSAP;CAD;GCLC;SESN2;CASTOR2;HIF1AN;RTN4R;THNSL2;GRIN1;SESN1;GNMT;NOS2;EPDR1;SRR;NOS1;SHMT2;GLRA1;MAG
prerank,triglyceride lipase activity (GO:0004806),-0.2431998402357706,-0.6889810031812357,0.87890625,0.9839854042387053,1.0,5/20,33.37%,PNPLA2;LCAT;DAGLB;LIPH;LIPE
prerank,actinin binding (GO:0042805),-0.23896268433892895,-0.684062793662703,0.8862815884476535,0.9857756268906493,1.0,6/21,21.50%,PROM1;RARA;CACNA1D;RELA;CACNA1C;PKD2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.2723218890648472,0.6824581528820379,0.8436724565756824,1.0,1.0,3/13,15.07%,ZGRF1;GEN1;ENDOV
prerank,methyltransferase activity (GO:0008168),0.2040725083753677,0.6822841584352161,0.9288617886178862,1.0,1.0,12/46,21.59%,FTSJ1;HENMT1;COQ5;DNMT1;COMT;NDUFAF7;METTL3;BCDIN3D;ARMT1;METTL27;GCSH;DNMT3B
prerank,5'-3' exonuclease activity (GO:0008409),-0.26276291122416207,-0.6808784098718192,0.8717472118959108,0.9856542781430165,1.0,6/14,33.10%,DCLRE1C;FAN1;EXO1;MRE11;XRN2;DCP2
prerank,methylation-dependent protein binding (GO:0140034),-0.18816272175001658,-0.6762635311284098,0.9690522243713733,0.9869185634829,1.0,7/57,9.11%,RBBP5;ING5;MPHOSPH8;CBX5;ZMYND11;SPIN1;ZMYND8
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.21938168256444504,0.670576417729543,0.9245283018867925,1.0,1.0,14/28,29.34%,POP4;ENDOV;DROSHA;RNASEH1;AGO3;AGO2;PRORP;MRPL44;DICER1;EDC3;DBR1;RPP14;FEN1;POP1
prerank,sequence-specific mRNA binding (GO:1990825),0.29146545322648043,0.6701385209305396,0.8340807174887892,1.0,1.0,4/10,22.72%,LARP6;RBM24;SHFL;SSB
prerank,carboxy-lyase activity (GO:0016831),-0.2282391487553416,-0.6699218933488127,0.9262759924385633,0.989363240067805,1.0,9/23,46.28%,AMD1;DDC;FAHD1;UMPS;UXS1;PCK2;ODC1;GAD1;AZIN1
prerank,pentosyltransferase activity (GO:0016763),0.21085363248069677,0.6653061210068353,0.9527896995708155,1.0,1.0,14/36,24.81%,PARP16;SIRT2;PARP11;TIPARP;SIRT6;PARP4;PARP3;PARP1;ZC3HAV1;TNKS;SIRT3;SIRT1;LACC1;PARP8
prerank,SUMO transferase activity (GO:0019789),0.2540468345625176,0.66502113171462,0.8632286995515696,1.0,1.0,5/16,18.37%,MDM2;TOPORS;PIAS1;PIAS2;NSMCE2
prerank,CoA hydrolase activity (GO:0016289),-0.2492439046906247,-0.6645843040348064,0.9032882011605415,0.990553916254961,1.0,10/16,41.34%,ACAA2;ACOT8;HIBCH;ACOT2;ACOT13;ACOT1;ACOT6;ACOT12;ACOT7;ABCD1
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.2383822271531596,-0.6605282184601983,0.9223484848484849,0.9908941849051545,1.0,2/20,5.05%,TJP2;MAGI3
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.25384027916742236,0.6595430959717251,0.8796498905908097,1.0,1.0,3/16,13.05%,MTMR7;PTEN;MTMR10
prerank,general transcription initiation factor binding (GO:0140296),-0.22451276701296058,-0.6568648074690783,0.9212880143112702,0.9907829595416556,1.0,6/25,17.07%,ESR1;HHEX;PSMC5;DRAP1;PSMC1;RELA
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.2592820032601661,0.6534544507467811,0.8776371308016878,1.0,1.0,5/14,19.75%,KMO;MICAL1;CYB5R4;AIFM1;NOX4
prerank,serine-type peptidase activity (GO:0008236),-0.16490371410759777,-0.6530305692282481,0.9940476190476191,0.9908314237030676,1.0,6/96,5.95%,DPP4;F3;FAP;TPP1;RHBDD1;PIK3IP1
prerank,AMP binding (GO:0016208),0.2741145089412509,0.6494735753833724,0.8969072164948454,1.0,1.0,4/11,20.96%,PRKAG2;ACSS2;APRT;MPPED2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.2700775449444991,0.6490601178070633,0.8508771929824561,1.0,1.0,3/11,19.35%,DDAH2;PADI1;PADI2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.2687804497436997,0.6475009042160498,0.8626126126126126,1.0,1.0,6/11,24.56%,HSPBP1;HSPH1;BAG3;GRPEL2;BAG4;SIL1
prerank,adenyl nucleotide binding (GO:0030554),0.2687804497436997,0.6475009042160498,0.8626126126126126,1.0,1.0,6/11,24.56%,HSPBP1;HSPH1;BAG3;GRPEL2;BAG4;SIL1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.22869835023265356,0.6443608422996433,0.920997920997921,1.0,1.0,2/21,6.23%,KL;NPTN
prerank,lipoprotein particle receptor binding (GO:0070325),0.2136157601230424,0.6414993865601883,0.919661733615222,1.0,1.0,10/27,25.27%,LRP1;SYT1;HSP90B1;HSPG2;LDLRAP1;CRP;APBB3;LANCL1;RELN;CLTC
prerank,lysophospholipase activity (GO:0004622),-0.22761286122095867,-0.6406216921984794,0.9264705882352942,0.9969146125352503,1.0,9/20,36.30%,MGLL;LYPLA1;GDE1;ENPP2;PLA2G4B;ABHD16A;PLB1;LYPLAL1;LYPLA2
prerank,dynactin binding (GO:0034452),0.26641545347447193,0.6404112972024819,0.873015873015873,1.0,1.0,7/12,27.92%,BICD1;MAPT;SNX6;BBS4;BICDL1;SNX5;PAFAH1B1
prerank,vitamin D receptor binding (GO:0042809),-0.24822277512976162,-0.6364091820426208,0.9261992619926199,0.9968272978516788,1.0,3/14,22.43%,MED24;MED14;MED13
prerank,diacylglycerol kinase activity (GO:0004143),-0.2698445388808046,-0.6359491716258108,0.8861209964412812,0.9943007525524219,1.0,1/11,1.69%,DGKH
prerank,ubiquitin-specific protease binding (GO:1990381),0.2377044283052804,0.635387738744517,0.9142259414225942,1.0,1.0,5/19,16.84%,PRKN;SUMO1;PTEN;SART3;SPATA2
prerank,pseudouridine synthase activity (GO:0009982),0.2512915671389612,0.634965118595943,0.9214876033057852,1.0,1.0,5/13,22.80%,RPUSD2;RPUSD3;PUS7;PUS1;PUS10
prerank,neuropeptide hormone activity (GO:0005184),-0.21846655627343223,-0.6331269326426202,0.9407407407407408,0.9931951288858863,1.0,15/22,54.64%,AGRP;SPX;NPFF;ADCYAP1;NPY;VIP;GAL;CALCB;PENK;UCN;NMB;GRP;NPPA;GHRH;QRFP
prerank,cardiolipin binding (GO:1901612),0.2708627542790692,0.6302518674891622,0.9040178571428571,1.0,1.0,2/10,13.50%,GSDMD;GSDME
prerank,RNA methyltransferase activity (GO:0008173),0.23556531535885908,0.6297666176420691,0.9285714285714286,1.0,1.0,5/19,16.82%,FTSJ1;HENMT1;METTL3;BCDIN3D;METTL8
prerank,H4 histone acetyltransferase activity (GO:0010485),0.2693743343989209,0.6231501479994295,0.897196261682243,1.0,1.0,5/10,22.86%,KAT8;EP300;ATF2;MSL3;NAA40
prerank,tau-protein kinase activity (GO:0050321),0.2213776365480014,0.6211842828329647,0.9375,1.0,1.0,2/20,10.85%,ROCK2;BRSK1
prerank,endonuclease activity (GO:0004519),0.18344444934302767,0.6168534125041706,0.9753593429158111,1.0,1.0,14/49,23.08%,SETMAR;NYNRIN;EXOG;ANG;PIWIL2;ANKLE1;RCL1;RNASEL;AGO3;AGO1;AGO2;ZRANB3;APLF;DICER1
prerank,serine-type endopeptidase activity (GO:0004252),0.16582292155560185,0.6165175139431035,0.9898373983739838,1.0,1.0,6/80,9.83%,PRTN3;RHBDL3;CORIN;PLG;PCSK2;PARL
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.25661822198910605,-0.6129324606987672,0.9349005424954792,1.0,1.0,4/10,30.78%,GALM;RENBP;GALE;GNE
prerank,mRNA methyltransferase activity (GO:0008174),-0.24380827977003308,-0.6108459044276363,0.9236234458259325,1.0,1.0,3/12,18.60%,TRMT10C;PCIF1;TRMT61B
prerank,endopeptidase regulator activity (GO:0061135),0.18517732564801,0.6106033905332393,0.9686192468619247,1.0,1.0,5/40,12.14%,AHSG;RECK;PSMF1;PSME3;SPINK1
prerank,peptidase inhibitor activity (GO:0030414),0.193331297375551,0.6083361688705456,0.9764957264957265,1.0,1.0,2/33,2.53%,AHSG;RECK
prerank,mannose binding (GO:0005537),0.24648658901665388,0.6078934299348562,0.921875,1.0,1.0,1/12,4.55%,LMAN1L
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.20583809334396494,0.6066820206759053,0.9567901234567902,1.0,1.0,11/27,26.21%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;PRIM1;POLR2B;CRCP;POLR3K;MED21;POLR3F
prerank,heme binding (GO:0020037),0.167611564307927,0.604172466119275,0.9918032786885246,1.0,1.0,15/65,19.75%,CYP27A1;PTGIS;CYP2A6;PTGES2;TDO2;CYP46A1;CYB5R4;HCCS;BACH1;CYP26B1;CYP51A1;HEBP1;EIF2AK1;PTGS2;NOX4
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),-0.17827216292490505,-0.5967829569932038,0.9885496183206107,1.0,1.0,14/40,32.70%,PRMT8;CARNMT1;ICMT;LCMT1;MEPCE;NNMT;PEMT;METTL2A;METTL2B;METTL18;GNMT;PCMTD2;COMTD1;DPH5
prerank,calcium-activated potassium channel activity (GO:0015269),0.24315842329902093,0.5864318361987424,0.9387755102040817,1.0,1.0,11/11,75.70%,KCNMA1;KCNN1;KCNU1;KCNN2;KCNMB3;KCNMB2;PKD2L1;KCNN4;KCNMB1;KCNMB4;KCNN3
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",-0.19866464446072507,-0.5851859943648214,0.9675675675675676,1.0,1.0,1/24,0.61%,ITPKB
prerank,ubiquitin conjugating enzyme activity (GO:0061631),-0.18951127035323406,-0.5816370305080194,0.9749478079331941,1.0,1.0,5/31,14.47%,UBE2Q2;UBE2L6;UBE2G2;UBE2Q1;UBE2G1
prerank,telomerase RNA binding (GO:0070034),-0.2014105807574133,-0.5790854926195633,0.9862068965517241,1.0,1.0,10/22,35.68%,SNRPD3;DKC1;SMG7;SNRPB;SMG6;TERT;HNRNPC;DCP2;WRAP53;NOP10
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),-0.22793991687942805,-0.5715341772622962,0.9615384615384616,1.0,1.0,3/13,21.70%,AGPAT1;AGPAT5;LPCAT2
prerank,muscle alpha-actinin binding (GO:0051371),0.2181688141756462,0.569647254421243,0.9488888888888889,1.0,1.0,7/15,26.24%,PDLIM2;PDLIM5;LDB3;PRICKLE4;PALLD;PDLIM7;SYNPO2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.19042938896881248,0.5631910513494278,0.9671457905544147,1.0,1.0,11/27,26.21%,POLR1A;POLR2G;POLR1B;POLR3H;POLR2D;TENT2;POLR2B;CRCP;POLR3K;MED21;POLR3F
prerank,chemokine receptor binding (GO:0042379),0.17336862059350303,0.5599898324986403,0.9877551020408163,1.0,1.0,6/35,18.42%,CXCL16;PPBP;CCL25;CXCL1;CKLF;CXCL12
prerank,lysine N-methyltransferase activity (GO:0016278),0.19450831896107443,0.5565576665135729,0.9773242630385488,1.0,1.0,3/20,11.57%,METTL21A;SETD7;EHMT2
prerank,3'-5' DNA helicase activity (GO:0043138),0.2144702701419788,0.5541870524888672,0.9723502304147466,1.0,1.0,6/16,23.13%,BLM;MCM2;FANCM;NAV2;FBH1;MCM7
prerank,receptor antagonist activity (GO:0048019),0.20453436395154162,0.5538675372668606,0.9611231101511879,1.0,1.0,1/17,3.34%,DKK3
prerank,DNA polymerase activity (GO:0034061),-0.19199908551955722,-0.5528817490424606,0.9758364312267658,1.0,1.0,10/22,34.22%,REV3L;POLQ;POLK;POLE3;POLL;CHRAC1;POLB;TERT;POLE;POLA1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",-0.14590313251230957,-0.5523248700907283,1.0,1.0,1.0,9/75,18.03%,ABCC4;ME1;KDSR;IMPDH1;LDHA;ME2;SPR;CBR1;HSD17B10
prerank,alpha-actinin binding (GO:0051393),0.19159169411442198,0.5522196419873461,0.9813953488372092,1.0,1.0,6/24,18.82%,PDLIM2;MAGI1;PDLIM5;DAG1;LDB3;PPARG
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.23596028715066042,-0.5485371119231286,0.9708029197080292,1.0,1.0,2/10,15.59%,OTUD5;TNFAIP3
prerank,ribonuclease activity (GO:0004540),-0.15275707777108327,-0.5465279701861382,0.9922178988326849,1.0,1.0,20/56,35.81%,CNOT7;N4BP1;PPP1R8;NOB1;DIS3L2;SAMHD1;RNASE12;EXOSC8;RNASEK;TSNAX;EXOSC9;ERN1;SMG6;ENDOG;RNASE7;RPP40;ZC3H12D;PIWIL4;RNASEH2A;ENDOU
prerank,enoyl-CoA hydratase activity (GO:0004300),0.22994390500473494,0.5406591927305215,0.9682539682539683,1.0,1.0,1/10,4.94%,ECHDC2
prerank,adenylyltransferase activity (GO:0070566),-0.18664462751969219,-0.5338772317227981,0.9867424242424242,1.0,1.0,8/21,32.96%,OAS2;PAPOLG;NMNAT3;SELENOO;FICD;NMNAT2;KARS1;ABL1
prerank,neuropeptide receptor activity (GO:0008188),0.17318084705290915,0.5240377534141832,0.9868131868131869,1.0,1.0,29/29,82.71%,SORCS1;NPY5R;GRPR;GALR1;OPRM1;TACR3;SORCS3;TACR1;HCRTR2;GPR37;SSTR5;GALR3;GALR2;NPSR1;SSTR4;MCHR1;TACR2;GAL;NPFFR1;NTSR1;NMUR1;SSTR1;NPY2R;GPR143;SORCS2;SSTR2;KISS1R;NMUR2;NPY1R
prerank,N-methyltransferase activity (GO:0008170),0.18782467154916477,0.5212858495490976,0.9704545454545455,1.0,1.0,6/20,23.77%,HNMT;DIMT1;TFB1M;TRMT1L;METTL15;RNMT
prerank,acyl-CoA hydrolase activity (GO:0047617),0.19115721114834894,0.510997134216084,0.9774127310061602,1.0,1.0,2/17,7.30%,BAAT;ACOT11
prerank,tRNA methyltransferase activity (GO:0008175),-0.19121292269132215,-0.5008763090926965,0.9909255898366606,1.0,1.0,7/16,32.80%,TRMT9B;TRDMT1;TRMT44;TYW3;METTL2A;METTL2B;TRMT13
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.17889104915343856,0.5000023829546445,0.9827586206896551,1.0,1.0,7/21,21.10%,POLN;POLE4;POLI;POLD4;POLD1;POLD3;POLM
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.20737098790764558,0.4948582125704731,0.9697674418604652,0.9980980019174092,1.0,3/11,21.07%,SLC25A42;SLC25A24;SLC19A1
prerank,peptide N-acetyltransferase activity (GO:0034212),-0.21559457231748813,-0.49467100640307116,0.9837251356238698,1.0,1.0,6/10,50.19%,NAA60;NAA50;NAA80;NAA11;NAA25;NAA10
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.20127433612615128,0.48736676361311626,0.9786729857819905,0.9962375311140217,1.0,3/12,21.07%,SLC25A42;SLC25A24;SLC19A1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.20551689914323013,0.4806761872704762,0.980349344978166,0.9942859127420713,1.0,2/10,17.91%,DPYSL3;DPYSL2
prerank,O-acyltransferase activity (GO:0008374),-0.1573401193564029,-0.47895929488177125,0.9981167608286252,1.0,1.0,6/30,21.70%,LPCAT3;MBOAT7;MBOAT1;PIGW;LCAT;LPCAT2
prerank,neuropeptide binding (GO:0042923),0.17242222875823138,0.463603411743877,0.9938271604938271,0.9938113357458985,1.0,1/18,5.02%,OPRK1
prerank,tRNA-specific ribonuclease activity (GO:0004549),-0.18034773538888477,-0.4607901481429304,0.9924242424242424,1.0,1.0,9/14,51.02%,RPP38;RPP21;TSEN2;RPP40;RPP30;RPP25;ELAC2;TSEN34;POP5
prerank,ribonuclease P RNA binding (GO:0033204),-0.1913101501254495,-0.44924531062147754,0.9923371647509579,1.0,1.0,5/10,43.91%,RPP38;RPP21;RPP40;RPP30;RPP25
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),-0.17474265628922922,-0.41785898519979736,0.9963898916967509,1.0,1.0,11/11,82.54%,NAA60;NAA50;NAA80;NAA11;NAA25;NAA10;NAA30;NAA16;NAA15;NAA40;NAA20
prerank,ribonuclease P activity (GO:0004526),-0.1424633456443226,-0.34059559817061014,1.0,0.9999295007022815,1.0,2/11,19.88%,RPP38;RPP21
